Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.7616518146520084,-2.0537553668452104,0.0,0.0058993250553866766,0.006,10/19,8.98%,GRM3;GRIK1;GRM5;GRM1;GRM7;GRIA4;GRIA2;GRID2;GRM8;GRIK2
prerank,solute:sodium symporter activity (GO:0015370),0.8329940022478634,2.0303093940371704,0.0,0.0030255931123005855,0.003,3/27,1.06%,SLC4A10;SLC4A4;SLC5A6
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.5471830520012065,-1.8951969283830492,0.0,0.09684725299259794,0.16,33/57,26.44%,COX4I1;CYB5A;UQCR10;UQCRH;NDUFA8;COX8A;COX6B1;NDUFB3;NDUFS4;COX6A1;NDUFA6;COX5B;NDUFS3;UQCR11;NDUFA12;NDUFC2;NDUFS2;NDUFB7;NDUFA1;NDUFB8;COX10;NDUFA3;NDUFB9;NDUFB4;NDUFS5;NDUFC1;NDUFA4L2;NDUFA10;UQCRFS1;NDUFA9;NDUFA5;COX4I2;NDUFS6
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.7682457712815706,1.8805479305374566,0.0,0.11900666241715639,0.182,8/27,8.41%,SLC9A2;SLC9B2;SLC23A1;CNNM4;SLC9C1;SLC9A8;SLC4A8;PKD2L1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.8166342372571809,-1.878946967314921,0.0,0.07800218684344606,0.191,3/10,3.21%,SLC6A13;SLC6A12;SLC6A1
prerank,retinoic acid binding (GO:0001972),-0.7634757171807234,-1.8595414289655923,0.0,0.07570800487746235,0.238,2/12,1.91%,NR2F2;CYP26B1
prerank,outward rectifier potassium channel activity (GO:0015271),-0.7834357015648048,-1.8533949233254752,0.002197802197802198,0.06685901729438233,0.258,6/11,12.56%,KCNK2;KCNT2;KCNQ1;KCND3;KCND2;KCNT1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.8804307093934767,1.84320032321447,0.001851851851851852,0.1640543820891873,0.331,2/11,0.26%,SLC23A1;SLC23A2
prerank,metalloendopeptidase activity (GO:0004222),0.6367532384711686,1.8409042723626643,0.0012626262626262627,0.1283355745134165,0.343,16/76,8.30%,ADAMTSL3;TRABD2B;ADAMTSL1;THSD4;ADAMTS17;MMP28;ADAMTS2;ADAMTSL5;ADAM9;PHEX;ADAMTS5;MMP16;MMP14;IDE;NLN;ADAM10
prerank,retinoid binding (GO:0005501),-0.6342952896539387,-1.813497009327792,0.002840909090909091,0.09717499327345275,0.406,6/22,2.28%,ALDH1A2;PTGDS;NR2F2;ABCA4;CYP26B1;RBP4
prerank,metal ion:proton antiporter activity (GO:0051139),0.834744211514294,1.8019981302700905,0.00505902192242833,0.19787378954445833,0.559,4/13,6.83%,SLC9A2;SLC9B2;SLC9C1;SLC9A8
prerank,symporter activity (GO:0015293),0.8792635440425389,1.789423725932273,0.00686106346483705,0.20338709254909493,0.621,2/10,1.06%,SLC4A4;SLC5A6
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.8411778400559596,1.78346891188064,0.006825938566552901,0.19349388332474698,0.654,4/12,6.83%,SLC9A2;SLC9B2;SLC9C1;SLC9A8
prerank,sulfate transmembrane transporter activity (GO:0015116),0.8226868044570778,1.780639076296351,0.0016863406408094434,0.1767450643102259,0.668,2/14,0.36%,SLC26A7;SLC26A2
prerank,anion:anion antiporter activity (GO:0015301),0.7985724222845081,1.773651511913133,0.0016474464579901153,0.17469998748431903,0.713,2/17,0.36%,SLC26A7;SLC26A2
prerank,cell adhesion mediator activity (GO:0098631),-0.6134065025451558,-1.759229631524352,0.005333333333333333,0.15773671517141044,0.628,11/24,10.98%,BSG;ESAM;LRRC4C;CD47;CNTN4;CNTN2;JAM3;ROBO4;SIRPA;NINJ1;PALLD
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.7025193080065149,1.751799832935155,0.00727802037845706,0.2142119923508815,0.82,5/31,5.21%,KCNK5;SLC12A7;SLC12A2;SLC12A8;KCNK7
prerank,sodium:proton antiporter activity (GO:0015385),0.8413296564955753,1.739175424504615,0.008695652173913044,0.232420561808545,0.868,4/11,6.83%,SLC9A2;SLC9B2;SLC9C1;SLC9A8
prerank,metal ion transmembrane transporter activity (GO:0046873),0.7060861072382626,1.7186679167619539,0.007575757575757576,0.27524492896623387,0.92,9/27,7.46%,SLC9B2;SLC23A1;SLC12A2;CNNM2;CNNM4;CLDN16;ITPR2;SLC4A8;ATP2B4
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.7877805803040944,1.713433764848388,0.008130081300813009,0.2712948490696192,0.926,2/15,0.36%,SLC26A7;SLC26A2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.7572443711048952,1.7118034430854765,0.009316770186335404,0.25775171799551183,0.928,6/18,5.13%,STXBP6;BAIAP2L1;ANXA1;ANXA2;TMOD3;PDLIM5
prerank,monocarboxylic acid binding (GO:0033293),-0.6328144091576512,-1.7046946694992269,0.013089005235602094,0.24506779500918818,0.819,5/18,14.43%,NR2F2;CYP26B1;PSAP;NAPEPLD;NR1H4
prerank,cation:chloride symporter activity (GO:0015377),0.8389695836097384,1.7014624432035417,0.008620689655172414,0.27035355343468126,0.946,3/10,1.55%,SLC12A7;SLC12A2;SLC12A8
prerank,chloride transmembrane transporter activity (GO:0015108),0.7769811640414197,1.695062558769604,0.008223684210526315,0.27205124734769437,0.953,2/16,0.36%,SLC26A7;SLC26A2
prerank,potassium ion antiporter activity (GO:0022821),0.7517135394236966,1.6877441599787684,0.01644736842105263,0.27770198742507923,0.961,4/15,6.83%,SLC9A2;SLC24A3;SLC9C1;SLC9A8
prerank,organic anion transmembrane transporter activity (GO:0008514),0.5493229477442192,1.6852702108059439,0.003432494279176201,0.2701182295259468,0.966,20/134,6.88%,SLC26A7;SLC38A2;SLC23A1;SLC23A2;SLC26A2;SLCO3A1;SLC38A1;SLC5A6;SLC6A7;SLCO4A1;SLC16A1;SLCO2A1;ABCG2;SLC7A2;SLC38A6;SFXN1;SLC38A7;SFXN2;ABCC4;SLC4A8
prerank,metallopeptidase activity (GO:0008237),0.5504886869467785,1.6710598064775675,0.0011904761904761906,0.2986313482421596,0.981,29/113,14.54%,ADAMTSL3;TRABD2B;ADAMTSL1;THSD4;ADAMTS17;MMP28;ADAMTS2;ADAMTSL5;BMP1;ADAM9;ADAM12;PHEX;ADAMTS5;MMP16;MMP14;IDE;NLN;ADAM10;ERAP1;LAP3;PMPCB;OMA1;MYSM1;ADAM8;SPG7;PITRM1;METAP1D;COPS5;ADAMTS18
prerank,MAP kinase kinase kinase activity (GO:0004709),0.8095461082854107,1.6639682005943768,0.014760147601476014,0.3057866105498459,0.985,2/11,0.80%,EGFR;MAP3K5
prerank,5'-nucleotidase activity (GO:0008253),0.796517188756714,1.658280875889112,0.017152658662092625,0.3087065480296534,0.988,4/13,8.56%,NT5E;NT5C1A;NT5DC3;ACP3
prerank,receptor antagonist activity (GO:0048019),0.7267077391187062,1.655886692018963,0.023769100169779286,0.3025593112300586,0.989,6/17,9.66%,ESR2;LRPAP1;ADH7;IGSF1;IL18BP;AGTR2
prerank,histone acetyltransferase activity (GO:0004402),0.6609509094235363,1.6499309531221567,0.009146341463414634,0.3076896647683074,0.995,17/30,17.41%,KAT6B;NAA40;EP300;TADA3;KAT2A;CREBBP;KAT5;BRCA2;TAF1;USP22;BAZ1A;TAF9;KAT2B;SRCAP;KAT14;EPC1;ATF2
prerank,potassium:proton antiporter activity (GO:0015386),0.808267327339901,1.6440897904976575,0.02434782608695652,0.3128127101106328,0.995,5/10,13.01%,SLC9A2;SLC9C1;SLC9A8;SLC9A1;SLC9A3
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6496510483112309,1.6384766059101505,0.0237741456166419,0.31833273665551903,0.997,8/32,5.71%,SLC38A2;SLC38A1;SLC6A7;SLC6A19;SLC38A6;SFXN1;SLC38A7;SFXN2
prerank,nucleotidase activity (GO:0008252),0.7673239551650698,1.6343018499653263,0.015306122448979591,0.3190061250712823,0.997,4/15,8.56%,NT5E;NT5C1A;NT5DC3;ACP3
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.768395613759783,1.631075626660074,0.026622296173044926,0.3170522757679923,0.997,3/13,2.58%,BMP4;BMP5;BMP6
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.5359435723168331,-1.623542096271078,0.012195121951219513,0.41029805760214333,0.979,22/34,30.59%,NDUFA8;NDUFB3;NDUFS4;NDUFA6;NDUFS3;NDUFA12;NDUFC2;NDUFS2;NDUFB7;NDUFA1;NDUFB8;NDUFA3;NDUFB9;NDUFB4;NDUFS5;NDUFC1;NDUFA10;NDUFA9;NDUFA5;NDUFS6;NDUFS1;NDUFA2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.5359435723168331,-1.623542096271078,0.012195121951219513,0.41029805760214333,0.979,22/34,30.59%,NDUFA8;NDUFB3;NDUFS4;NDUFA6;NDUFS3;NDUFA12;NDUFC2;NDUFS2;NDUFB7;NDUFA1;NDUFB8;NDUFA3;NDUFB9;NDUFB4;NDUFS5;NDUFC1;NDUFA10;NDUFA9;NDUFA5;NDUFS6;NDUFS1;NDUFA2
prerank,cAMP binding (GO:0030552),-0.6868375438953706,-1.6211457349431926,0.024271844660194174,0.37961262894283654,0.98,7/11,8.85%,RAPGEF4;PDE4B;RAPGEF2;HCN1;PDE4A;PDE4D;PDE2A
prerank,gated channel activity (GO:0022836),0.7468041667508387,1.6162365508436083,0.028428093645484948,0.35168918033932045,0.999,3/14,2.90%,PIEZO2;TMC6;TMC1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.5980713052081146,1.6148015140975274,0.017735334242837655,0.34418729922343566,0.999,11/46,9.59%,MGAT4C;EXT1;MGAT3;B3GNT2;LARGE1;GCNT2;HEXA;POMGNT2;B4GAT1;B3GNT6;GCNT4
prerank,BMP receptor binding (GO:0070700),0.7683972218499776,1.6075739814848153,0.03685092127303183,0.3565157217327524,0.999,3/12,2.58%,BMP4;BMP5;BMP6
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.6645419483902545,-1.6067927665142285,0.0225,0.3973031554662499,0.983,11/12,17.96%,PDE8B;PDE4B;PDE7B;PDE4A;PDE4D;PDE2A;PDE1B;PDE3A;PDE3B;PDE4C;PDE8A
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6681299796429103,-1.6064755725690623,0.02493765586034913,0.3675733303740929,0.983,8/13,16.55%,ALDH1A2;ALDH1A1;ALDH7A1;ALDH9A1;ALDH1L1;ALDH4A1;ADH5;ALDH1A3
prerank,mechanosensitive ion channel activity (GO:0008381),0.754505860549318,1.605619274835631,0.035653650254668934,0.3512616003603164,0.999,3/12,2.90%,PIEZO2;TMC6;TMC1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.6243325450503555,-1.601263515391113,0.038929440389294405,0.35578548488796313,0.984,4/14,6.19%,SLC7A11;SLC1A3;SLC1A1;SLC1A2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.580728858557955,1.5935101779079297,0.02127659574468085,0.3801216513276809,0.999,9/55,5.58%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC16A9;SLC16A1;SLC7A2;SLC38A6;SLC38A7
prerank,cytochrome-c oxidase activity (GO:0004129),-0.6125619571868396,-1.5883119459348678,0.03299492385786802,0.3681178834561286,0.986,8/15,21.48%,COX4I1;CYB5A;COX8A;COX6B1;COX6A1;COX5B;COX10;NDUFA4L2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6295265639507696,-1.5873496309042656,0.031331592689295036,0.3475685678465317,0.987,7/15,16.55%,ALDH1A2;ALDH1A1;ALDH7A1;ALDH9A1;ALDH1L1;ALDH4A1;ALDH1A3
prerank,sterol transfer activity (GO:0120015),-0.5923188287241068,-1.5829071239643708,0.028277634961439587,0.33874849852352706,0.988,6/17,11.94%,PLTP;ABCA1;GRAMD1B;NPC2;OSBP;STARD5
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.59412372858928,1.5768487492031542,0.02631578947368421,0.4246526898526934,1.0,8/48,6.50%,PIEZO2;SLC12A7;SLC12A2;TRPM6;NALCN;TRPM4;CALHM2;CALHM5
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.5586528793857793,-1.571628069702989,0.03299492385786802,0.33093143622103327,0.991,6/21,9.56%,CDK8;CDK14;CDK19;CDK6;CDK15;CDK10
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.5586528793857793,-1.571628069702989,0.03299492385786802,0.33093143622103327,0.991,6/21,9.56%,CDK8;CDK14;CDK19;CDK6;CDK15;CDK10
prerank,delayed rectifier potassium channel activity (GO:0005251),0.6337814010107164,1.5687099157961673,0.03254437869822485,0.44043143658273626,1.0,4/32,4.00%,KCNB2;KCNQ5;KCNS3;KCNB1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5764552240189516,1.5660806522614117,0.02766798418972332,0.43793299162613625,1.0,8/53,5.58%,SLC47A1;SLC38A2;SLC38A1;SLC6A7;SLC7A2;SLC38A6;SFXN1;SLC38A7
prerank,phosphatase activator activity (GO:0019211),-0.6238748183964617,-1.5653357938435282,0.03307888040712468,0.3286415666271661,0.994,5/14,11.18%,CALM1;BMP2;CALM3;FRS2;PPP2R5A
prerank,lysine-acetylated histone binding (GO:0070577),0.6749911133119287,1.5604422872920447,0.043478260869565216,0.43255078467655855,1.0,8/20,14.38%,MLLT3;ZMYND8;SMARCA4;BRD9;TAF1;BAZ2A;BRD3;CARM1
prerank,acetylation-dependent protein binding (GO:0140033),0.6749911133119287,1.5604422872920447,0.043478260869565216,0.43255078467655855,1.0,8/20,14.38%,MLLT3;ZMYND8;SMARCA4;BRD9;TAF1;BAZ2A;BRD3;CARM1
prerank,insulin-like growth factor I binding (GO:0031994),-0.6137057158233961,-1.5502687719196735,0.03864734299516908,0.3494179594313553,0.998,6/13,4.91%,IGFBP2;IGF1R;ITGA6;IGFBP3;IGFBP4;INSR
prerank,cholesterol transfer activity (GO:0120020),-0.5907309300068908,-1.5488480507323978,0.030534351145038167,0.337244748999605,0.999,4/16,4.17%,PLTP;ABCA1;GRAMD1B;NPC2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.6294988476917928,1.5428907277744386,0.04215116279069767,0.483112907221119,1.0,2/29,0.36%,SLC26A7;SLC26A2
prerank,cation transmembrane transporter activity (GO:0008324),0.5740919231943722,1.542142930548442,0.04477611940298507,0.4732079347178498,1.0,10/48,8.41%,SLC38A2;SLC38A1;SLC6A7;SLC7A2;SLC38A6;SFXN1;SLC38A7;SFXN2;CHRNE;PKD2L1
prerank,solute:anion antiporter activity (GO:0140323),0.7201043032000182,1.5419739218394524,0.05574324324324324,0.46198285497236363,1.0,2/14,0.36%,SLC26A7;SLC26A2
prerank,adenylate cyclase binding (GO:0008179),-0.6764720530440749,-1.5318668008100802,0.035164835164835165,0.3639199579457013,0.999,5/10,8.48%,ADCY5;CALM1;ADCY2;CAP2;CALM3
prerank,calcium activated cation channel activity (GO:0005227),0.6722646408289449,1.5260105958156753,0.04823151125401929,0.5070205303312169,1.0,6/17,11.35%,KCNMB3;KCNMB2;ANO6;TRPM4;PKD2L1;ANO10
prerank,calcium-activated potassium channel activity (GO:0015269),0.7192578420264875,1.5238698192591296,0.06525573192239859,0.5024405577918846,1.0,2/11,0.60%,KCNMB3;KCNMB2
prerank,rRNA binding (GO:0019843),-0.4618675959017259,-1.514412545933087,0.021739130434782608,0.39480413582473195,0.999,17/42,26.03%,RPS14;RPS9;RPS5;RPL5;RPS13;RPL23;RPS3;FASTKD2;EMG1;RPL12;RPL11;MRPS11;RPLP0;MRPL11;RCC1L;MTERF4;MRPS6
prerank,microtubule plus-end binding (GO:0051010),0.653064312174225,1.5114425480451308,0.06591639871382636,0.5336536440633739,1.0,6/20,11.24%,MAPRE2;CLIP4;PAFAH1B1;CLIP1;FBXW11;KIF2C
prerank,gap junction channel activity (GO:0005243),-0.5258746777553021,-1.5025490945910271,0.025787965616045846,0.4093738300101328,1.0,5/22,7.25%,GJB6;GJB2;GJC1;GJD3;GJA1
prerank,chemoattractant activity (GO:0042056),0.6107657805478347,1.5009851329233632,0.0530421216848674,0.5621872898893673,1.0,4/26,7.51%,BMP4;PGF;GDNF;FGF2
prerank,wide pore channel activity (GO:0022829),-0.519337893607338,-1.4978413352685536,0.02932551319648094,0.40546514899907654,1.0,5/23,7.25%,GJB6;GJB2;GJC1;GJD3;GJA1
prerank,GTPase regulator activity (GO:0030695),-0.34787401933548834,-1.4967832998442632,0.014084507042253521,0.3929605967449236,1.0,63/212,12.87%,RANBP3L;ASAP1;PLCB1;PREX2;ARHGAP29;ARHGAP28;TBC1D4;CHN2;ERRFI1;ARHGAP24;ARHGAP32;RASGRP3;ALDH1A1;RABGAP1L;RGS3;RGS5;RAPGEF2;CPEB2;CHN1;USP6NL;RGS7;RALGAPA2;RIMS1;RGS12;TNK2;CCDC88A;ARAP3;ARHGAP26;TBC1D12;GPSM1;RALGAPA1;GMIP;IQGAP2;ARL2BP;ARHGAP25;ARHGAP15;ARRB1;OPHN1;GPS2;RHOH;TBC1D9;ACAP2;SIRPA;STARD8;PREX1;SGSM1;TBC1D8;VAV3;LRRK2;SMAP2;RP2;GARNL3;TBC1D2;TBC1D16;SEC23B;ARHGAP39;BNIP2;TBC1D1;IPO5;RABGAP1;RGS16;RANBP3;SH3BP4
prerank,transmitter-gated ion channel activity (GO:0022824),-0.4975255293472764,-1.4938489621299165,0.038781163434903045,0.3855630304056292,1.0,17/29,25.25%,GRIK1;GABRG3;GRIA4;GRIA2;GRID2;GABRA1;GABRA2;GRIK2;GABRB2;GABRB1;GABRA4;GABRG1;GLRA3;GRIK3;GABRB3;GRID1;GABRA5
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6858685127060261,1.4888552108789694,0.08006814310051108,0.5958849605173924,1.0,4/14,8.13%,CAPN5;CAPN2;CAPN6;CAPN10
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5577365966087335,1.4864544898156047,0.04223433242506812,0.5921392665001031,1.0,7/47,5.58%,SLC47A1;SLC38A2;SLC38A1;SLC7A2;SLC6A19;SLC38A6;SLC38A7
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.4688830968980196,1.4820696176369605,0.012141280353200883,0.5959130944801388,1.0,56/188,14.70%,BNC2;VSX1;TCF7L2;SIX1;HDAC4;FOXO3;PBX1;GRHL1;CRY2;KLF4;SMAD6;FOXK1;EGR2;DDIT3;NFE2L2;ARID4A;GATA1;CTCFL;ZBED4;FOXC2;NFKB1;HNF4A;HNF1A;TFAP2A;TBL1X;JUN;GLIS2;CREB3L3;ETV5;GATA4;CALCOCO1;NFYA;PER2;ARID4B;FOXA1;FOXK2;GATA3;NKX2-1;GABPB1;GABPB2;RNF10;IRF1;TAF9;REST;RXRA;STAT3;FOXC1;CIITA;XRCC5;CEBPB;HNRNPL;TFE3;KMT2D;CARM1;TFEB;PER3
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.5610100056253131,-1.4814184544766542,0.05167958656330749,0.39135466936873503,1.0,4/16,3.75%,PTPRG;PTPRM;PTPRB;PTPRT
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.5610100056253131,-1.4814184544766542,0.05167958656330749,0.39135466936873503,1.0,4/16,3.75%,PTPRG;PTPRM;PTPRB;PTPRT
prerank,cytokine activity (GO:0005125),0.4833290687653558,1.4761928399655573,0.024447031431897557,0.605286710966356,1.0,17/131,7.91%,TNFRSF11B;BMP4;BMP5;WNT9A;TGFB3;WNT11;INHBA;BMP6;GDF6;IL10;GDF5;WNT16;BMP15;TNFSF11;CLCF1;FGF2;FAM3C
prerank,phospholipase inhibitor activity (GO:0004859),0.7147339351599507,1.4737434820623598,0.08545454545454545,0.6026693327977787,1.0,3/10,3.89%,ANXA1;ANXA2;ANXA4
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.7018459814914115,1.4718450551891338,0.07078039927404718,0.5973731040926277,1.0,2/12,6.84%,AOX1;FDX1
prerank,androgen receptor binding (GO:0050681),0.610062790818132,1.470702980396491,0.08,0.5899906568986143,1.0,6/25,8.85%,FOXP1;DDX5;EP300;TGFB1I1;KDM1A;SMARCA4
prerank,ATPase binding (GO:0051117),0.5112755428408714,1.4696783089105174,0.04392764857881137,0.5819611982544318,1.0,9/71,4.72%,EGFR;SLC2A13;PTPN3;ANK2;ATP1B1;EZR;PPP3CA;ATP6V0A4;TOR1AIP1
prerank,glucuronosyltransferase activity (GO:0015020),0.6289006984670696,1.469041352965718,0.08695652173913043,0.5736448425371915,1.0,4/19,12.90%,EXT1;LARGE1;B4GAT1;LARGE2
prerank,potassium channel activity (GO:0005267),0.4988781616593891,1.4672869734980027,0.03337453646477132,0.5694838591374659,1.0,8/89,5.21%,KCNB2;KCNK5;KCNMB3;KCNMB2;KCNQ5;KCNS3;KCNB1;KCNK7
prerank,ephrin receptor activity (GO:0005003),-0.5391925834198286,-1.4667202916607913,0.059113300492610835,0.40198369635220776,1.0,6/17,10.39%,EPHA7;EPHB4;EPHB1;EPHA4;EPHA8;EFNB3
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5391925834198286,-1.4667202916607913,0.059113300492610835,0.40198369635220776,1.0,6/17,10.39%,EPHA7;EPHB4;EPHB1;EPHA4;EPHA8;EFNB3
prerank,proton transmembrane transporter activity (GO:0015078),-0.45426732367690953,-1.464541218756435,0.04225352112676056,0.3948376547170921,1.0,14/39,21.48%,SLC33A1;COX4I1;CYB5A;UQCR10;UQCRH;COX8A;COX6B1;COX6A1;COX5B;UQCR11;SLC11A2;COX10;ATP6V1F;NDUFA4L2
prerank,endopeptidase activity (GO:0004175),0.45167958275531933,1.4602720406343834,0.005405405405405406,0.5825091902936529,1.0,40/257,13.54%,ADAMTSL3;F3;TRABD2B;ADAMTSL1;THSD4;ADAMTS17;PCSK5;MMP28;ADAMTS2;HTRA3;USP13;ADAMTSL5;ADAM9;USP46;DDI2;USP24;PHEX;ADAMTS5;MMP16;MMP14;USP2;TASP1;IDE;NLN;USP49;USP7;ADAM10;USP10;USP33;PRSS12;PARL;PMPCB;OMA1;USP34;USP25;USP47;SPG7;PITRM1;PREP;NAPSA
prerank,MHC protein binding (GO:0042287),-0.5118603558724256,-1.4510949733665859,0.07253886010362694,0.41613376248536404,1.0,14/20,41.92%,ATP5F1B;CD81;TAP2;ATP5F1A;CD74;LAG3;ABCB9;LILRB1;TAPBP;TUBB4B;CD8B;COL2A1;KIR3DL2;TAP1
prerank,insulin-like growth factor binding (GO:0005520),-0.5620987508963909,-1.4510289325501813,0.07556675062972293,0.40432850248657354,1.0,6/15,4.91%,IGFBP2;IGF1R;ITGA6;IGFBP3;IGFBP4;INSR
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.7132294455328948,1.4499360476326315,0.10600706713780919,0.6078200448818142,1.0,5/10,16.07%,DSE;GLCE;GALE;GNE;FUOM
prerank,I-SMAD binding (GO:0070411),0.6893051334034687,1.4486146122630001,0.087248322147651,0.6021638034557066,1.0,4/13,7.62%,SMAD9;SMAD6;TGFBR1;TGFB1I1
prerank,protein phosphatase activator activity (GO:0072542),-0.5940178359287616,-1.445710911161513,0.07672634271099744,0.40601558459897374,1.0,4/13,11.18%,IGFBP3;CALM1;CALM3;PPP2R5A
prerank,endopeptidase activator activity (GO:0061133),-0.6239229655290068,-1.4414868772296376,0.08447488584474885,0.4054855901808347,1.0,7/10,25.96%,PSME2;APH1B;PSENEN;VSIR;ADRM1;PSME1;APH1A
prerank,death receptor binding (GO:0005123),0.6514290878018365,1.4390159900568043,0.09735973597359736,0.6270107013588898,1.0,2/15,1.18%,NGF;EDA
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5284648232281114,-1.436899270729824,0.07584269662921349,0.4065876926330975,1.0,7/18,16.55%,ALDH1A2;ALDH1A1;FAR2;ALDH9A1;HSD17B12;ALDH18A1;ALDH1A3
prerank,mRNA 5'-UTR binding (GO:0048027),-0.4833103761064871,-1.434526741023452,0.06983240223463687,0.40193563828217854,1.0,14/24,28.57%,RPS14;RPL41;RPL5;RPS13;RPS7;CCT5;RPL26;MRPS11;MYH10;SHMT2;GNL3;SHMT1;IGF2BP1;RSL1D1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.521814792367265,1.4335887531012048,0.06938775510204082,0.6369984594908549,1.0,5/51,2.33%,SLC4A4;SLCO3A1;SLC5A6;SLCO4A1;SLCO2A1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.5019211779930702,1.4275371020133467,0.05290322580645161,0.6495948412109358,1.0,13/70,10.18%,MGAT4C;EXT1;B3GNT2;LARGE1;GCNT2;HEXA;POGLUT3;POMGNT2;B4GAT1;B3GNT6;GXYLT2;GCNT4;B4GALT1
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.5258589766576948,-1.4269162038667724,0.09813084112149532,0.41056844333384857,1.0,11/16,31.24%,SLC22A4;SLC44A1;SLC22A2;SLC44A2;SLC7A8;SLC22A5;SLC25A26;SLC25A42;SLC22A3;SLC29A4;SLC5A7
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.6479521579584363,1.4262087182040701,0.11855670103092783,0.6440545338233297,1.0,7/15,17.42%,PNPLA3;ABHD4;ABHD5;GPAT3;AGPAT4;LCLAT1;AGPAT5
prerank,cation channel activity (GO:0005261),0.484942488615732,1.4241230438313859,0.04551045510455105,0.6416372059929926,1.0,13/94,6.50%,PIEZO2;KCNK5;SLC24A3;PKD1;TRPM6;ANXA2;ANO6;NALCN;PKD2L2;TRPM4;KCNK7;CALHM2;CALHM5
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.6468166677587387,1.423891601769968,0.12265758091993186,0.6322529098958288,1.0,9/14,20.88%,USP13;MINDY3;OTUD7B;USP7;DESI2;USP9X;MINDY2;OTUD5;MINDY4
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.5858544100286203,1.4232556833657863,0.09682299546142209,0.6248164942849908,1.0,6/27,9.87%,SLC26A7;SLC26A2;AQP6;SLC39A14;SLC25A14;SLC26A6
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.7067830927961535,1.416809102632793,0.1054481546572935,0.6372830046231895,1.0,5/10,7.87%,CXADR;DSP;DSG2;DSC2;JUP
prerank,anion channel activity (GO:0005253),0.49739581846305325,1.4095527877334308,0.07529722589167767,0.6543227124682378,1.0,5/61,4.47%,SLC26A7;CLIC4;LRRC8D;ANO6;GLRB
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.6156504754163606,-1.4089122694506286,0.09977324263038549,0.44525515570473345,1.0,5/10,22.32%,APOBEC1;ADARB2;LACC1;GDA;CDA
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.62864037640099,-1.406444576203274,0.07223476297968397,0.44041270740868865,1.0,4/10,8.99%,PRKAG2;PRKAR2B;PRKAR1B;PRKAR1A
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.6503226677061072,1.4005443718449224,0.13636363636363635,0.6768447477343077,1.0,6/13,17.42%,PNPLA3;ABHD5;GPAT3;AGPAT4;LCLAT1;AGPAT5
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.5872512899996366,-1.3989724292654857,0.10101010101010101,0.44908040344106326,1.0,3/11,15.23%,PPP1R1A;PPP1R14A;PABIR1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.420034536614864,1.3986700482300254,0.002014098690835851,0.6737283956831687,1.0,117/597,14.70%,BNC2;FOXP1;KLF12;NR3C2;VSX1;KLF5;TFCP2L1;RARB;TCF7L1;TCF7L2;PRRX2;TBX15;NFIB;ZIC4;SIX1;HOXA5;HDAC4;FOXO3;GLI3;PBX1;GRHL1;KLF3;NFAT5;NR2F1;ISL1;CRY2;KLF4;CUX1;SMAD6;FOXK1;MYOG;PITX3;BARHL2;PHOX2A;HOXB6;ELF1;ZBTB7B;ZIC1;ABL1;MEOX2;EGR2;DDIT3;NFE2L2;ARID4A;GATA1;CTCFL;ZBED4;NR4A2;FOXC2;HOXA6;NFKB1;GLIS1;MBNL2;HNF4A;HNF1A;RARG;FOXD2;TFAP2A;HOXB5;LBX1;TBL1X;JUN;FOXE1;NR6A1;KLF10;MCM7;GLIS2;BHLHE40;HES1;NFATC4;CREB3L3;ETV5;GATA4;JDP2;TEAD1;CALCOCO1;NFYA;BCL6;NFKB2;SIX4;E2F3;PER2;BCL11B;ARID4B;FOXA1;FOXK2;GATA3;NKX2-1;GABPB1;GABPB2;MBD4;RNF10;KIF2C;IRF1;HSF5;ZBTB37;TAF9;REST;XPA;KLF16;RXRA;STAT3;FOXC1;RFX5;CIITA;XRCC5;HES7;DDX11;CEBPB;ZNF76;HNRNPL;TFE3;KMT2D;CARM1;TFEB;ZBTB32;PER3
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.4698479818805622,-1.3956544270467803,0.07356948228882834,0.44705264037146153,1.0,6/25,8.85%,PARP14;ART3;PARP8;PARP11;PARP1;TIPARP
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.6115451910693178,-1.3914205864628761,0.09954751131221719,0.44834870420938744,1.0,5/10,20.81%,CASP4;CASP12;CFLAR;CASP3;CASP1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4159648262090073,1.391349842660866,0.002004008016032064,0.690536816413183,1.0,133/731,12.82%,FOXP2;ZBTB7C;FOXP1;MKX;KLF12;NR3C2;PBX3;KLF5;TFCP2L1;SMAD9;RARB;TCF7L1;ZFHX3;TCF7L2;PRRX2;TBX15;PLAGL1;NFIB;FOXN3;ZIC4;ZFHX4;SIX1;HOXA5;FOXD1;HDAC4;FOXO3;GLI3;ZBTB16;PBX1;ESR2;GRHL1;NFIA;KLF3;NFAT5;NR2F1;ISL1;HOXA3;KLF4;FOXK1;FOXP4;SKIL;MYOG;NOBOX;PITX3;HOXB6;ELF1;ZBTB7B;ZIC1;MEF2A;ZNF148;MEOX2;EGR2;DDIT3;NFE2L2;GATA1;KLF7;CTCFL;NR4A2;E2F5;FOXC2;HOXA6;ATF1;NR4A3;NFKB1;ZNF8;ZNF423;BPTF;FOXO6;GLIS1;HNF4A;HNF1A;RARG;FOXD2;PRRX1;TFAP2A;HOXB5;E2F6;JUN;FOXE1;HIVEP3;NR6A1;KLF10;KLF9;GLIS2;BHLHE40;HES1;NFATC4;CREB3L3;GATA4;HIF3A;JDP2;TEAD1;CALCOCO1;CARF;NFYA;BCL6;TCF3;MXD1;NFKB2;SIX4;E2F3;BCL11B;ZNF585B;ZNF585A;ZKSCAN1;ATOH8;SKI;FOXA1;FOXK2;PRDM15;GATA3;NKX2-1;EBF4;ZNF383;ZFP62;RBMX;IRF1;HSF5;ZBTB11;ZBTB49;ZBTB37;REST;KLF16;NFIL3;RXRA;STAT3;WIZ;FOXC1;EHF;PGBD1;RFX5;HIVEP2;STAT5A
prerank,leucine zipper domain binding (GO:0043522),0.6836489541439129,1.3912642469896148,0.12701252236135957,0.6807872654401299,1.0,5/10,15.36%,PAWR;DDIT3;ERC1;MRTFA;AATF
prerank,sequence-specific DNA binding (GO:0043565),0.4173499811667765,1.3892293388848256,0.0010070493454179255,0.6779317224303182,1.0,87/590,10.39%,FOXP2;FOXP1;KLF12;NR3C2;VSX1;KLF5;SLTM;TFCP2L1;RARB;TCF7L1;TCF7L2;PRRX2;TBX15;NFIB;ZIC4;SIX1;HOXA5;FOXD1;HDAC4;FOXO3;GLI3;PBX1;GRHL1;KLF3;NFAT5;NR2F1;ISL1;KLF4;CUX1;FOXK1;MYOG;NOBOX;PITX3;BARHL2;PHOX2A;HOXB6;ELF1;ZBTB7B;ZIC1;MEF2A;ZNF148;ABL1;MEOX2;EGR2;NFE2L2;GATA1;CTCFL;NR4A2;FOXC2;HOXA6;ZNF423;BPTF;GLIS1;MBNL2;HNF4A;SMG6;RARG;FOXD2;TFAP2A;HOXB5;LBX1;JUN;FOXE1;NR6A1;KLF10;KDM1A;GLIS2;BHLHE40;HES1;NFATC4;SMG1;ETV5;GATA4;JDP2;TEAD1;CALCOCO1;CBFB;TELO2;BCL6;NFKB2;SIX4;E2F3;BCL11B;MBD1;FOXA1;FOXK2;GATA3
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6583273371060964,1.3883498414985291,0.1404109589041096,0.6719758258166482,1.0,5/12,12.70%,SULF1;ARSI;SGSH;SULF2;ARSB
prerank,poly-purine tract binding (GO:0070717),-0.4729040009030896,-1.3842725477557785,0.08985507246376812,0.455851106725477,1.0,6/27,8.10%,RBPMS;RBMS1;ATXN1;KHDRBS2;TIA1;ELAVL4
prerank,protein kinase C binding (GO:0005080),0.5242436292233333,1.3778291873409199,0.09239130434782608,0.6998652780042149,1.0,11/43,7.70%,GRK5;DSP;HDAC9;ADAM9;ABL1;PDLIM5;PRKCSH;IRS1;ITGAV;CAVIN2;NELL1
prerank,acid-thiol ligase activity (GO:0016878),-0.5644959287560603,-1.376551378211397,0.12949640287769784,0.4662977144842873,1.0,2/13,1.09%,ACSS3;ACSL1
prerank,double-stranded DNA binding (GO:0003690),0.41628493576766257,1.3764680016745743,0.004052684903748734,0.6947961120048823,1.0,70/531,10.12%,EGFR;FOXP1;KLF12;NR3C2;VSX1;KLF5;TFCP2L1;RARB;TCF7L1;PRRX2;TBX15;NFIB;ZIC4;SIX1;HOXA5;FOXO3;GLI3;PBX1;GRHL1;KLF3;NFAT5;NR2F1;ISL1;KLF4;CUX1;FOXK1;MYOG;PITX3;BARHL2;PHOX2A;HOXB6;ELF1;ZBTB7B;ZIC1;ABL1;MEOX2;EGR2;HDGFL3;GATA1;NR4A2;FOXC2;HOXA6;GLIS1;MBNL2;HNF4A;RARG;FOXD2;TFAP2A;HOXB5;LBX1;CAMTA2;JUN;FOXE1;NR6A1;KLF10;GLIS2;BHLHE40;HES1;NFATC4;ETV5;GATA4;JDP2;TEAD1;BCL6;NFKB2;SIX4;E2F3;BCL11B;MBD1;FOXA1
prerank,lipid phosphatase activity (GO:0042577),0.6374364937230473,1.3762894670579853,0.14189189189189189,0.685975917501288,1.0,2/14,2.51%,PLPPR2;PLPP3
prerank,chemokine receptor binding (GO:0042379),-0.4301324317311168,-1.3762384304793374,0.045454545454545456,0.4575663996084291,1.0,21/35,46.53%,CXCL12;CX3CR1;CCL19;CCL2;CCL25;CCRL2;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CX3CL1;CCL7;PPBP;CCL8;CCL1;CCL3;XCL1;CXCL13;CXCL2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.4757440320297301,-1.3759721570632408,0.07303370786516854,0.44879015030196734,1.0,15/23,17.96%,PDE8B;PDE4B;PDE7B;PDE1C;PDE4A;PDE4D;PDE9A;PDE2A;PDE11A;PDE1B;PDE3A;PDE3B;PDE4C;CNP;PDE8A
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.41038560889054565,1.3720866652746029,0.002008032128514056,0.6920778841483002,1.0,131/730,12.82%,FOXP2;ZBTB7C;FOXP1;MKX;KLF12;NR3C2;PBX3;KLF5;TFCP2L1;SMAD9;RARB;TCF7L1;ZFHX3;TCF7L2;PRRX2;TBX15;PLAGL1;NFIB;ZIC4;ZFHX4;SIX1;HOXA5;FOXD1;HDAC4;FOXO3;GLI3;ZBTB16;PBX1;ESR2;GRHL1;NFIA;KLF3;NFAT5;NR2F1;HOXA3;KLF4;FOXK1;FOXP4;SKIL;MYOG;NOBOX;PITX3;HOXB6;ELF1;ZBTB7B;ZIC1;MEF2A;ZNF148;MEOX2;EGR2;DDIT3;NFE2L2;GATA1;KLF7;CTCFL;NR4A2;E2F5;FOXC2;HOXA6;ATF1;NR4A3;NFKB1;ZNF8;ZNF423;BPTF;FOXO6;GLIS1;HNF4A;HNF1A;RARG;FOXD2;PRRX1;TFAP2A;HOXB5;E2F6;JUN;FOXE1;HIVEP3;NR6A1;KLF10;KLF9;GLIS2;BHLHE40;HES1;NFATC4;CREB3L3;GATA4;HIF3A;JDP2;TEAD1;CALCOCO1;CARF;NFYA;BCL6;TCF3;MXD1;NFKB2;SIX4;E2F3;BCL11B;ZNF585B;ZNF585A;ZKSCAN1;ATOH8;SKI;FOXA1;FOXK2;PRDM15;GATA3;NKX2-1;EBF4;ZNF383;ZFP62;RBMX;IRF1;HSF5;ZBTB11;ZBTB49;ZBTB37;REST;KLF16;NFIL3;RXRA;STAT3;WIZ;FOXC1;EHF;PGBD1;RFX5;HIVEP2;STAT5A
prerank,thiol-dependent deubiquitinase (GO:0004843),0.4704310369189991,1.3719761489671514,0.08239700374531835,0.6835089894606324,1.0,37/83,20.84%,USP13;MINDY3;TANK;USP46;USP24;JOSD1;OTUD1;USP2;OTUD7B;USP49;BAP1;USP7;USP32;USP10;UFD1;USP33;USP22;USP34;USP3;USP25;USP21;USP47;MYSM1;COPS5;USP4;STAMBP;USP1;OTUD3;DESI2;ZRANB1;OTUB1;VCPIP1;USP9X;USP48;OTUD5;USP31;USP37
prerank,chloride channel activity (GO:0005254),0.4852184782752156,1.3663144952043889,0.0901749663526245,0.6934685273163133,1.0,4/59,4.47%,SLC26A7;CLIC4;ANO6;GLRB
prerank,deubiquitinase activity (GO:0101005),0.46296751408528286,1.3630304486034388,0.08271604938271605,0.6962183374363914,1.0,39/88,20.88%,USP13;MINDY3;TANK;USP46;USP24;JOSD1;OTUD1;USP2;OTUD7B;USP49;BAP1;USP7;USP32;USP10;UFD1;USP33;USP22;USP34;USP3;USP25;USP21;USP47;MYSM1;COPS5;USP4;STAMBP;USP1;OTUD3;DESI2;ZRANB1;OTUB1;VCPIP1;USP9X;USP48;MINDY2;OTUD5;USP31;USP37;MINDY4
prerank,hexose transmembrane transporter activity (GO:0015149),-0.5654855614550625,-1.3627067873008811,0.14805825242718446,0.4733421780273756,1.0,10/12,41.40%,SLC2A1;SLC5A3;MFSD4A;SLC2A8;SLC2A2;SLC2A4;SLC2A3;PPBP;SLC2A5;SLC2A6
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.5576254614133751,-1.360926279167115,0.12866817155756208,0.4681673517810786,1.0,9/12,25.25%,GABRG3;GABRA1;GABRA2;GABRB2;GABRB1;GABRA4;GABRG1;GABRB3;GABRA5
prerank,CoA-ligase activity (GO:0016405),-0.5418454766879754,-1.3572415640508673,0.14153132250580047,0.46856145576133723,1.0,2/14,1.09%,ACSS3;ACSL1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.47834270011214003,-1.3551737945165798,0.10112359550561797,0.46474808580989624,1.0,13/21,15.12%,PDE8B;PDE4B;PDE7B;PDE1C;PDE4A;PDE4D;PDE9A;PDE2A;PDE11A;PDE1B;PDE3A;PDE3B;PDE4C
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5818186002342813,-1.3536373396305135,0.11682242990654206,0.4600927309400183,1.0,4/11,12.16%,CASP4;CASP12;CFLAR;CASP3
prerank,receptor ligand activity (GO:0048018),0.41723636270121556,1.353146981559073,0.04432432432432432,0.7216291705596256,1.0,31/245,7.91%,TNFRSF11B;BMP4;NGF;BMP5;EDA;WNT9A;OSGIN2;TGFB3;SEMA3D;LRPAP1;SEMA3C;WNT11;INHBA;BMP6;PGF;SEMA3E;GDF6;IL10;GDF5;C1QTNF12;WNT16;PDGFA;ERFE;GDNF;BMP15;TNFSF11;FGF22;JAG1;CLCF1;FGF2;FAM3C
prerank,ligand-gated channel activity (GO:0022834),-0.4430417351853132,-1.35221709427168,0.11711711711711711,0.4544089199481028,1.0,10/29,9.59%,GRIK1;GRIN2A;GRIA4;GRIA2;GRIA3;GRIN2B;GRID2;GRIN3A;GRIK2;GABRB1
prerank,glucose transmembrane transporter activity (GO:0005355),-0.5121575341926581,-1.3515777706562448,0.1306532663316583,0.44803266893856314,1.0,12/17,41.40%,SLC2A1;SLC5A3;SLC5A11;MFSD4A;SLC2A8;SLC2A2;SLC2A4;SLC2A3;PPBP;SLC2A10;SLC2A5;SLC2A6
prerank,Notch binding (GO:0005112),0.5792652168172369,1.3508446387493884,0.14668769716088328,0.720576749745563,1.0,7/22,15.67%,CCN3;SNED1;TCIM;JAG1;AAK1;GALNT11;SNW1
prerank,ligand-gated ion channel activity (GO:0015276),-0.4397744083433865,-1.3499304796479108,0.11598746081504702,0.4438983361851483,1.0,10/30,9.59%,GRIK1;GRIN2A;GRIA4;GRIA2;GRIA3;GRIN2B;GRID2;GRIN3A;GRIK2;GABRB1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.5687591274418876,-1.3476276876390088,0.13926940639269406,0.4412627333095264,1.0,3/11,14.09%,ITPR1;RYR2;RYR3
prerank,cadherin binding (GO:0045296),0.41202186291775744,1.3471408949615609,0.016824395373291272,0.724998525165783,1.0,72/315,13.31%,CDH1;EGFR;STXBP6;TES;FMNL2;CDH11;BAIAP2L1;NDRG1;ANXA1;CALD1;CTNND2;EZR;AHNAK;PHLDB2;PARVA;ABI1;FLNB;SPTAN1;CTNNA1;ITGB1;ANXA2;TMOD3;ESYT2;PAICS;MPP7;PDXDC1;FXYD5;GIPC1;CAST;PLCB3;STX5;HDLBP;SH3GLB2;PDLIM5;CLINT1;SHTN1;VCL;PKP4;MPRIP;DLG1;ERC1;P2RX4;PFKP;MARK2;JUP;IQGAP1;KTN1;UNC45A;CTNND1;RDX;VAPA;CD46;SERBP1;CDH17;CCS;PAK4;TBC1D10A;TRIM25;PKN2;PAK2;NIBAN2;IST1;ACVR1;BZW1;EHD1;GAPVD1;TXNDC9;SFN;CAPZA1;PLEC;CTTN;ADD1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.5226895110724469,-1.345729988506686,0.13513513513513514,0.438266524383091,1.0,8/15,22.81%,LANCL2;PLEKHA5;JPH2;PLA2G4E;PHLDA3;SAP30L;RUBCNL;SH3PXD2B
prerank,GTPase activator activity (GO:0005096),-0.29916052249277936,-1.3451167483639228,0.0,0.43228943044750145,1.0,72/313,10.58%,RANBP3L;ASAP1;PLCB1;PREX2;ARHGAP29;ARHGAP28;TBC1D4;RAPGEF5;DOCK10;CHN2;ERRFI1;DOCK4;DENND2A;ARHGAP24;RAPGEF4;ARHGAP32;RAPGEF3;RASGRP3;ELMO1;ALDH1A1;RABGAP1L;RALGPS1;FGD5;RGS3;RGS5;DOCK11;RAPGEF2;DENND1A;CHN1;USP6NL;SBF2;RGS7;RALGAPA2;CCDC88A;ARAP3;ARHGAP26;RAB3IP;TBC1D12;RALGAPA1;RASGRP2;GMIP;EEF1B2;ARHGEF15;IQGAP2;RASGRF2;RGL1;ARHGAP25;ARHGAP15;EPS8L2;ARRB1;OPHN1;RAPGEF1;DENND5A;TBC1D9;ACAP2;CYTH1;DENND5B;STARD8;PREX1;SGSM1;TBC1D8;SPATA13;VAV3;LRRK2;SMAP2;RASGRF1;RP2;GARNL3;TBC1D2;TBC1D16;RCC1;SEC23B
prerank,tropomyosin binding (GO:0005523),0.6109721512516804,1.3447892707466549,0.1611842105263158,0.7245019651442669,1.0,3/16,3.37%,CALD1;TMOD3;NEBL
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.5191601767046382,-1.3429675065570288,0.1319796954314721,0.42944185095810716,1.0,4/15,6.19%,SLC1A3;SLC1A5;SLC1A1;SLC1A2
prerank,ankyrin binding (GO:0030506),0.5943693442245176,1.3416321146887649,0.1598694942903752,0.7273309728176872,1.0,1/19,0.12%,CDH1
prerank,cyclic nucleotide binding (GO:0030551),-0.4702048256165142,-1.3416079690193736,0.12129380053908356,0.4254650320187342,1.0,8/21,10.43%,RAPGEF4;PDE4B;RAPGEF2;HCN1;PDE4A;PDE4D;PDE2A;PDE11A
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6252028376697755,1.3399062752821072,0.16785714285714284,0.7243269910847604,1.0,1/14,0.42%,KCNJ2
prerank,chemokine activity (GO:0008009),-0.43229527741039425,-1.3390766147966309,0.09868421052631579,0.4241115301061718,1.0,19/31,46.53%,CXCL12;CCL19;CCL2;CCL25;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CX3CL1;CCL7;PPBP;CCL8;CCL1;CCL3;XCL1;CXCL13;CXCL2
prerank,copper ion binding (GO:0005507),-0.4045274202103727,-1.337978575867373,0.1039426523297491,0.4198045741236883,1.0,8/42,9.82%,MOXD1;PAM;LOXL3;SNCA;ATOX1;SOD3;COX17;LACC1
prerank,amino acid:sodium symporter activity (GO:0005283),0.6239811527064606,1.336824475067222,0.19332161687170474,0.72634170773861,1.0,2/11,0.55%,SLC38A2;SLC38A1
prerank,R-SMAD binding (GO:0070412),0.5754624527613118,1.3292602713069956,0.16293929712460065,0.7437742516410647,1.0,8/18,16.20%,DDX5;SMAD6;JUN;PPM1A;LDLRAD4;SMURF1;DROSHA;PAX6
prerank,GABA receptor binding (GO:0050811),-0.5555334990313566,-1.3273439998653538,0.16511627906976745,0.43636853640460216,1.0,5/11,17.11%,PLCL2;GABARAP;TRAK2;JAKMIP1;GABARAPL1
prerank,phosphatase binding (GO:0019902),0.440401811882484,1.3221982975459483,0.09495896834701055,0.7601573483055806,1.0,29/105,17.26%,EGFR;MET;MAP3K5;WNK1;CRY2;PPP1R3C;SFI1;CNST;VCP;AP3B1;ANAPC5;SHOC2;DLG1;JUP;IQGAP1;CDKN1B;EIF2AK3;PPP1R3F;IKBKE;STAT3;MAPK1;STYXL1;VRK3;PPP6R3;SH3YL1;PPME1;CSRNP2;RCAN3;STAT6
prerank,transforming growth factor beta binding (GO:0050431),0.5579551429833312,1.3201914313509155,0.1534954407294833,0.758370012912376,1.0,11/23,12.28%,THBS1;CD109;TGFB3;LTBP3;TGFBR1;TGFBR2;ITGAV;TSKU;LTBP4;ACVR1;CD36
prerank,filamin binding (GO:0031005),0.6264707551625404,1.3200141238652505,0.17825311942959002,0.7504591508547046,1.0,2/11,3.37%,DPYSL3;NEBL
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3941846607608334,1.3196234004503684,0.004008016032064128,0.7434536159683074,1.0,142/830,12.82%,FOXP2;ZBTB7C;FOXP1;MKX;KLF12;NR3C2;PBX3;KLF5;TFCP2L1;SMAD9;RARB;TCF7L1;ZFHX3;TCF7L2;PRRX2;TBX15;PLAGL1;NFIB;ZIC4;ZFHX4;SIX1;HOXA5;FOXD1;HDAC4;FOXO3;GLI3;ZBTB16;PBX1;ESR2;GRHL1;NFIA;KLF3;NFAT5;NR2F1;HOXA3;KLF4;CUX1;PURG;FOXK1;FOXP4;SKIL;MYOG;NOBOX;PITX3;BARHL2;LHX2;PHOX2A;HOXB6;ELF1;ZBTB7B;ZIC1;MEF2A;ZNF148;MEOX2;EGR2;DDIT3;NFE2L2;GATA1;KLF7;CTCFL;NR4A2;E2F5;FOXC2;HOXA6;ATF1;NR4A3;NFKB1;ZNF8;ZNF423;BPTF;FOXO6;GLIS1;TWIST2;HNF4A;HNF1A;RARG;FOXD2;PRRX1;TFAP2A;HOXB5;E2F6;JUN;FOXE1;HIVEP3;NR6A1;KLF10;KLF9;GLIS2;BHLHE40;HES1;NFATC4;CREB3L3;ETV5;GATA4;HIF3A;JDP2;TEAD1;CALCOCO1;CARF;NFYA;BCL6;TCF3;MXD1;NFKB2;SIX4;E2F3;BCL11B;ZNF585B;ZNF585A;ZKSCAN1;ATOH8;SKI;FOXA1;FOXK2;PRDM15;GATA3;TCF23;NKX2-1;EBF4;ZNF383;TAF1;ZFP62;RBMX;IRF1;RB1;RBL2;HSF5;ZBTB11;ZBTB49;ZBTB37;REST;KLF16;NFIL3;RXRA;STAT3;WIZ;FOXC1;EHF;PGBD1;RFX5;HIVEP2;STAT5A
prerank,tau-protein kinase activity (GO:0050321),0.5650740719272881,1.3189553917323456,0.1732283464566929,0.7379158505847885,1.0,5/20,10.41%,MARK1;GSK3B;SIK3;MARK2;MARK3
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.634990444620142,1.3175471413046702,0.18871252204585537,0.7344925501652999,1.0,3/10,2.33%,SLCO3A1;SLCO4A1;SLCO2A1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5499589544996701,1.314486977409832,0.17391304347826086,0.7374400403821142,1.0,5/23,5.41%,PLCE1;EDNRA;CHRM5;PLCB3;PLCD3
prerank,manganese ion binding (GO:0030145),0.48772142099182003,1.3141177911350903,0.14685314685314685,0.7309195992347204,1.0,11/48,15.15%,ME1;MPPED2;LARGE1;ABL1;DYRK2;B4GALT1;B4GALT7;XPNPEP1;LARGE2;EXD2;XPNPEP3
prerank,H4 histone acetyltransferase activity (GO:0010485),0.6403110244336029,1.3057032390325367,0.2077922077922078,0.7511770288500998,1.0,5/10,17.41%,NAA40;EP300;BRCA2;USP22;ATF2
prerank,NAD binding (GO:0051287),0.533301507403241,1.302619081552247,0.1618320610687023,0.7538509574135875,1.0,2/26,1.78%,ME1;BDH2
prerank,GABA-A receptor activity (GO:0004890),-0.48277661859707655,-1.3020291144555989,0.14652956298200515,0.48694757092278856,1.0,9/18,25.25%,GABRG3;GABRA1;GABRA2;GABRB2;GABRB1;GABRA4;GABRG1;GABRB3;GABRA5
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5493667423580246,-1.3009810909425663,0.17633410672853828,0.4819249622360658,1.0,6/12,6.81%,IGF1;PIK3R1;GNAS;INSR;IGF2;ARRB1
prerank,poly(A) binding (GO:0008143),-0.4709036398735663,-1.2987761883829705,0.16842105263157894,0.4797250163912234,1.0,7/21,15.13%,RBPMS;RBMS1;KHDRBS2;TIA1;ELAVL4;PABPC4L;PPIE
prerank,cholesterol binding (GO:0015485),-0.3858733821406523,-1.2977102134581378,0.10380622837370242,0.47503816273291216,1.0,11/47,6.04%,OSBPL8;APOD;PROM1;SIDT1;ABCA1;GRAMD1B;PTCH1;NPC2;OSBPL10;NR1H3;CD81
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.40001459109436827,1.2960979644889803,0.060988433228180865,0.7684800682582786,1.0,54/254,12.75%,KLF5;TFCP2L1;PLAGL1;NFIB;SIX1;HOXA5;FOXO3;ZBTB16;GRHL1;NFIA;NFAT5;KLF4;MYOG;ELF1;MEF2A;MEOX2;EGR2;DDIT3;GATA1;KLF7;CTCFL;NR4A2;FOXC2;ATF1;NR4A3;NFKB1;PLSCR1;HNF4A;HNF1A;FOXD2;PRRX1;TFAP2A;JUN;KLF10;GLIS2;CREB3L3;ETV5;GATA4;MDM4;TCF3;NFKB2;E2F3;ZNF585B;ZNF585A;FOXA1;FOXK2;PRDM15;GATA3;ZFP62;IRF1;STAT3;FOXC1;EHF;RFX5
prerank,MHC class I protein binding (GO:0042288),-0.5201066435674473,-1.2958220464631163,0.16363636363636364,0.4725359369364728,1.0,9/13,41.92%,ATP5F1B;TAP2;ATP5F1A;ABCB9;LILRB1;TAPBP;TUBB4B;CD8B;TAP1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.5646736292345774,1.2954158964851155,0.1967479674796748,0.7628875131341885,1.0,4/17,9.62%,BDH2;PECR;DECR1;LBR
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.6047649568793847,1.2946012365263093,0.18181818181818182,0.7580522689765374,1.0,1/12,0.73%,CYFIP2
prerank,E-box binding (GO:0070888),-0.4129055489178288,-1.2907487531663808,0.12130177514792899,0.47756836586869705,1.0,6/34,10.91%,TCF4;ZEB1;AHR;TAL1;CIART;MITF
prerank,O-acyltransferase activity (GO:0008374),0.5212569270439187,1.2905728041477376,0.162406015037594,0.7639572681279898,1.0,9/30,19.03%,SOAT1;MOGAT3;DGAT2L6;GPAT3;LCAT;PLA2G4A;PLA2G15;MBOAT1;MOGAT1
prerank,leak channel activity (GO:0022840),0.560300624640228,1.2868356001409276,0.1953125,0.7686984017081594,1.0,3/18,5.21%,KCNK5;NALCN;KCNK7
prerank,fibroblast growth factor binding (GO:0017134),0.5668434847774746,1.2866765896994872,0.1839258114374034,0.7618815536184743,1.0,6/21,13.07%,THBS1;FGFR1;ITGAV;KLB;CEP57;ITGB3
prerank,alkali metal ion binding (GO:0031420),-0.5197920778052287,-1.2851127282150845,0.17772511848341233,0.48390852468213486,1.0,1/13,0.02%,ATP1A2
prerank,omega peptidase activity (GO:0008242),0.43517065426329443,1.2848248211720141,0.1329268292682927,0.7605390737769169,1.0,37/89,20.84%,USP13;MINDY3;TANK;USP46;USP24;JOSD1;OTUD1;USP2;OTUD7B;USP49;BAP1;USP7;USP32;USP10;UFD1;USP33;USP22;USP34;USP3;USP25;USP21;USP47;MYSM1;COPS5;USP4;STAMBP;USP1;OTUD3;DESI2;ZRANB1;OTUB1;VCPIP1;USP9X;USP48;OTUD5;USP31;USP37
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.40653378631261256,1.284674720845325,0.0806979280261723,0.7537472822053213,1.0,42/181,12.67%,ZFPM2;TCF7L2;HDAC4;TACC2;WWP2;ISL1;KLF4;ANXA4;GSK3B;MDFIC;MEF2A;EGR2;NFE2L2;GATA1;DDRGK1;PIAS3;HNF4A;PRRX1;EP300;PIAS2;HCLS1;JUN;TADA3;KDM1A;CREBBP;JUP;BHLHE40;HES1;GATA4;BCL10;SMARCA4;TCERG1;TCF3;BCAS3;TCF23;TAF1;RB1;RBL2;MTDH;RXRA;STAT3;BAZ2A
prerank,transcription cis-regulatory region binding (GO:0000976),0.3890962576357183,1.2832362002858761,0.03182751540041068,0.7515078539879688,1.0,84/406,14.70%,BNC2;FOXP1;VSX1;TCF7L2;PLAGL1;FOXN3;SIX1;HDAC4;FOXO3;GLI3;PBX1;GRHL1;ISL1;CRY2;KLF4;CUX1;SMAD6;PURG;FOXK1;MYOG;BARHL2;LHX2;PHOX2A;ZBTB7B;MEF2A;EGR2;DDIT3;NFE2L2;ARID4A;GATA1;CTCFL;ZBED4;FOXC2;ATF1;NFKB1;TWIST2;HNF4A;HNF1A;TFAP2A;TBL1X;E2F6;JUN;KLF10;GLIS2;CREB3L3;ETV5;GATA4;HIF3A;TEAD1;CALCOCO1;NFYA;TCF3;E2F3;PER2;ARID4B;FOXA1;FOXK2;GATA3;TCF23;NKX2-1;GABPB1;GABPB2;RNF10;IRF1;RB1;RBL2;TAF9;REST;NFIL3;RXRA;STAT3;FOXC1;RFX5;ZBTB4;CIITA;XRCC5;FOXM1;CEBPB;HNRNPL;TFE3;KMT2D;CARM1;TFEB;PER3
prerank,protein serine/threonine kinase activity (GO:0004674),0.3890961305386917,1.2791963357131289,0.044238683127572016,0.7578969363457253,1.0,96/335,17.53%,STK39;EGFR;MAP3K5;GRK5;STK19;MARK1;PTK2B;CAMK2D;LIMK2;WNK1;CIT;PRKCD;HIPK1;CLK1;ALPK1;MKNK2;NEK7;BCR;GSK3B;STK35;RIPK3;BMPR1A;SGK3;ULK2;SIK3;TLK1;TGFBR1;TRIO;TGFBR2;SIK2;GAK;STK16;PLK3;CHUK;RIPK2;ATM;MARK2;DYRK2;SMG1;IRAK4;EIF2AK4;CDC42BPG;DYRK3;CLK2;CHEK2;CSNK1G3;MARK3;MTOR;PAK4;CSNK1E;PKN2;PAK2;PIM2;TAF1;EIF2AK3;CHEK1;ACVR1;CSNK2A2;CSNK2A1;SQSTM1;IKBKE;NLK;NEK8;CASK;PRKCE;AAK1;CSNK1A1;MAPK1;SRPK1;CPNE3;VRK3;SBK3;CAMK4;ILK;AMHR2;HTATIP2;CDK12;STK11;FAM20A;MAPK15;PRKAA1;ERN2;PRKCA;PRKACA;CSNK1D;WNK3;CDKL2;MAP3K12;PRKDC;MAP4K1;TOP1;TAOK3;MAPK8;VRK2;MAPKAPK2;TLK2
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5315415121291447,-1.2771220863567594,0.19080459770114944,0.4965399942737105,1.0,3/12,5.42%,CDK8;CDK19;CDK6
prerank,SUMO transferase activity (GO:0019789),0.571682619167718,1.2762649577428873,0.20875420875420875,0.7602643137186417,1.0,6/16,13.82%,HDAC4;EGR2;PIAS3;PIAS2;RANBP2;NSMCE2
prerank,calcium channel regulator activity (GO:0005246),-0.3934340077097365,-1.2742565954861107,0.1505016722408027,0.496433518118046,1.0,9/37,11.64%,ITPR1;PRKG1;NRXN1;CALM1;SGK1;REM1;CACNG4;CACNG7;SLC30A1
prerank,small GTPase binding (GO:0031267),0.40402864810762995,1.2725449588525761,0.10143329658213891,0.7656508564002248,1.0,40/170,11.88%,PLCE1;STK19;NDRG1;ARHGDIB;AKAP13;CDC42EP5;SGSM2;EXOC4;DOCK7;YBX3;RAPGEF6;MLPH;PDE6D;RAB3GAP2;EXOC5;ANKRD27;MYCBP2;ERC1;RAB11FIP3;OCRL;FGD6;NCKAP1;EXPH5;IQGAP1;SGSM3;SRGAP2;STRN3;UNC13B;PIH1D2;USP33;NOX1;RGP1;HPS4;PAK2;TRIOBP;RANBP2;TRIP11;GGA2;BRK1;EHD1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.584051224001375,1.2708760172552935,0.20347826086956522,0.763604690760808,1.0,1/14,2.44%,ADH7
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5533792409971756,-1.26584238919075,0.21052631578947367,0.5096492463404722,1.0,3/11,5.83%,SASH1;ROR2;DAB2IP
prerank,sodium channel activity (GO:0005272),-0.391953572193194,-1.2631754620470734,0.14012738853503184,0.5090367170050429,1.0,11/37,20.65%,SCN7A;SHROOM2;HCN1;GRIK1;SCN1A;GRIK2;SCN3A;CACNA1I;SCN2A;HCN2;GRIK3
prerank,histone deacetylase activity (GO:0004407),0.5550861569553078,1.2628040498936082,0.2107843137254902,0.7831470652301403,1.0,4/19,10.68%,HDAC4;HDAC9;HDAC10;HDAC8
prerank,sterol binding (GO:0032934),-0.36582398465944393,-1.2622587709252193,0.11764705882352941,0.5046221360688876,1.0,20/56,18.08%,OSBPL8;APOD;PROM1;SIDT1;ABCA1;GRAMD1B;PTCH1;NPC2;OSBPL10;NR1H3;CD81;INSIG2;OSBP;STARD5;OSBPL1A;SYP;STARD3;SCP2;ABCG1;TSPO
prerank,phospholipase C activity (GO:0004629),0.5170751411918787,1.2615617844227027,0.21417797888386123,0.7803959139212211,1.0,5/25,5.41%,PLCE1;EDNRA;CHRM5;PLCB3;PLCD3
prerank,estrogen receptor binding (GO:0030331),-0.40177509498046654,-1.2611123131103372,0.16825396825396827,0.5008501761232453,1.0,6/32,7.13%,LEF1;TACC1;NCOA1;PPARGC1B;RERG;WIPI1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5321580539343878,-1.2589953057377106,0.19683257918552036,0.4990405838519822,1.0,5/11,13.51%,ITPR1;TRPC3;RPH3A;TRPC4;TRPC6
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.40220167525317074,1.2586757199703622,0.10045146726862303,0.7829860122389914,1.0,35/173,14.58%,FOXP2;FOXP1;KLF12;ZFHX3;PLAGL1;FOXO3;ZBTB16;NR2F1;FOXK1;FOXP4;SKIL;ZNF148;NFKB1;TFAP2A;E2F6;JUN;BHLHE40;HES1;NFATC4;JDP2;BCL6;TCF3;MXD1;SKI;FOXK2;GATA3;ZBTB49;ZBTB37;REST;NFIL3;ZBTB4;CEBPB;THAP1;GTF2IRD1;ZBTB32
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.4171627513169205,-1.2530955067964593,0.1761194029850746,0.5056950598519587,1.0,12/30,16.90%,SLC30A10;SLC39A10;SLC40A1;SLC39A8;SLC39A7;TTYH1;SLC30A4;SLC31A1;SLC30A1;SLC39A3;SLC11A2;ATP7A
prerank,DNA-binding transcription factor binding (GO:0140297),0.3937649879827249,1.250031862822026,0.11366120218579236,0.8039407850503025,1.0,44/189,12.38%,ZFPM2;TCF7L2;HDAC4;WWP2;HDAC9;ISL1;KLF4;GSK3B;MEF2A;EGR2;DDIT3;TLE6;NFE2L2;GATA1;DDRGK1;ZMYND8;PIAS3;HNF4A;PRRX1;EP300;PIAS2;HCLS1;JUN;TXLNG;KDM1A;CREBBP;BHLHE40;HES1;GATA4;TCERG1;KAT5;TLE4;TCF3;SKI;TCF23;TAF1;RB1;TLE3;RBL2;TLE2;ZBTB49;TAF9;MTDH;STAT3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6046189317487056,1.2482787854696313,0.243006993006993,0.8029397929939267,1.0,2/10,10.09%,DPYSL3;CAD
prerank,mRNA methyltransferase activity (GO:0008174),0.5799378611550413,1.2461445400656803,0.22185430463576158,0.8029993673910406,1.0,1/12,0.68%,RNMT
prerank,WW domain binding (GO:0050699),-0.4263131442208844,-1.2448278612681036,0.17857142857142858,0.5186793407750466,1.0,9/26,23.65%,RAPGEF2;TNK2;NDFIP2;LITAF;TCEAL9;DAZAP2;TCEAL3;TRAF4;TCEAL5
prerank,diacylglycerol kinase activity (GO:0004143),-0.5313687557486197,-1.2447982202685626,0.2087378640776699,0.5124259259491971,1.0,5/11,15.24%,DGKB;DGKI;DGKD;DGKG;DGKE
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5816708319413312,1.2425257801138774,0.23392857142857143,0.8078333609842565,1.0,3/12,8.63%,B3GNT2;B4GAT1;B3GNT6
prerank,vinculin binding (GO:0017166),0.5995261080347541,1.2407529441128313,0.23309608540925267,0.8073376423387382,1.0,3/11,4.49%,SORBS3;CTNNA1;DMD
prerank,phosphatidate phosphatase activity (GO:0008195),0.5730278648137375,1.2380849422668803,0.22857142857142856,0.8098419480083888,1.0,2/13,2.51%,PLPPR2;PLPP3
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5321773176343685,1.2369510184961625,0.2119205298013245,0.8067491901190155,1.0,9/20,19.03%,PNPLA3;MOGAT3;ABHD5;GPAT3;AGPAT4;PLA2G15;LCLAT1;AGPAT5;MOGAT1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.5330705525907231,1.2311212718744458,0.24126984126984127,0.8190188870357918,1.0,13/20,25.35%,USP7;USP25;USP21;USP47;COPS5;DESI2;OTUB1;SENP3;USP9X;UFSP2;OTUD5;SENP1;YOD1
prerank,DNA binding (GO:0003677),0.3695076238733581,1.2304472750596738,0.04408817635270541,0.8143722794318787,1.0,164/694,18.68%,FOXP2;EGFR;KLF12;SLTM;RARB;TCF7L1;TCF7L2;PLAGL1;NFIB;ZIC4;SIX1;HOXA5;FOXD1;HDAC4;FOXO3;ZBTB16;PBX1;ESR2;GRHL1;NR2F1;CRY2;CUX1;COLEC11;MPG;MYOG;NOBOX;RNF138;MEF2A;RBM6;ZNF148;ABL1;MEOX2;EGR2;HDGFL3;DDIT3;CEBPZ;NFE2L2;ARID4A;IGHMBP2;GATA1;CTCFL;NR4A2;FOXC2;SLPI;NR4A3;ZNF8;ZNF423;BPTF;HNF4A;HNF1A;BCLAF1;RARG;FOXD2;EP300;TFAP2A;CAMTA2;TRIM26;JUN;FOXE1;NR6A1;MCM7;CREBBP;HES1;ETV5;GATA4;TEAD1;TAF6L;CALCOCO1;CBFB;SMARCA4;CARF;SWSAP1;NFYA;BCL6;TCF3;TOP3A;E2F3;ERCC3;RAD52;MBD1;BRCA2;FOXA1;ERCC1;FOXK2;GATA3;QRICH1;NKX2-1;RAD51C;STN1;MBD4;AIFM2;MYRFL;TAF1;IRF1;RPA1;ZBTB49;RAD51AP1;TAF9;XPA;RXRA;STAT3;FOXC1;EHF;RTF1;RFX5;HIVEP2;ZBTB4;SMC1A;CIITA;XRCC5;HES7;TSG101;DDX11;GLYR1;CEBPB;C1D;SOX21;ZNF76;THAP1;KMT2D;TRIM16;RAD23B;ZBTB32;FOXL1;RBBP8;TAF12;XPC;DHX9;SNAPC4;JRK;CENPX;ZNF711;ZBTB18;PAX6;ZNF496;PRKDC;TOP1;CSRNP2;POLG2;MAEL;RORA;NR4A1;ZNF513;WRN;ATAD5;ZBTB7A;HUWE1;YY1;MCM9;POLA1;CLSPN;E2F2;NBN;ATF6;CSRNP1;INO80;ARID1A;SRRT;IKZF3;REXO4;CCDC25;POLR2H;CREM;RC3H2
prerank,ion channel inhibitor activity (GO:0008200),0.4867443772893435,1.2283520661724376,0.21897810218978103,0.8149012776856199,1.0,9/35,11.56%,KCNMB2;NEDD4;CAMK2D;WNK1;TNNI3;STX8;MCUB;COMMD1;PHPT1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.5951786010401043,1.2275402462125546,0.24786324786324787,0.8108101542076489,1.0,3/10,6.64%,EHHADH;AUH;ECHDC1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5078984566122665,-1.2244293421872487,0.2300469483568075,0.5523095007677679,1.0,3/12,0.82%,LTBP1;ENG;TGFBR3
prerank,transcription corepressor binding (GO:0001222),0.4958972005826978,1.222995024271677,0.23088923556942278,0.8190804991137152,1.0,13/27,24.46%,ZBTB16;PER2;WIZ;EHMT2;EHMT1;LCOR;PER3;SUZ12;RORA;ZBTB7A;NEK6;EED;EZH2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.47914645461733185,-1.220427028899648,0.20993227990970656,0.5549111155273244,1.0,6/14,9.45%,TIMP3;COL4A3;SPOCK2;BST2;SPOCK3;SPOCK1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.5940208989176821,1.2166984739009084,0.2637571157495256,0.8335989277263083,1.0,4/11,14.50%,UBE4B;UBR5;UBE4A;PPIL2
prerank,actinin binding (GO:0042805),0.5204416159870064,1.216491993375992,0.24088748019017434,0.8278372167582333,1.0,7/21,8.41%,CSRP3;CACNA1C;CSRP2;PDLIM5;NFKB1;MAGI1;PKD2L1
prerank,beta-tubulin binding (GO:0048487),-0.4015287738879471,-1.2138214712670274,0.16825396825396827,0.5636053215660008,1.0,13/31,23.38%,GJB6;TTLL7;EML4;PDCD5;ARL8B;GABARAP;CCT5;PACRG;GABARAPL1;TRPV4;CDK5R1;HTT;DLEC1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5954733044494054,1.2111123742820384,0.2807971014492754,0.8388850861289873,1.0,3/10,11.77%,SMYD2;SETD5;SETD2
prerank,ubiquitin binding (GO:0043130),0.4207434681514654,1.21007448678828,0.20628930817610064,0.8356344181091684,1.0,19/73,18.14%,NEDD4;USP13;DDI2;RNF185;NPLOC4;UBAP1;RNF168;USP33;CXCR4;SQSTM1;USP25;FAF2;TSG101;RNF31;RAD23B;UBE2N;FAF1;OTUB1;CKS1B
prerank,RNA cap binding (GO:0000339),0.5419160397955268,1.2100285389751075,0.24448217317487267,0.8293073141505334,1.0,1/16,0.73%,CYFIP2
prerank,hexosyltransferase activity (GO:0016758),0.4081195247473093,1.2096171864846164,0.18487394957983194,0.8241392292078001,1.0,16/101,10.77%,TMTC1;MGAT4C;EXT1;B3GNT2;LARGE1;GCNT2;HEXA;A4GALT;POGLUT3;POMGNT2;B4GAT1;B3GNT6;PIGB;GCNT4;B4GALT1;B4GALT7
prerank,FAD binding (GO:0071949),0.5131673712550904,1.2081218459199394,0.2530487804878049,0.822777957266226,1.0,2/24,2.73%,MICAL2;CRY2
prerank,ion channel activity (GO:0005216),0.42225275334713686,1.2072130427914538,0.2069408740359897,0.8193594299834966,1.0,13/80,8.55%,PIEZO2;TMEM120A;TRPM6;TMC6;TMC1;P2RX2;NALCN;TRPM4;CALHM2;GRIN2C;CALHM5;PKD2L1;MCUB
prerank,protein phosphatase binding (GO:0019903),0.40077523157415357,1.2062719763570524,0.18663594470046083,0.8162026633247496,1.0,21/117,12.38%,EGFR;MET;MAP3K5;PPP1R3B;PPP1R3C;STRN;VCP;AP3B1;ANAPC5;SHOC2;ATP2B4;BOD1L1;JUP;IQGAP1;STRN3;CDKN1B;EIF2AK3;PPP1R3F;IKBKE;SLC9A1;STAT3
prerank,GTPase inhibitor activity (GO:0005095),0.5598164261246501,1.2062417194276196,0.2660098522167488,0.8102314236732651,1.0,3/13,7.98%,SLIT2;PDE6D;IQGAP1
prerank,calcium ion binding (GO:0005509),0.36998866898491667,1.2062066925266888,0.11042311661506708,0.8044369844023112,1.0,27/323,5.11%,CDH1;SLIT3;SLIT2;SMOC2;THBS1;ACER3;CDH11;ANXA3;ANXA1;ESYT3;PPP3CA;DSPP;GLCE;ANXA2;ESYT2;COLEC11;OC90;TGM3;GSN;STIM2;DSG2;ANXA4;SYT8;ITPR2;DSC3;DSC2;TRPM4
prerank,NAD+ binding (GO:0070403),-0.5000263735494835,-1.205993028089632,0.2403846153846154,0.5747726120823833,1.0,8/12,35.57%,CRYL1;SIRT5;GLUD1;HADH;SIRT3;UXS1;HPGD;SIRT6
prerank,nuclear receptor binding (GO:0016922),0.409687056797099,1.2025977770072676,0.17328519855595667,0.8101743308375693,1.0,31/111,16.82%,FOXP1;TCF7L2;DDX5;TACC2;ISL1;STRN;NR4A2;JMJD1C;NR4A3;EP300;TRIP6;TRIP12;TADA3;TGFB1I1;KDM1A;JUP;SMARCA4;DCAF1;MED14;BCAS3;ZNHIT3;TAF1;RXRA;BAZ2A;BRD8;LCOR;NRIP1;SNW1;PRMT2;MED17;NR4A1
prerank,triglyceride lipase activity (GO:0004806),0.5158372905600527,1.2025036387683605,0.2566510172143975,0.8045665974064826,1.0,5/20,15.95%,PNPLA3;DAGLB;ABHD5;LCAT;PLA2G15
prerank,voltage-gated potassium channel activity (GO:0005249),0.41640181538566146,1.2024825238404906,0.2231920199501247,0.7988871827888928,1.0,5/80,4.00%,KCNB2;KCNJ2;KCNQ5;KCNS3;KCNB1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4299241241255026,1.2018870543914872,0.21171770972037285,0.7951907040507147,1.0,7/60,2.86%,EGFR;CRIM1;MET;NTRK3;FGFR1;DDR2;EFEMP1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.5922628096317909,1.2017946879360086,0.29259259259259257,0.789779940143957,1.0,8/11,26.24%,CARM1;PRMT6;PRMT2;PRMT8;FBXO11;NDUFAF7;PRMT3;PRMT9
prerank,growth factor activity (GO:0008083),0.4128178038212706,1.2016836468609573,0.21121251629726207,0.78456612381079,1.0,11/74,7.51%,NGF;OSGIN2;INHBA;PGF;IL10;PDGFA;GDNF;FGF22;JAG1;CLCF1;FGF2
prerank,histone acetyltransferase binding (GO:0035035),0.49504651424921714,1.200579565256286,0.26053042121684866,0.7826553483714054,1.0,8/21,17.52%,GLI3;MEF2A;KANSL1L;BCAS3;KANSL1;PAX6;CITED2;ZBTB7A
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.43582583793460306,-1.1993682913310293,0.22458628841607564,0.5839427693713211,1.0,11/19,25.25%,GRIK1;GABRG3;GRID2;GABRA1;GABRA2;GRIK2;GABRA4;GABRG1;GRIK3;GRID1;GABRA5
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4416419932606518,1.196490410528057,0.23553719008264462,0.7897428355002925,1.0,7/49,4.30%,ANXA3;ANXA1;ESYT3;ANXA2;ESYT2;ANXA4;SYT8
prerank,potassium channel regulator activity (GO:0015459),0.44816674894688163,1.1952259001069374,0.2349799732977303,0.7878018479648872,1.0,7/49,6.47%,KCNMB3;KCNMB2;WNK1;KCNS3;ADRB2;SGK3;DLG1
prerank,potassium ion leak channel activity (GO:0022841),0.5420524398260096,1.193726438205045,0.28115015974440893,0.7873587993749894,1.0,2/15,5.21%,KCNK5;KCNK7
prerank,endopeptidase regulator activity (GO:0061135),-0.3676412345040328,-1.193505755771936,0.21474358974358973,0.5916084501566752,1.0,18/40,27.79%,PROS1;ITIH2;CST3;TFPI;SERPIND1;A2M;PSME2;APH1B;PSENEN;VSIR;ADRM1;PSME1;HRG;APH1A;UCHL5;ABCA2;AHSG;PCSK1N
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.47749325230779593,1.1934543558587942,0.24303405572755418,0.7827984646876921,1.0,10/28,22.01%,EDA;TNFSF11;TRAF5;TRAP1;CASP8AP2;MYD88;FEM1B;FADD;TRAF3;PIDD1
prerank,sialyltransferase activity (GO:0008373),-0.4309226505496743,-1.191132938876108,0.2282051282051282,0.5909820109324162,1.0,8/20,8.05%,ST6GALNAC3;ST3GAL1;ST3GAL6;ST8SIA4;ST6GAL1;ST3GAL3;ST8SIA6;ST6GALNAC2
prerank,SUMO binding (GO:0032183),0.5471742268450177,1.1903629145953993,0.2857142857142857,0.7865996940069399,1.0,8/13,24.47%,HERC2;SERBP1;USP25;RNF111;PML;CASP8AP2;TDG;SIMC1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5184378874254648,-1.187325962824611,0.2633832976445396,0.5932099083472159,1.0,2/10,3.90%,MECOM;PRDM16
prerank,myosin binding (GO:0017022),0.4326730759416149,1.1869693730465132,0.25,0.7916697897265969,1.0,12/55,11.89%,CALD1;NPHS1;GSN;GIPC1;MLPH;DMD;RAB6A;NCKIPSD;RAB27B;CXCR4;TRIOBP;RHOA
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.478284372494484,1.1839154153550564,0.26443768996960487,0.7950989757515958,1.0,14/29,27.15%,ACER3;HPSE;HYAL3;GANC;MGAM;NEU3;IDUA;GAA;ENGASE;GALC;MOGS;HEXD;HPSE2;NEU1
prerank,protein phosphatase 1 binding (GO:0008157),0.5216347690430864,1.1825180276191951,0.284329563812601,0.7937807165951165,1.0,4/21,11.57%,PPP1R3B;PPP1R3C;SHOC2;PPP1R3F
prerank,GDP binding (GO:0019003),0.4255772810268766,1.1789689766491216,0.23234916559691912,0.7988892830996485,1.0,18/63,19.30%,MRAS;NRAS;KRAS;RAP1A;ARL3;RAP2C;RAB18;RAB27B;RIT1;RAB42;RAN;RAB5A;RRAS2;RAB17;DIRAS1;RAB22A;RAB7A;MIEF1
prerank,RNA polymerase binding (GO:0070063),0.5209322361300948,1.1757526736582726,0.28115015974440893,0.803285083756615,1.0,6/18,10.79%,NEDD4;STOM;TCERG1;SCAF8;PHRF1;PKN2
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.44970261155007674,-1.173874365862718,0.25728155339805825,0.6199801666724228,1.0,8/17,8.98%,GRIK1;GRIN2A;GRIA4;GRIA2;GRIA3;GRIN2B;GRIN3A;GRIK2
prerank,syntaxin-1 binding (GO:0017075),-0.4056526144967266,-1.1726794962794969,0.26436781609195403,0.615795488571341,1.0,10/22,26.21%,UNC13C;DAPK1;LRRK2;CPLX1;SYP;SNAP25;UNC13A;SYT1;STXBP3;VAMP3
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5146219638636278,1.1708635196902895,0.2791095890410959,0.8122604193044193,1.0,5/17,8.32%,ATP10A;PITPNA;PITPNC1;ATP8B1;PITPNB
prerank,GTPase binding (GO:0051020),0.36749811085485395,1.1702839987880642,0.18675352877307275,0.808653199117912,1.0,42/195,11.88%,PLCE1;STK19;NDRG1;ARHGDIB;AKAP13;CDC42EP5;SGSM2;EXOC4;DOCK7;YBX3;RAPGEF6;MLPH;PDE6D;RAB3GAP2;EXOC5;ANKRD27;BECN1;MYCBP2;ERC1;RAB11FIP3;OCRL;FGD6;NCKAP1;EXPH5;IQGAP1;SGSM3;SRGAP2;STRN3;UNC13B;PIH1D2;USP33;NOX1;RGP1;HPS4;PAK2;GNB3;TRIOBP;RANBP2;TRIP11;GGA2;BRK1;EHD1
prerank,SH3 domain binding (GO:0017124),0.4206765736144866,1.1691651700764456,0.27080581241743723,0.8069218040850377,1.0,9/62,7.25%,AFAP1L1;DPYSL3;ABI1;ADAM9;ABL1;ESPN;ADAM12;PLSCR1;AFAP1
prerank,voltage-gated cation channel activity (GO:0022843),0.3956334475688177,1.1687028462919002,0.22760290556900725,0.803002690027887,1.0,10/97,6.37%,KCNB2;KCNQ5;PTK2B;TMC1;KCNS3;CACNA1C;CACHD1;KCNB1;GRIN2C;ITGAV
prerank,sodium channel regulator activity (GO:0017080),0.451070622350124,1.1673605226922155,0.28939828080229224,0.801973667994611,1.0,8/37,7.87%,PTPN3;NEDD4;CAMK2D;FXYD5;SGK3;ATP2B4;FGF13;FXYD7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5975256028376958,1.1669595221001512,0.32413793103448274,0.793115111156711,1.0,3/10,9.99%,DUSP16;DUSP10;DUSP5
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5975256028376958,1.1669595221001512,0.32413793103448274,0.793115111156711,1.0,3/10,9.99%,DUSP16;DUSP10;DUSP5
prerank,ligand-gated anion channel activity (GO:0099095),-0.4363672435215148,-1.164799701890872,0.25547445255474455,0.6284895637411679,1.0,11/17,25.25%,GABRG3;GABRA1;GABRA2;GLRA1;GABRB2;GABRB1;GABRA4;GABRG1;GLRA3;GABRB3;GABRA5
prerank,metalloaminopeptidase activity (GO:0070006),0.5193018190758948,1.1646127448523103,0.28314238952536824,0.795342610123123,1.0,7/16,17.05%,NPEPPS;MMP16;MMP14;ERAP1;XPNPEP1;XPNPEP3;MMP17
prerank,voltage-gated sodium channel activity (GO:0005248),-0.4074307734858544,-1.16285882347736,0.2717678100263852,0.6266045510070819,1.0,10/22,26.18%,SCN7A;HCN1;SCN1A;SCN3A;CACNA1I;SCN2A;HCN2;SCN3B;SCN4B;SCN1B
prerank,myosin II binding (GO:0045159),0.5824488501749315,1.1620730064871971,0.3137254901960784,0.7978725606145425,1.0,6/10,24.48%,GSN;TRIOBP;MYL3;LLGL1;SHROOM4;STXBP5L
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.5534927457062684,1.157707592536321,0.3259668508287293,0.8056492416209802,1.0,1/11,4.18%,NAA40
prerank,serine-type peptidase activity (GO:0008236),0.38802154161079777,1.1536561029467793,0.26805385556915545,0.8126300329915622,1.0,5/96,6.02%,F3;PCSK5;HTRA3;HTRA1;TMPRSS2
prerank,active ion transmembrane transporter activity (GO:0022853),-0.3588650004978489,-1.1527181561052886,0.26557377049180325,0.6450653205738339,1.0,17/37,16.91%,SLC22A8;SLCO2B1;SLCO1C1;SLC22A6;SLC22A4;COX4I1;CYB5A;UQCR10;UQCRH;COX8A;COX6B1;COX6A1;COX5B;UQCR11;ATP13A3;SLC16A7;COX10
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.4413729204976659,-1.1519289516471596,0.2972292191435768,0.6403328156038722,1.0,5/16,15.19%,SLC13A3;SLC1A5;SLC1A1;SLC25A18;SLC25A11
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.3987763288298133,-1.150463891483861,0.2677165354330709,0.6372690141446055,1.0,9/24,17.92%,OSBPL8;DAB2IP;LANCL2;CERT1;PLEKHA5;OSBP;JPH2;PLA2G4E;GSDMD
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.44964171651415286,1.150001761008477,0.3035971223021583,0.8182976345362941,1.0,7/35,15.21%,FOXP1;TAF1C;KLF10;SMARCA4;TAF1;BAZ2A;RRN3
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.4259619849885893,-1.1438820053400918,0.3116883116883117,0.6463673753287187,1.0,3/18,0.82%,LTBP1;ENG;TGFBR3
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.4975376494924958,-1.1432910206382028,0.29954954954954954,0.6411493730649792,1.0,5/10,17.14%,GABRG3;GABRA1;GABRA2;GABRA4;GABRG1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.48457972077125505,-1.1424466573375456,0.3165938864628821,0.6365961667267762,1.0,4/11,18.41%,KCNQ1;KCND3;KCNJ8;KCNJ3
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4946797733856263,1.1373089847209144,0.3312,0.8511212142475931,1.0,5/18,6.07%,TGFB3;SMAD6;BAMBI;TGFBR1;TGFBR2
prerank,voltage-gated ion channel activity (GO:0005244),-0.453212117881021,-1.1358015731148006,0.28746928746928746,0.6467938217903402,1.0,4/14,10.97%,CACNA1E;HCN1;VDAC3;KCND2
prerank,calcium channel activity (GO:0005262),0.38541706767219164,1.1357497799245437,0.28004956629491945,0.8508136926813489,1.0,20/84,15.73%,SLC24A3;PKD1;ANXA2;TMC1;CACNA1C;CACHD1;STIM2;PKD2L2;TRPM4;ITGAV;P2RX4;PKD2L1;CACNB2;PKD1L2;TRPC5;CACNG5;MCU;TRPM7;TRPC7;TRPM2
prerank,iron ion binding (GO:0005506),0.4170541898779297,1.1354910685617656,0.3085399449035813,0.846415676327026,1.0,6/48,7.78%,AOX1;EGLN3;FTO;CDO1;FDX1;SCD
prerank,protease binding (GO:0002020),0.378760397983178,1.1336427770592536,0.28519417475728154,0.8468199483662283,1.0,14/99,8.66%,F3;FN1;SLC2A13;ITGB1;ANXA2;COL3A1;GSK3B;VCP;SERPINB9;CRADD;ITGAV;RIPK2;TIMP2;BCL10
prerank,actin binding (GO:0003779),0.3602654827094505,1.1313253259607265,0.2749445676274945,0.848311050798427,1.0,29/170,10.20%,MICAL2;PHACTR1;COBL;CALD1;SORBS1;EZR;PAWR;PARVA;FLNB;PDLIM7;ITGB1;FXYD5;GSN;GIPC1;MLPH;ABL1;DMD;NCALD;PDLIM5;SYNE2;TNNI3;VCL;MSRB2;SPEF1;RDX;DMTN;SSH3;CXCR4;MRTFA
prerank,CARD domain binding (GO:0050700),0.5257933352056046,1.1293489778836312,0.35800344234079173,0.8495311062161574,1.0,5/14,10.95%,CARD14;MAVS;RIPK2;BCL10;CARD19
prerank,damaged DNA binding (GO:0003684),0.42043947902698026,1.1292312531169917,0.3019867549668874,0.8449789663455437,1.0,21/44,27.90%,CRY2;MPG;EP300;CREBBP;ERCC3;ERCC1;RPA1;XPA;RBBP8;XPC;NBN;TDG;UNG;APEX1;ERCC2;ERCC5;HMGB2;CUL4B;XRCC1;NTHL1;POLQ
prerank,cell-cell adhesion mediator activity (GO:0098632),0.43504819045671494,1.1291131816123254,0.3215796897038082,0.8405202599836196,1.0,6/42,5.13%,STXBP6;BAIAP2L1;ANXA1;ANXA2;TMOD3;PDLIM5
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4761679956848454,1.1248792655996345,0.3328125,0.8484412256294248,1.0,9/20,25.71%,MAGI3;DLG1;CASK;AK9;DLG2;CMPK1;AK3;AK6;DTYMK
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.40000452830929467,1.1239047797623523,0.2971576227390181,0.8463822987522157,1.0,9/72,4.73%,KCNJ2;STXBP6;VILL;MARK1;ANXA2;SNX18;GSN;FZD7;PLEKHA4
prerank,calcium:sodium antiporter activity (GO:0005432),0.555625297410036,1.1226521876933337,0.35765124555160144,0.8450687853095012,1.0,1/10,0.72%,SLC24A3
prerank,N-methyltransferase activity (GO:0008170),0.48777078178862987,1.1200659234602237,0.35893416927899685,0.8475478317803677,1.0,6/20,20.97%,RNMT;GNMT;TRMT1L;ZCCHC4;NNMT;METTL18
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.46553638760579136,-1.1191215698613568,0.31910112359550563,0.6816805053379658,1.0,10/14,35.96%,CIAO3;ACO2;EXO5;RSAD1;ACO1;ISCA2;NDUFS1;RSAD2;SDHB;NUBPL
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4144240032497464,1.1164964533003083,0.3178717598908595,0.8523843696771768,1.0,3/53,2.73%,MICAL2;AOX1;CRY2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.42831302053183773,-1.116281160114921,0.3309002433090024,0.6828134647440275,1.0,3/14,5.54%,CTSH;MAL;NOD1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3988525638953049,1.1161865444086587,0.3113207547169811,0.8486028056036364,1.0,14/55,15.73%,SLC24A3;PKD1;ATP2C2;ANXA2;PKD2L2;ITPR2;ATP2B4;PKD2L1;CACNB2;PKD1L2;TRPC5;MCU;TRPM7;TRPM2
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5243898243688163,1.1158495230487546,0.348294434470377,0.8448072294066112,1.0,5/12,24.23%,DDI2;SPPL2A;NAPSA;BACE2;SPPL3
prerank,3'-5' exonuclease activity (GO:0008408),0.41654096832863924,1.112635813045878,0.3243626062322946,0.8495174531999483,1.0,18/45,22.42%,REV3L;ERI3;CNOT7;APLF;ANGEL1;EXOSC7;DIS3L2;REXO2;EXD2;PNLDC1;WRN;EXOSC5;REXO4;MRE11;EXOSC4;TATDN1;APEX1;ANGEL2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.47375797889559873,-1.1103273920352803,0.3438202247191011,0.6912042523228056,1.0,9/11,50.82%,PADI2;DDAH2;ARG2;ARG1;PADI1;PADI4;AGMAT;PADI3;PADI6
prerank,serine-type endopeptidase activity (GO:0004252),0.3778377460463388,1.1053066687380737,0.31296758104738154,0.8661120473616654,1.0,2/80,1.11%,F3;PCSK5
prerank,mannose binding (GO:0005537),0.5295941040877852,1.1050887248315995,0.34582623509369675,0.8620405264716673,1.0,2/12,9.31%,COLEC11;LMAN2L
prerank,sulfotransferase activity (GO:0008146),0.43726314865627736,1.105002957763855,0.3521739130434783,0.8575966940758815,1.0,5/33,4.37%,UST;HS3ST1;SULT1A1;CHST13;CHST5
prerank,protein phosphorylated amino acid binding (GO:0045309),0.42615758386880803,1.1049447228182276,0.33946251768033947,0.8531136788054613,1.0,8/42,8.42%,PTPN3;NEDD4;SHC1;ABL1;NCK2;IRS1;VAV2;BCAR3
prerank,lipase activator activity (GO:0060229),-0.47040894755248464,-1.104098665283541,0.34872979214780603,0.6998472317293483,1.0,7/10,37.56%,ARHGAP6;SRC;BTK;CCL5;APOH;LCK;CCL8
prerank,galactosyltransferase activity (GO:0008378),0.5203654487566063,1.1026182309904091,0.35478260869565215,0.8551312977559374,1.0,5/11,14.74%,A4GALT;B3GNT6;B4GALT1;B4GALT7;B3GALT6
prerank,phospholipid transfer activity (GO:0120014),0.4643683423172576,1.0991425287786127,0.352755905511811,0.860411805283398,1.0,3/21,2.59%,TNFAIP8L3;PITPNA;PITPNC1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.4287333066941894,1.094893192617463,0.37337192474674386,0.8677283026488595,1.0,16/33,24.06%,SMYD2;ELOF1;SCAF8;CTR9;WDR43;PAF1;RRN3;ELP4;DHX9;ZNF326;UVSSA;URI1;NCOA3;RECQL5;ERCC5;WAC
prerank,frizzled binding (GO:0005109),0.42427069502715936,1.0940320936958856,0.34643377001455605,0.8655917734137829,1.0,6/34,4.03%,WNT9A;WNT11;LRP6;WNT16;BAMBI;FZD7
prerank,chemorepellent activity (GO:0045499),-0.36292239423161676,-1.0924706717092894,0.34277620396600567,0.7231960323794543,1.0,11/25,16.15%,SEMA6A;EPHA7;SEMA7A;NRG3;SEMA6D;SEMA5B;DPP4;SEMA3G;SEMA6B;SEMA4C;SEMA4A
prerank,glutamate receptor binding (GO:0035254),-0.4018661775726877,-1.0917618707400547,0.32653061224489793,0.7184036326404762,1.0,5/17,11.10%,SHANK3;GNAS;IGSF11;CAMK2A;HIP1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.36031709381744104,-1.0905827722629837,0.3225806451612903,0.7147014096807578,1.0,8/28,15.27%,TNK2;MAP2K6;SGK1;LRRK2;PRKAA2;RPS6KA1;RPS6KB1;AKT1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.3591528816405606,-1.0905022577135348,0.31805929919137466,0.7084061068803321,1.0,12/28,25.25%,GRIK1;GABRG3;GRID2;GABRA1;GABRA2;GRIK2;CHRNA7;GABRA4;GABRG1;GRIK3;GRID1;GABRA5
prerank,RNA polymerase II complex binding (GO:0000993),0.43168620856825485,1.0901911103402564,0.36603221083455345,0.8717689206994503,1.0,16/32,24.06%,SMYD2;ELOF1;SCAF8;CTR9;WDR43;PAF1;ELP4;DHX9;ZNF326;UVSSA;URI1;NCOA3;RECQL5;PCIF1;ERCC5;WAC
prerank,metal ion binding (GO:0046872),0.3304080023085632,1.0901217025113816,0.26903553299492383,0.8673894948649516,1.0,47/477,9.02%,CDH1;SLIT3;SLIT2;SMOC2;THBS1;ACER3;EYA2;MAP3K5;CDH11;ANXA3;ANXA1;MARK1;ESYT3;PPP3CA;DSPP;GLCE;ANXA2;ESYT2;COLEC11;OC90;TGM3;GSN;STIM2;DSG2;ANXA4;DXO;ABL1;SYT8;GCLC;ITPR2;SIK3;DSC3;DSC2;TRPM4;PLSCR1;SIK2;HACL1;PITPNM3;TRIM26;MARK2;DYRK2;IQGAP1;PKD2L1;CDC42BPG;DYRK3;PLA2G4F;CD320
prerank,GABA receptor activity (GO:0016917),0.4666991002481562,1.089835602862567,0.36920529801324503,0.8637490531377976,1.0,1/21,0.33%,GPR156
prerank,histone methyltransferase activity (GO:0042054),0.4362205286547449,1.0881227706210812,0.374079528718704,0.864096851554447,1.0,13/32,25.29%,SMYD2;SETD2;EHMT2;EHMT1;KMT2C;CARM1;PRMT6;SUZ12;PRMT2;PRMT8;EED;EZH2;KMT5A
prerank,fatty acid synthase activity (GO:0004312),-0.4731061300085991,-1.0880209191576542,0.358974358974359,0.7080709589584339,1.0,3/10,9.35%,ELOVL7;ELOVL6;ELOVL4
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.37524292131344117,1.084733831445458,0.350253807106599,0.8691250152695209,1.0,4/75,2.44%,ME1;BDH2;EHHADH;ADH7
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4710728427464559,-1.0795931763227284,0.3877551020408163,0.7229153389568661,1.0,3/10,7.52%,SHANK3;GNAS;IGSF11
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5134991432968913,1.0791733101078187,0.38169257340241797,0.8800752149887259,1.0,4/11,20.20%,ALDH3A1;AKR1B10;AKR1B1;RDH13
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.42359266104211524,1.0784173974213123,0.3942446043165468,0.8776329707943882,1.0,17/33,24.06%,SMYD2;ELOF1;SCAF8;CTR9;WDR43;PAF1;LLPH;ELP4;DHX9;AR;ZNF326;UVSSA;URI1;NCOA3;RECQL5;ERCC5;WAC
prerank,NF-kappaB binding (GO:0051059),0.44840742231967745,1.075770475519583,0.40062597809076683,0.8805653429579526,1.0,5/24,12.18%,ANXA4;GSK3B;EP300;BCL10;MTDH
prerank,cGMP binding (GO:0030553),0.5111470649286417,1.073780945302986,0.39752650176678445,0.8816853383163208,1.0,3/11,10.41%,PDE5A;PDE10A;CNGB3
prerank,clathrin adaptor activity (GO:0035615),0.48899384894054976,1.0719025296509013,0.40765391014975044,0.8825964256285751,1.0,3/15,7.36%,STON1;AP2A2;AP2A1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.3913965741858152,1.0713567962378614,0.3772845953002611,0.8797063253669568,1.0,7/54,10.68%,ACER3;HDAC4;HDAC9;VNN1;HDAC10;PIGL;HDAC8
prerank,inward rectifier potassium channel activity (GO:0005242),0.45038288013222655,1.0677103766934912,0.382262996941896,0.8853246711440744,1.0,1/24,0.42%,KCNJ2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.4511263228369864,1.0641388648960908,0.38323353293413176,0.890607796972427,1.0,4/24,4.98%,PTK2B;CAMK2D;MKNK2;PHKA2
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.3867996525205986,-1.063903388135157,0.395,0.7565357658082038,1.0,7/20,14.69%,SLC30A10;SLC39A10;SLC39A8;SLC39A7;SLC30A4;SLC30A1;SLC39A3
prerank,protein phosphatase 2A binding (GO:0051721),-0.3643974303648223,-1.0624721583693748,0.3522727272727273,0.7533385889312366,1.0,14/23,28.47%,MFHAS1;FOXO1;DAB2IP;GRIN3A;SPHK1;MAPT;ENSA;ADCY8;IGBP1;BOD1;SMG7;CTTNBP2NL;SMG5;TP53
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.36460973815604075,1.0618019336801365,0.3710462287104623,0.8927635978558139,1.0,15/91,10.75%,KCNJ2;STXBP6;VILL;MARK1;ANXA2;SNX18;GSN;WIPI2;FZD7;PLEKHA4;RLBP1;SDCBP2;PLCD1;COMMD1;PARD3
prerank,Wnt-activated receptor activity (GO:0042813),0.4799789907508138,1.0601125007171184,0.4079861111111111,0.8929256953779129,1.0,8/15,19.38%,PKD1;FZD7;FZD2;LRP5;ROR1;FZD9;FZD3;RYK
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.4358069804254736,1.0545153393197806,0.4015267175572519,0.9042587674900961,1.0,2/25,3.69%,MICAL2;FMO1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.34069201366074936,1.0535021384595866,0.37970353477765106,0.9025177797413654,1.0,22/147,7.94%,DOCK5;PLCE1;ARHGEF28;CYTH3;AKAP13;RASGEF1B;RAP1A;DNMBP;BCR;RAPGEF6;ARHGEF6;RAB3GAP2;ARHGEF10;ARHGEF5;ANKRD27;HERC2;MYCBP2;DENND6A;DENND2C;VAV2;FGD6;SMCR8
prerank,calcium channel inhibitor activity (GO:0019855),-0.4475343421822378,-1.0434886364680482,0.4158878504672897,0.7965986268503278,1.0,2/11,3.34%,ITPR1;CALM1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4315039180771972,1.0427772229998549,0.4199395770392749,0.9277316233040714,1.0,10/24,25.71%,IP6K2;IP6K3;PPIP5K2;AK9;NME6;CMPK1;ITPKA;AK3;AK5;DTYMK
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.4112731129613997,1.042676023736996,0.41374474053295934,0.9236059358919505,1.0,17/35,30.36%,FTO;TRMT13;PUS10;DUS1L;QTRT2;QTRT1;TRDMT1;PTRH2;ELAC1;TRMT12;AARS1;DUS2;MTFMT;ELAC2;QRSL1;TRPT1;GATB
prerank,receptor tyrosine kinase binding (GO:0030971),-0.2992404057879946,-1.0414290913484392,0.36900369003690037,0.795323064677152,1.0,10/56,8.90%,DOCK4;PIK3R1;GRB14;NRG3;CBLB;SOCS5;ANGPT2;GAS6;FRS2;DUSP3
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.4042138116948858,-1.0400989843808879,0.4049382716049383,0.79214543347884,1.0,8/15,25.93%,PIK3R1;SOCS5;PIK3R6;PIK3R5;SOCS7;CCKBR;SOCS1;CISH
prerank,aminopeptidase activity (GO:0004177),0.418676019627039,1.0400579714535059,0.4177978883861237,0.9263188686069496,1.0,10/26,19.65%,NPEPPS;MMP16;MMP14;ERAP1;LAP3;XPNPEP1;METAP1D;XPNPEP3;MMP17;METAP1
prerank,phospholipase activator activity (GO:0016004),-0.44788074390431964,-1.0395551949704698,0.4149184149184149,0.7867615531843468,1.0,6/10,37.56%,ARHGAP6;SRC;BTK;CCL5;LCK;CCL8
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.40881712562876404,1.0390649388219073,0.4177583697234352,0.9247461208665508,1.0,9/34,10.75%,CYTH3;ARAP1;ARAP2;ZFYVE1;GAB2;IQGAP1;DAPP1;COMMD1;PARD3
prerank,ATP binding (GO:0005524),-0.23857186585187137,-1.0379709603976104,0.2641509433962264,0.7838853153045372,1.0,65/266,18.00%,ATP1A2;MYO1B;KSR1;PEAK1;RPS6KA5;PRKAG2;ENPP1;ABCA1;MAP3K20;AKT3;SNRK;HSPA8;DMPK;MAP4K3;ERN1;PRKACB;INSR;MYO18A;CDK6;ABCC6;MYH9;DAPK2;RHOBTB3;MAP4K4;ACLY;SYN1;WNK2;LANCL2;DAPK1;P2RY1;PNPLA8;MTHFS;CDKL5;PEX6;HSPA9;SPHK1;HSP90AB1;ABCB8;TAP2;MLKL;UHMK1;OAS2;STK17B;KCNJ8;ATP5F1D;BRSK2;BLM;PFKM;PDK2;AKT1;P2RX7;ATP5F1A;PNKP;MYH10;ACVR1B;STK3;PIM1;ATP7A;ABCG1;STK26;GUK1;TWF2;PRPS1L1;PRPS1;MYO1F
prerank,ligand-gated calcium channel activity (GO:0099604),-0.3863260175947686,-1.0375459984974975,0.42297650130548303,0.7783886752702008,1.0,6/19,14.09%,ITPR1;GRIN2A;GRIN2B;RYR2;GRIN1;RYR3
prerank,hormone receptor binding (GO:0051427),0.47574004991166385,1.0366936968573464,0.4318555008210181,0.9269786366719605,1.0,4/14,19.62%,SOCS2;VIP;PTHLH;ADCYAP1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.45064470042530685,1.0352083081201848,0.41883116883116883,0.9267353645201697,1.0,2/19,1.89%,EFNA5;ABI1
prerank,NADP binding (GO:0050661),0.40387737465078005,1.034180256162362,0.4117647058823529,0.925107054576527,1.0,7/32,13.14%,ME1;GMDS;DECR1;LBR;NOX1;DUOX1;NNT
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3236437106620051,1.0319233571757547,0.4247020585048754,0.9268305978776984,1.0,42/232,14.70%,WWP1;TRAF3IP2;NEDD4;WWP2;BIRC7;RNF138;RNF115;EGR2;RNF19A;UBR4;RNF185;PIAS3;HERC2;MYCBP2;PIAS2;ARIH1;TRIM44;TRIP12;TRIM26;LRSAM1;RNF135;TRIM7;RNF2;UBE2D3;ASB1;MKRN1;UHRF2;TRIM25;ARIH2;CDC42;FBXO17;RNF10;KCMF1;UBR5;BIRC3;RNF111;BFAR;NSMCE2;SMURF1;PPIL2;TRIM41;UFL1
prerank,ferrous iron binding (GO:0008198),0.438212371947442,1.0301821407092646,0.41185897435897434,0.9270417296088995,1.0,3/21,6.30%,EGLN3;FTO;CDO1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.4167201228600067,1.0288631536319057,0.4114285714285714,0.9261676693764571,1.0,9/29,20.67%,ABL1;DUSP16;DUSP10;DUSP5;ATF7;DIRAS1;MAPKAPK2;TNIP1;NFATC1
prerank,peptidoglycan binding (GO:0042834),-0.44947857512633094,-1.027643923735779,0.42572062084257206,0.7980885514165822,1.0,3/10,16.12%,PGLYRP1;NOD1;HK1
prerank,ribosomal large subunit binding (GO:0043023),-0.4320749769612807,-1.0274853418094612,0.4405940594059406,0.7919234452450065,1.0,2/11,6.00%,CPEB2;CPSF6
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.38604209122345273,-1.0269453202978145,0.4403183023872679,0.786826508855815,1.0,8/18,22.48%,PIK3R1;SOCS5;PIK3R6;WDR91;PIK3R5;SOCS7;CCKBR;SOCS1
prerank,phosphate ion binding (GO:0042301),-0.43586864059691643,-1.0261014611672261,0.4401805869074492,0.7825558603620453,1.0,6/10,38.89%,PDE2A;RPH3A;RELA;CHST14;ADSS1;PNP
prerank,lysine N-methyltransferase activity (GO:0016278),0.44987625231219014,1.0222541403432936,0.4675118858954041,0.9390307004114964,1.0,7/20,20.93%,SMYD2;SETD2;METTL21C;EHMT2;EHMT1;EEF1AKMT1;METTL21A
prerank,acetyltransferase activity (GO:0016407),0.41097045781410674,1.0217079840548642,0.432510885341074,0.9363054110279678,1.0,8/31,20.78%,KAT6B;EP300;CREBBP;KAT2B;PAFAH1B2;LCAT;SAT1;GNPNAT1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3648347689713978,1.0182178688719044,0.4416243654822335,0.9412081368114248,1.0,12/71,9.90%,EYA2;PTPN3;PTP4A2;PTPRU;CDC25B;EYA4;EYA3;PTPN2;PTPN21;PTPRF;PTPRA;PTPDC1
prerank,MAP kinase phosphatase activity (GO:0033549),0.5002486193291573,1.0155621091829174,0.46283783783783783,0.9438521083101211,1.0,3/12,9.99%,DUSP16;DUSP10;DUSP5
prerank,muscle alpha-actinin binding (GO:0051371),0.46692216240953727,1.0139275700250967,0.44201680672268906,0.9439576701046398,1.0,3/15,8.41%,PDLIM7;PDLIM5;PKD2L1
prerank,amyloid-beta binding (GO:0001540),0.35626185730106824,1.013681617993578,0.44065656565656564,0.9403915913503508,1.0,3/79,3.11%,COL25A1;LRPAP1;ADRB2
prerank,death receptor activity (GO:0005035),-0.4408570088496979,-1.0120032896120694,0.4321608040201005,0.8126875307819174,1.0,4/11,11.37%,TNFRSF19;FAS;TNFRSF1A;TNFRSF11A
prerank,1-phosphatidylinositol binding (GO:0005545),-0.39272079658321635,-1.0117955724421115,0.4509283819628647,0.8067051711405361,1.0,3/15,6.18%,PICALM;EPB41;SCARB1
prerank,ubiquitin protein ligase activity (GO:0061630),0.31699403321455877,1.0110517310203206,0.46912242686890576,0.9433338022961217,1.0,39/228,14.61%,WWP1;TRAF3IP2;NEDD4;UBE4B;WWP2;BIRC7;RNF138;RNF115;RNF19A;UBR4;RNF185;HERC2;MYCBP2;ARIH1;TRIM44;TRIP12;TRIM26;LRSAM1;RNF135;TRIM7;RNF2;UBE2D3;ASB1;MKRN1;UHRF2;TRIM25;ARIH2;CDC42;FBXO17;RNF10;KCMF1;UBR5;BIRC3;RNF111;BFAR;SMURF1;UBE4A;PPIL2;TRIM41
prerank,BMP binding (GO:0036122),-0.43176457052148254,-1.0100038966847886,0.4598698481561822,0.8050315731996911,1.0,2/11,2.35%,ENG;GREM2
prerank,chloride channel regulator activity (GO:0017081),0.46599040397873104,1.0098856744772795,0.4555921052631579,0.9419995055578355,1.0,3/14,6.79%,WNK1;SGK3;STX8
prerank,transcription coactivator binding (GO:0001223),-0.36813506921809425,-1.0096055979437357,0.4339622641509434,0.7996682208608205,1.0,5/20,6.69%,AHR;TEAD2;PPARD;VGLL4;RPL23
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.407150710380456,-1.0059587381390986,0.45248868778280543,0.8026922781742147,1.0,7/13,18.47%,GABRG3;GABRA1;GABRA2;GLRA1;GABRA4;GABRG1;GLRA3
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.35684572900496847,-1.0057302860531618,0.45231607629427795,0.7970491193049177,1.0,4/22,9.92%,CPEB2;HNRNPA0;ELAVL4;EXOSC8
prerank,adrenergic receptor binding (GO:0031690),-0.3836423957477716,-1.0056604350717382,0.43703703703703706,0.7911297428763553,1.0,5/16,8.87%,RAPGEF2;GNAS;ADRA2A;PDE4D;APLP1
prerank,kinase binding (GO:0019900),0.3039715996756576,1.005456211941869,0.48577235772357724,0.9496462719279096,1.0,88/435,17.48%,EGFR;SLC12A7;SLC12A2;TCF7L2;PKD1;ANK2;FOXO3;CCNA2;UNC5C;SHC1;WNK1;CIT;TAX1BP1;PRKCD;CNTLN;GSN;GSK3B;RNF138;CDC25B;PFKFB2;AP2A2;SPRED2;ACSL3;TTC28;NR4A3;DNAJC3;PIP5K1A;BECN1;TNNI3;TRIP6;DLG1;HCLS1;PRAM1;MAVS;PTPN2;AP2A1;SMCR8;IQGAP1;IRAK4;ADAM10;NSF;BCAR3;BCL10;TELO2;CHEK2;CDKN1B;SKI;RHOBTB1;PAK2;CDC42;PPP1R12A;RB1;NISCH;SQSTM1;FAM83H;RHOA;ATP1A4;STAT3;NEK9;TRADD;KAT2B;RB1CC1;ZBTB4;MOB1B;FOXM1;TRAP1;CAB39;DLG2;ILK;CDKN2D;UFL1;RND3;EMP2;PRDX3;DOK7;PRKACA;MAP3K12;LAX1;PAX6;CDK5RAP1;CCND3;FLNA;FBXW5;CARD16;FAF1;VRK2;ATF2;ADIPOR1
prerank,ion gated channel activity (GO:0022839),-0.35621431390885583,-1.0052633178116563,0.4270557029177719,0.7859762338423572,1.0,9/24,14.93%,KCNT2;ANO4;ANO3;TTYH2;TTYH3;TMEM63B;TTYH1;KCNT1;ANO2
prerank,protein kinase binding (GO:0019901),0.30434433108393755,1.0034834113214555,0.5060851926977687,0.9506252907886726,1.0,100/480,17.48%,SLC12A7;SLC12A2;GRK5;TCF7L2;PKD1;ANK2;FOXO3;EZR;CCNA2;DSP;UNC5C;ITGB1;SHC1;WNK1;CIT;HDAC9;PRKCD;CNTLN;ADAM9;GSK3B;RNF138;ABL1;CDC25B;PFKFB2;AP2A2;SPRED2;PDLIM5;ACSL3;DUSP16;NR4A3;DNAJC3;PRKCSH;BECN1;TNNI3;IRS1;PPEF2;ITGAV;DLG1;CAVIN2;HCLS1;PRAM1;MAVS;PTPN2;AP2A1;DUSP10;NELL1;SMCR8;IQGAP1;IRAK4;ADAM10;NSF;BCL10;TELO2;CHEK2;CDKN1B;TCF3;SKI;DUSP5;RHOBTB1;PAK2;CDC42;PPP1R12A;ACVR1;NISCH;SQSTM1;FAM83H;CSK;RHOA;STAT3;NEK9;PRKAR2A;KAT2B;RB1CC1;ZBTB4;FOXM1;TRAP1;MAPK8IP3;ILK;CDKN2D;UFL1;ATF7;RND3;EMP2;PRDX3;DOK7;PRKACA;DIRAS1;MAP3K12;LAX1;PAX6;DUSP22;CDK5RAP1;CCND3;FBXW5;FAF1;SPAG9;VRK2;ATF2;MAPKAPK2;ADIPOR1
prerank,transition metal ion binding (GO:0046914),0.3049110911832356,1.0028532619875155,0.4750254841997961,0.9481391326236874,1.0,71/397,15.15%,ME1;AOX1;ACER3;TES;ZFPM2;HDAC4;MPPED2;HHIP;NPEPPS;ADH7;KLF4;LARGE1;SEC24B;EEA1;ABL1;KLF7;ZMYND8;ZNF8;PLSCR1;ZFYVE1;PHEX;MYCBP2;TAB3;CLIP1;MMP16;ARIH1;FDX1;MSRB2;P2RX4;IDE;TK1;HDAC10;CZIB;DYRK2;SCD;RNF2;TIMP2;MDM4;MNAT1;ERAP1;USP33;RBSN;MBD1;SKI;CAD;B4GALT1;CCS;LACTB2;COMMD1;ITGB1BP2;ARIH2;B4GALT7;XPNPEP1;TYW5;ADAM8;RXRA;APIP;RABIF;LARGE2;PITRM1;ABCE1;EXD2;ZMYM2;SCO2;ZDHHC15;THAP1;DUSP12;ZBTB32;FBXL19;NFU1;XPNPEP3
prerank,low-density lipoprotein particle binding (GO:0030169),0.44469750131425867,1.0014222321206625,0.4773109243697479,0.9476122240671491,1.0,1/16,0.45%,THBS1
prerank,anion transmembrane transporter activity (GO:0008509),-0.405140357427921,-0.9995973421830164,0.4794520547945205,0.7942115328669247,1.0,3/12,5.63%,SLCO2B1;SLC22A6;SLC39A8
prerank,phosphotyrosine residue binding (GO:0001784),0.38915645713534025,0.9966251213063976,0.4631728045325779,0.9562459698509485,1.0,7/37,8.42%,PTPN3;SHC1;ABL1;NCK2;IRS1;VAV2;BCAR3
prerank,G protein-coupled receptor binding (GO:0001664),-0.24192401665149188,-0.9955024549379166,0.4666666666666667,0.7984418579035564,1.0,16/132,6.96%,WNT4;WNT5B;ZNRF3;WNT6;WNT5A;GNAS;HSPA8;GRK3;PTCH1;CXCL12;ACE;REEP1;S1PR1;ARRB1;SDCBP;GPRC5B
prerank,alpha-actinin binding (GO:0051393),0.4288677445539337,0.9954333863146112,0.4728434504792332,0.9553025232448087,1.0,5/24,8.41%,PDLIM7;CACNA1C;PDLIM5;MAGI1;PKD2L1
prerank,magnesium ion binding (GO:0000287),0.3314592709151885,0.9950440175883929,0.48826291079812206,0.9521930092645146,1.0,23/135,15.26%,EYA2;MAP3K5;MARK1;DXO;ABL1;GCLC;SIK3;PLSCR1;SIK2;HACL1;MARK2;DYRK2;CDC42BPG;DYRK3;DIS3L2;FOXK2;NLK;SRPK1;EXD2;RAN;CLYBL;STK11;ERN2
prerank,protein tyrosine kinase binding (GO:1990782),-0.27225969460588395,-0.994637706531782,0.47596153846153844,0.7947873018338674,1.0,12/71,8.90%,DOCK4;GRB14;NRG3;GRM5;CBLB;SOCS5;ANGPT2;NEDD9;EPHA4;SIRPA;GAS6;DUSP3
prerank,solute:proton symporter activity (GO:0015295),0.43248585812589035,0.9922408123633084,0.46942148760330576,0.9553092896262068,1.0,1/16,1.16%,SLC2A13
prerank,guanyl ribonucleotide binding (GO:0032561),0.3144565068049231,0.9921719546279496,0.5010729613733905,0.9513391035382102,1.0,40/196,16.32%,MPPED2;PDE5A;RHOJ;ATL3;MRAS;NRAS;KRAS;PDE10A;GNL1;RAP1A;BMS1;ARF4;RAB6A;ARF3;ARHGEF5;ARL3;RAP2C;ATL2;RAB18;RHOQ;RAB27B;RIT1;EIF2B2;CNGB3;RHOBTB1;CDC42;ARL8A;GTPBP4;RHOA;TUBB2B;LSG1;RAB42;RAN;RAB5A;RRAS2;RND3;RAB17;DIRAS1;RRAGB;GBP6
prerank,death domain binding (GO:0070513),0.4698460152688685,0.9878030281793425,0.45454545454545453,0.9587423598932205,1.0,3/11,12.87%,DAPL1;CRADD;TRADD
prerank,ubiquitin protein ligase binding (GO:0031625),0.30868480315625385,0.9865574216792391,0.5195227765726681,0.9578641547614425,1.0,56/254,17.17%,EGFR;SNCAIP;FHIT;USP13;TANK;SMAD6;MID1;GSK3B;EGR2;UBE2B;VCP;BECN1;HERC2;CLU;VCL;NPLOC4;ARIH1;USP2;JUN;FATE1;USP7;TNFRSF1B;CASC3;BCL10;CHEK2;MOAP1;CXCR4;SKI;WASHC1;RB1;TRIOBP;SQSTM1;USP25;IKBKE;GPI;NLK;TNFRSF14;CUL4A;FAF2;UBE2W;PRKAR2A;XRCC5;TRAF5;TSG101;RNF31;HSPA1L;AMBRA1;EIF4E2;SLC22A18;TCP1;PRKACA;PML;SPOP;UBE2N;FAF1;UBE2G1
prerank,single-stranded RNA binding (GO:0003727),0.3738715788851996,0.9860622697427699,0.47790055248618785,0.9551387205619416,1.0,7/43,15.78%,STRBP;L1TD1;ZFR;LACTB2;DDX11;JMJD6;DHX9
prerank,metalloexopeptidase activity (GO:0008235),0.3601520188133739,0.9860465620247384,0.4476584022038568,0.9511383872146848,1.0,16/51,17.05%,NPEPPS;CPA5;CPQ;CPA4;CPA3;MMP16;MMP14;CPB1;ERAP1;LAP3;XPNPEP1;METAP1D;CPE;XPNPEP3;AGTPBP1;MMP17
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4226684394299616,0.9860027289544928,0.48575949367088606,0.9472521830960233,1.0,5/21,16.23%,P2RX2;GLRB;P2RX4;CHRNA4;CHRNB1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.3379181790431287,0.9846661716050481,0.46514575411913817,0.9466097636121915,1.0,15/78,12.09%,CAPN5;USP13;USP46;CAPN2;CAPN6;USP24;USP2;USP49;CAPN10;USP7;USP10;USP33;USP34;USP25;USP47
prerank,chloride channel inhibitor activity (GO:0019869),0.47891745297781335,0.9836475981809629,0.48841354723707664,0.9454138033408137,1.0,2/10,6.79%,WNK1;STX8
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.2674937134558611,-0.9829288339652634,0.48186528497409326,0.818658805988567,1.0,24/74,23.69%,NADK2;DGKB;DGKI;GK;PGM2L1;DGKD;SPHK1;PANK1;PIK3C2A;IDNK;HK2;IPMK;PAPSS1;DGKG;DGKE;HK1;PKM;IPPK;PIK3CD;DCAKD;SPHK2;MVK;XYLB;PIK3CG
prerank,glycerophospholipid flippase activity (GO:0140333),0.46556136708233187,0.982414776702635,0.4956369982547993,0.9444495611836546,1.0,2/11,4.94%,ATP10A;ATP8B1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.30517389263395117,0.9814565728222645,0.5287846481876333,0.9429056727787113,1.0,57/269,17.17%,EGFR;SNCAIP;FHIT;USP13;TANK;SMAD6;MID1;GSK3B;EGR2;UBE2B;VCP;DDRGK1;BECN1;HERC2;CLU;VCL;NPLOC4;ARIH1;USP2;JUN;FATE1;USP7;TNFRSF1B;CASC3;BCL10;CHEK2;MOAP1;CXCR4;SKI;WASHC1;RB1;TRIOBP;SQSTM1;USP25;IKBKE;GPI;NLK;TNFRSF14;CUL4A;FAF2;UBE2W;PRKAR2A;XRCC5;TRAF5;TSG101;RNF31;HSPA1L;AMBRA1;EIF4E2;SLC22A18;TCP1;PRKACA;PML;SPOP;UBE2N;FAF1;UBE2G1
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.34971795415764884,0.9791602140672638,0.4874835309617918,0.9446615553962259,1.0,7/60,6.07%,EGFR;MET;NTRK3;FGFR1;DDR2;EPHB6;TGFBR2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.42352908328767397,-0.9791126140193339,0.5044843049327354,0.8224497756751213,1.0,4/10,19.64%,DPP4;PRCP;DPP10;DPP6
prerank,nucleotide diphosphatase activity (GO:0004551),0.4443247941894182,0.9769199259236434,0.48653198653198654,0.94626664584378,1.0,2/14,4.89%,FHIT;NUDT4
prerank,phospholipase activity (GO:0004620),0.34809376534831593,0.9759742000275909,0.507537688442211,0.9447836429613017,1.0,8/67,8.79%,PLCE1;PNPLA3;DDHD1;MGLL;PLCB3;PITPNM3;ABHD6;PLA2G4F
prerank,phosphatidylinositol binding (GO:0035091),0.3272479616468301,0.9758018773405408,0.4975669099756691,0.9413448315739325,1.0,25/91,19.17%,TNFAIP8L3;ESYT3;PITPNA;PITPNC1;ESYT2;EEA1;SNX24;ITPR2;ZFYVE1;SNX31;PITPNB;PIGU;BCAS3;PHF12;PARD3;SNX4;SNX12;SNX17;SH3YL1;SNX2;PITPNM2;FCHO2;GRAMD2A;GPAA1;SNX13
prerank,ubiquitin-protein transferase activity (GO:0004842),0.29909812621516396,0.9749578565923439,0.5502092050209205,0.9396691914970245,1.0,76/346,18.88%,WWP1;TRAF3IP2;NEDD4;FBXO10;WWP2;BIRC7;RNF138;KLHL13;RNF115;UBE2B;RNF19A;UBR4;RNF185;FBXW8;BIRC6;HERC2;MYCBP2;FBXW11;ARIH1;TRIM44;TRIP12;TRIM26;RNF141;LRSAM1;RNF135;TRIM45;TRIM7;RNF2;UBE2D3;FBXO4;RNF168;ASB1;FBXL6;MKRN1;UHRF2;UBE2Z;TRIM25;ARIH2;RNF214;CDC42;TAF1;FBXO17;RNF10;KCMF1;UBR5;FBXW2;ERCC8;BIRC3;RNF111;CUL4A;UBE2W;BFAR;TRAF5;RNF31;SMURF1;PPIL2;TRIM41;FBXL14;RNF146;FBXO25;PML;UBE3D;UBE2S;UBE2N;COP1;RNF122;UBE2G1;RNF114;HUWE1;RNF144A;DTX3;TRIM47;RC3H2;PEX12;MEX3C;SEL1L2
prerank,protein kinase C activity (GO:0004697),-0.39096174869136735,-0.974867262761455,0.4777227722772277,0.8265729496399631,1.0,7/14,18.79%,PRKCH;PRKD1;PRKCQ;PRKD3;PKN1;PRKCZ;PRKCI
prerank,microtubule binding (GO:0008017),0.30632630068885947,0.9738662152238509,0.5277185501066098,0.9386373965449397,1.0,37/222,13.30%,RP1;MAPRE2;NDRG1;CLIP4;EZR;KIF13A;FMN1;MTUS1;MID1;GAS2L2;CAPN6;HDGFL3;NDEL1;DYNC1I1;MAP7D3;PAFAH1B1;CLIP1;KIF1B;ARL3;FBXW11;KIF1C;FGF13;SPEF1;CEP295NL;VAPA;RMDN1;KIF27;TUBGCP4;KIF2C;TOGARAM1;CEP44;TUBGCP5;KIF7;CEP57;KIF9;MAP1B;CCDC66
prerank,carboxy-lyase activity (GO:0016831),0.40671398729614017,0.9736804531834843,0.4953416149068323,0.9352809016424228,1.0,8/23,22.46%,ECHDC1;MVD;ACOD1;CSAD;PPCDC;AZIN1;UMPS;PCK2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3403240937992676,0.9702120829242405,0.5012285012285013,0.9397976301703589,1.0,19/69,19.84%,SOAT1;MOGAT3;KAT6B;DGAT2L6;EP300;CREBBP;CERS6;CERS5;ZDHHC5;KAT2B;ZDHHC15;PLA2G4A;PLA2G15;CERS3;MCAT;ZDHHC7;NMT1;MOGAT1;LIPT1
prerank,snoRNA binding (GO:0030515),0.39028534007937093,0.9700520749095959,0.4766081871345029,0.9363989689713507,1.0,12/30,26.03%,BMS1;NUDT4;UTP6;WDR3;XRCC5;NUDT7;PRKDC;NOP58;NOP56;TSR1;DDX21;HEATR1
prerank,CoA hydrolase activity (GO:0016289),0.4255717398473055,0.9685399237793795,0.4991364421416235,0.9361649333903815,1.0,7/16,25.37%,ACOT8;NUDT7;HIBCH;ACOT13;ACOT12;ACOT9;ACOT1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.3957758587800295,0.9670511311143634,0.4945054945054945,0.9360603091309927,1.0,4/26,2.82%,SLC5A6;SLC16A9;SLC16A1;ABCG2
prerank,ephrin receptor binding (GO:0046875),-0.35090524903712106,-0.9655101684996594,0.5128865979381443,0.8441663412287194,1.0,7/21,13.11%,EFNB2;LYN;CHN1;SRC;GRB2;EFNB3;EFNB1
prerank,RNA methyltransferase activity (GO:0008173),0.426254291098716,0.9646731962010744,0.5169082125603864,0.9383706302230937,1.0,7/19,23.16%,TRMT13;MRM2;METTL4;MEPCE;TRDMT1;TRMT12;FTSJ3
prerank,lipase activity (GO:0016298),0.36252329271567174,0.9623937452080802,0.5048543689320388,0.9399548819117247,1.0,11/43,15.95%,PNPLA3;DDHD1;MGLL;DAGLB;PITPNM3;ABHD6;LDAH;ABHD5;ABHD15;LCAT;PLA2G15
prerank,amino acid binding (GO:0016597),-0.3097503507904305,-0.9621235696116005,0.5190615835777126,0.8468502337601299,1.0,11/31,18.47%,NOS3;GRM7;GRIN2B;GRIN3A;GLRA1;ASS1;AGXT;GRIN1;NOS1;DDAH2;GLRA3
prerank,voltage-gated calcium channel activity (GO:0005245),-0.30085509800506605,-0.9585880671976443,0.5137931034482759,0.8499944183969637,1.0,10/37,14.71%,CACNA2D3;CACNA1D;CACNA1E;CACNG4;CACNG7;CACNA1B;CACNA2D1;CACNB4;CACNA1I;CACNB1
prerank,lipoprotein particle binding (GO:0071813),0.40865299610214667,0.958204926149589,0.5129449838187702,0.9462739437438331,1.0,1/20,0.45%,THBS1
prerank,phosphatidylglycerol binding (GO:1901611),0.4531363824007756,0.957108928175015,0.5299295774647887,0.9451230821695172,1.0,2/13,2.59%,PITPNA;PITPNC1
prerank,MAP kinase activity (GO:0004707),-0.38797319649471435,-0.9551047714020203,0.5037220843672456,0.852103810630125,1.0,2/14,6.10%,MAPK4;MAPK3
prerank,translation initiation factor activity (GO:0003743),0.3734495676926449,0.9526906003728947,0.5214285714285715,0.9518304843406088,1.0,11/36,21.97%,EIF4G3;EIF4G1;EIF2D;EIF2B2;COPS5;EIF4E2;EIF2B3;EIF2S2;EIF4G2;EIF3A;EIF3E
prerank,ligand-gated cation channel activity (GO:0099094),0.32931769273145134,0.9524945005468823,0.5248756218905473,0.9486733574820686,1.0,7/75,8.29%,KCNJ2;PTK2B;P2RX2;TRPM4;GRIN2C;P2RX4;KCNJ15
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.3653985353168856,-0.9481412924885719,0.5325581395348837,0.8573685747161969,1.0,6/16,14.93%,ANO4;ANO3;TTYH2;TTYH3;TTYH1;ANO2
prerank,intracellular chloride channel activity (GO:0061778),-0.3653985353168856,-0.9481412924885719,0.5325581395348837,0.8573685747161969,1.0,6/16,14.93%,ANO4;ANO3;TTYH2;TTYH3;TTYH1;ANO2
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3705914697759005,0.9475769313356086,0.5491329479768786,0.9562736138323574,1.0,16/34,27.50%,ERI3;PAN3;CNOT7;ANGEL1;EXOSC7;DIS3L2;REXO2;EXD2;PNLDC1;EXOSC5;EXOSC4;ANGEL2;ERI2;TOE1;NOCT;PNPT1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.44209250165491576,0.9455564096552878,0.5490848585690515,0.9572930238075952,1.0,3/15,4.65%,HS3ST4;HS3ST1;HS6ST2
prerank,Hsp70 protein binding (GO:0030544),-0.3119758600772381,-0.9451466356889284,0.5283018867924528,0.8589048572827039,1.0,6/31,8.93%,ERN1;SNCA;SACS;GPR37;RPS3;DNAJC10
prerank,ATP hydrolysis activity (GO:0140603),-0.2959415082457324,-0.9435583547817473,0.5428571428571428,0.8568464505446282,1.0,8/41,9.97%,ABCA4;MYO18A;RHOBTB3;ATP2B1;KIF26A;RNF213;RUVBL1;SMCHD1
prerank,protein kinase inhibitor activity (GO:0004860),0.3569632830425674,0.941373163129283,0.5245664739884393,0.9634974320635482,1.0,6/42,8.98%,PARVA;CIT;SPRED2;DNAJC3;SMCR8;CDKN1B
prerank,methylated histone binding (GO:0035064),0.33671301242475493,0.9400457064446117,0.5506666666666666,0.9630436033421351,1.0,25/62,28.83%,TDRD3;SGF29;ZMYND8;BPTF;MBTD1;TAF1;CBX2;MORC3;GLYR1;SUZ12;LRWD1;ATRX;CBX5;SPIN4;MPHOSPH8;FMR1;ING3;JMJD7;ING1;WDR5;PHF19;KDM5A;NCAPD3;PYGO1;CHD5
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.4510227738666832,0.9389596473988197,0.5209790209790209,0.9617565903792251,1.0,2/11,13.69%,NUDT4;NUDT7
prerank,neurexin family protein binding (GO:0042043),0.45414796139176056,0.9383753599225658,0.5257548845470693,0.9594212845767655,1.0,4/10,18.22%,SYTL5;SYTL4;CPE;SYTL3
prerank,aspartic-type peptidase activity (GO:0070001),0.4575945360027819,0.9378409747795742,0.5328467153284672,0.9569708360122557,1.0,3/10,19.93%,DDI2;NAPSA;BACE2
prerank,methylation-dependent protein binding (GO:0140034),0.3389266356289161,0.936066699377837,0.554945054945055,0.957696540423115,1.0,23/57,28.27%,TDRD3;SGF29;ZMYND8;BPTF;MBTD1;CBX2;MORC3;GLYR1;SUZ12;LRWD1;ATRX;CBX5;SPIN4;MPHOSPH8;FMR1;ING3;JMJD7;ING1;WDR5;PHF19;KDM5A;NCAPD3;PYGO1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.39552986161900006,-0.9354649478033072,0.5661764705882353,0.8715309954827245,1.0,3/11,8.46%,LEF1;MBD2;GATA2
prerank,GTPase activity (GO:0003924),0.2986158089712904,0.9354121898159419,0.6021978021978022,0.9556621846540375,1.0,40/192,16.81%,ARHGDIB;RHOJ;ATL3;MRAS;NRAS;KRAS;GNL1;RAP1A;BMS1;RAB43;RAB6A;RAP2C;ATL2;RAB18;RHOQ;RAB27B;GNA13;RIT1;GFM2;SAR1B;RHOBTB1;CDC42;GNG8;GNB3;ARL8A;GTPBP4;RHOA;LSG1;RAB42;RAN;RAB5A;RRAS2;RND3;RAB17;DIRAS1;NKIRAS2;RRAGB;GBP6;GSPT1;RAB22A
prerank,zinc ion binding (GO:0008270),0.28883440219620665,0.9347389882543118,0.640625,0.953627957462612,1.0,50/293,14.58%,ACER3;TES;ZFPM2;HDAC4;HHIP;NPEPPS;ADH7;KLF4;SEC24B;EEA1;KLF7;ZMYND8;ZNF8;PLSCR1;ZFYVE1;PHEX;MYCBP2;TAB3;CLIP1;MMP16;ARIH1;MSRB2;P2RX4;IDE;TK1;HDAC10;CZIB;RNF2;TIMP2;MDM4;MNAT1;ERAP1;USP33;RBSN;MBD1;SKI;CAD;LACTB2;ITGB1BP2;ARIH2;ADAM8;RXRA;APIP;RABIF;PITRM1;ZMYM2;ZDHHC15;THAP1;DUSP12;ZBTB32
prerank,protein tyrosine kinase activity (GO:0004713),0.3128201843940118,0.9329742887031977,0.5631768953068592,0.9541936263166932,1.0,9/108,4.13%,EGFR;MET;NTRK3;PTK2B;FGFR1;DDR2;HIPK1;CLK1;ABL1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.3618485007946112,0.9303245299171499,0.5256410256410257,0.9567945116682116,1.0,6/37,13.56%,WARS2;EARS2;YARS1;CARS2;NARS2;FARSA
prerank,single-stranded DNA binding (GO:0003697),0.3194881149532268,0.9301833294849854,0.5700123915737298,0.9535957585709728,1.0,31/93,24.03%,CRY2;RNF138;IGHMBP2;MCM7;SWSAP1;TOP3A;RAD52;BRCA2;ERCC1;STN1;RPA1;RAD51AP1;RTF1;DDX11;RAD23B;RBBP8;XPC;DHX9;TOP1;MCM9;POLA1;REXO4;POLR2H;LONP1;PMS2;SHOC1;MCM6;MCMDC2;FUBP1;ERCC5;HMGB2
prerank,DNA polymerase activity (GO:0034061),0.40017919860717827,0.9301185796630661,0.5592417061611374,0.9502689751940994,1.0,9/22,27.90%,REV3L;REV1;POLD3;POLB;POLA1;CHRAC1;TERT;POLK;POLQ
prerank,semaphorin receptor binding (GO:0030215),0.38644043670429595,0.9299595458714458,0.5396825396825397,0.9471578749584678,1.0,3/23,2.85%,SEMA3D;SEMA3C;SEMA3E
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.40831449384576723,0.9275564629755346,0.5552,0.9489873649834532,1.0,17/17,59.21%,AK9;NME6;CMPK1;AK3;AK5;DTYMK;AK4;AK8;NOL9;CLP1;CMPK2;NME4;AK1;NME1;NME2;NME3;AK7
prerank,telomeric DNA binding (GO:0042162),0.36463911958907796,0.9258776969858239,0.5560407569141194,0.9492615684945003,1.0,10/32,19.49%,SMG6;KDM1A;SMG1;TELO2;STN1;RPA1;XRCC5;WRN;ACD;UPF3A
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.3428306035832467,-0.9241147755889538,0.5805626598465473,0.8933999398787457,1.0,15/18,50.66%,HSD17B7;HSD11B1;HSD17B10;HSD17B14;HSD17B1;SRD5A2;HSD3B2;HSD17B8;AKR1C1;DHRS9;RDH16;DHRS11;HSD17B6;HSD17B3;RDH5
prerank,sequence-specific mRNA binding (GO:1990825),0.459374702432424,0.9235770974018631,0.5496575342465754,0.9510120001433666,1.0,5/10,32.69%,ETF1;DHX9;FMR1;DHFR;SSB
prerank,AMP binding (GO:0016208),0.44319277828334724,0.9226178884397319,0.5682242990654206,0.9495355995531543,1.0,2/11,7.17%,MPPED2;PFKP
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.3743100820474214,0.9224651856209614,0.5432835820895522,0.9464973416149022,1.0,14/31,26.52%,UBE2B;BIRC6;UBE2D3;UBE2Z;TAF1;UBE2W;UBE2S;UBE2N;UBE2G1;UBE2Q2;UBE2L6;UBE2H;UBE2K;UBE2R2
prerank,hydro-lyase activity (GO:0016836),0.3480103069481224,0.9220964271125764,0.5514285714285714,0.9439778472446583,1.0,6/41,8.51%,GMDS;EHHADH;AUH;ECHDC1;TGDS;CYP2S1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.3802701988232885,-0.9220203638913026,0.5696821515892421,0.8924257124608767,1.0,5/12,23.33%,SLC38A5;SLC6A6;SLC3A2;SLC7A8;SLC36A2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3664969413728046,0.9178381524298511,0.5623145400593472,0.9502085130267853,1.0,10/34,17.17%,UBE2B;BIRC6;UBE2F;UBE2D3;UBE2Z;TAF1;UBE2W;UBE2S;UBE2N;UBE2G1
prerank,deoxyribonuclease activity (GO:0004536),0.424657231916882,0.9175509763464421,0.5498338870431894,0.9474612644008515,1.0,6/14,23.94%,APLF;DFFB;MBD4;MRE11;APEX1;ERCC5
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.36324984285699546,0.9168695734516763,0.5644916540212443,0.9455994134404592,1.0,9/32,19.50%,EGLN3;FTO;RIOX2;TYW5;JMJD4;KDM2A;TMLHE;RIOX1;ALKBH5
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.4332309366047954,0.9156348372372778,0.5591985428051002,0.9450219914002145,1.0,4/12,12.60%,JMJD1C;KDM1A;KDM4D;KDM3B
prerank,heme binding (GO:0020037),-0.253471054059559,-0.9141890558868526,0.616822429906542,0.905434216442636,1.0,9/65,9.23%,FLVCR2;NOS3;CYP26B1;CYP27A1;GUCY1B1;CYB5A;BACH1;SRC;CAT
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.39348189845962356,0.9137681042825194,0.5806962025316456,0.9458004069051631,1.0,5/21,17.81%,REV3L;REV1;POLD3;POLB;POLA1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.4389781614490387,0.91368633900224,0.5533980582524272,0.9426415184319711,1.0,2/13,5.58%,SLC7A2;SLC38A7
prerank,ADP binding (GO:0043531),0.375358158711454,0.9112130744789637,0.5876777251184834,0.9444172786252543,1.0,2/25,4.46%,ME1;GCLC
prerank,platelet-derived growth factor binding (GO:0048407),0.4269186725291557,0.9055293027932669,0.575503355704698,0.9535380811423616,1.0,3/11,5.02%,COL6A1;COL3A1;PDGFA
prerank,acetylcholine receptor activity (GO:0015464),0.3858159241210218,0.9027288780849086,0.6024844720496895,0.9562095639240445,1.0,5/22,16.23%,CHRM5;CHRNG;CHRNE;CHRNA4;CHRNB1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.3601420803971134,-0.9014195458061995,0.6120481927710844,0.930271122789542,1.0,5/14,20.26%,BLVRB;QDPR;ALDH1L1;ALDH4A1;PYCR2
prerank,kinase inhibitor activity (GO:0019210),0.35273181892051453,0.9005811496111333,0.5913818722139673,0.9575306661784849,1.0,5/33,8.98%,PARVA;LRP6;DNAJC3;SMCR8;CDKN1B
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.30957798879887966,-0.8996478464856432,0.6190476190476191,0.9283493058737798,1.0,9/25,19.41%,ADAP2;ARAP3;PLEKHA2;PLEK;HIP1;HIP1R;AKT1;PLA2G4E;PHLDA3
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.3172358996696538,-0.8995996675402238,0.6121883656509696,0.9223969900471206,1.0,3/22,1.90%,APOE;HSPG2;PICALM
prerank,growth factor receptor binding (GO:0070851),0.3065367347707681,0.8995659661683293,0.6148238153098421,0.9562849708035958,1.0,18/95,13.07%,PDGFC;SHC1;PGF;EFEMP1;IL10;ITGA5;ARF4;PDGFA;PLSCR1;TRIP6;FGF22;FGF2;ERAP1;AGR2;KLB;SNX4;PIBF1;ITGB3
prerank,protein heterodimerization activity (GO:0046982),0.28691883715041144,0.899561189546335,0.668859649122807,0.9530100222734464,1.0,31/178,14.65%,KCNB2;EXT1;ATP1B1;ADRA1B;AGTR1;ITGB1;BMP6;KCNB1;MEF2A;DDIT3;NR4A2;PDGFA;HEXA;PAFAH1B1;CHUK;TLR6;BHLHE40;CREB3L3;SDCBP2;TCF3;VAPA;MICU1;TAF1;TLR4;ATP1A1;SMC1A;ADD1;TUBB2B;PAFAH1B2;RAN;FXR2
prerank,poly(U) RNA binding (GO:0008266),-0.329621137484341,-0.898428694604403,0.6135135135135135,0.9193243403577905,1.0,2/20,1.39%,RBMS1;ATXN1
prerank,N-acetyltransferase activity (GO:0008080),0.39771234379279863,0.8982408637423118,0.5973377703826955,0.9526522222058975,1.0,5/19,20.78%,ATAT1;EP300;KAT2B;SAT1;GNPNAT1
prerank,cytokine receptor binding (GO:0005126),-0.2381502320349469,-0.8974909176465947,0.6565656565656566,0.9156914474228607,1.0,9/83,6.86%,IL34;TGFBR3;OSMR;IL13RA1;CXCL12;CSF1;IL6ST;IL6R;SDCBP
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.30509129761620224,-0.8974809128179209,0.6151603498542274,0.909796447385843,1.0,11/23,22.93%,CLVS2;WIPI1;PLEKHA5;CLVS1;HIP1;JPH2;HIP1R;PLA2G4E;PHLDA3;SH3PXD2B;SNX14
prerank,steroid hydroxylase activity (GO:0008395),-0.34243818340441856,-0.8967867569395862,0.6240601503759399,0.9055653040949809,1.0,2/16,2.17%,CYP7B1;CYP27A1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.4082375839768945,0.894950512876389,0.5807504078303426,0.956114866508412,1.0,14/14,59.21%,AK9;NME6;CMPK1;AK5;DTYMK;AK4;AK8;CMPK2;NME4;AK1;NME1;NME2;NME3;AK7
prerank,Hsp90 protein binding (GO:0051879),0.35763440695056953,0.8941662718680391,0.5971223021582733,0.9545147988184448,1.0,7/33,13.00%,SLC12A2;PPEF2;UNC45A;TELO2;HDAC8;CSNK2A1;PPP5C
prerank,protein homodimerization activity (GO:0042803),0.26821848565237133,0.8934598086213938,0.7877263581488934,0.9527551824241136,1.0,82/590,13.89%,FOXP2;SLIT2;AOX1;MAP3K5;ABCD3;EXT1;PDGFC;ZBTB16;NECTIN3;CAMK2D;GRHL1;FGFR1;GLCE;MYOM3;ABCG2;LRP6;ADRB2;MID1;ZBTB7B;PON3;NFS1;EEA1;MGLL;BMPR1A;DDIT3;PDCD6IP;RABEP1;PDGFA;NAGA;GDNF;CPQ;NR4A3;HNF4A;CEP131;RAB11FIP3;CHUK;RIPK2;IDE;NR6A1;CARNMT1;MVD;JUP;BHLHE40;HES1;CREB3L3;SDCBP2;SPPL2A;ADAM10;MKLN1;PRPS2;SRGAP2;MMACHC;ACP3;GALE;FBXO4;CHEK2;TCF3;KYAT1;HPS4;COMMD1;NOG;XPNPEP1;ACVR1;GLB1;NPR3;TGFB2;TYW5;XPA;PNPO;CEP57;STAT3;BNIP3;INHBB;ST3GAL2;ZBTB4;S100A10;CCDC66;ADD1;EXD2;TSG101;CEBPB;TPD52
prerank,TBP-class protein binding (GO:0017025),-0.31219004633476644,-0.8928059058050346,0.5984455958549223,0.9090471632056352,1.0,7/21,22.02%,AHR;RUVBL1;DRAP1;RUVBL2;HHEX;PSMC5;THRA
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.3715353761777816,-0.8925323556093164,0.5895691609977324,0.9039097689031557,1.0,6/12,32.42%,TBPL1;RUVBL2;RELA;STAT1;GTF2A1;TBP
prerank,carboxylic acid binding (GO:0031406),-0.2788351814751338,-0.8916490012971723,0.6503267973856209,0.9001417732571925,1.0,19/38,28.21%,NOS3;GRM7;GRIN2B;GRIN3A;GLRA1;PSAP;MAG;GRIN1;NOS1;GLRA3;UBR1;SHMT2;RTN4R;GLUD1;GLDC;PHYH;SHMT1;HIF1AN;SESN1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.3860696687941044,-0.8914971063332237,0.5862831858407079,0.8949460462929569,1.0,2/10,4.79%,KDM7A;KDM2B
prerank,PDZ domain binding (GO:0030165),0.3173520963937546,0.8890021230626086,0.6167979002624672,0.9588922943183658,1.0,11/61,10.66%,CRIM1;CXADR;CIT;FZD7;ERC1;ATP2B4;KIDINS220;NSF;FZD2;SLC26A6;TBC1D10A
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.4141536466508098,0.8881148362290059,0.5760135135135135,0.9575393020610086,1.0,2/12,3.99%,PGF;ITGA5
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.28499720336735157,-0.8854427851415398,0.6575342465753424,0.9026700170152222,1.0,12/35,19.46%,LYN;PEAK1;TNK2;PTK2;TEC;SRC;BMX;ABL2;FES;SYK;HCK;TXK
prerank,nuclease activity (GO:0004518),0.32447119236575417,0.885338127316342,0.6338797814207651,0.9598449605294631,1.0,27/52,30.03%,N4BP2;PLSCR1;STK31;RNASE6;DFFB;DIS3L2;DDX1;ERN2;WRN;REXO4;RNASE7;MRE11;REXO1;N4BP1;RNASEH1;RNASEH2A;APEX1;ERCC5;EXO1;NTHL1;ZC3H12A;RNASE12;ANG;DNASE1L1;PARN;DNA2;EXOG
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.33878934944022937,0.8851880697410579,0.6164978292329957,0.9569312277883045,1.0,5/38,6.41%,ANXA2;SLPI;SERPINB9;SERPINB7;SERPINE2
prerank,pre-mRNA binding (GO:0036002),0.3602660788268455,0.884313120504186,0.6253968253968254,0.9555077694355699,1.0,5/28,13.98%,DDX5;CELF1;U2AF1L4;SRSF6;HNRNPL
prerank,poly-pyrimidine tract binding (GO:0008187),-0.3102082876207375,-0.8829697309934916,0.6243093922651933,0.9025481793584793,1.0,2/23,1.39%,RBMS1;ATXN1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.41518509598000675,0.8808695891619993,0.6105263157894737,0.9590061523833987,1.0,4/13,12.76%,EZR;GSK3B;CSK;PRKAR2A
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.2982397934402011,0.8808425314766863,0.6654456654456654,0.9558910428559336,1.0,17/100,10.75%,CYTH3;ARAP1;ARAP2;WIPI2;SNX24;PLEKHA4;GOLPH3;ZFYVE1;RLBP1;GAB2;IQGAP1;ARFIP1;OSBPL5;DAPP1;ZFYVE26;COMMD1;PARD3
prerank,histone demethylase activity (GO:0032452),0.35734885095880753,0.8799163725018766,0.6115444617784711,0.9545348164951466,1.0,10/27,18.95%,JMJD1C;RIOX2;KDM1A;KDM4D;KDM3B;FBXL19;JMJD6;KDM6B;KDM2A;RIOX1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.42720347789268587,0.8797178637963194,0.5942028985507246,0.9517325534007557,1.0,7/10,32.32%,B4GALT1;B4GALT7;B3GALT6;A3GALT2;B3GALT1;B4GALT6;B3GALT5
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.33800278363471103,-0.8783200877189452,0.633495145631068,0.9065899371415092,1.0,3/15,19.32%,CCR9;CX3CR1;CCR5
prerank,GTP binding (GO:0005525),0.28225686353301854,0.8782014956967116,0.6875,0.9517434891492813,1.0,35/172,16.81%,RHOJ;ATL3;MRAS;NRAS;KRAS;GNL1;RAP1A;BMS1;ARF4;RAB6A;ARF3;ARHGEF5;ARL3;RAP2C;ATL2;RHOQ;RAB27B;RIT1;EIF2B2;RHOBTB1;CDC42;ARL8A;GTPBP4;RHOA;TUBB2B;LSG1;RAB42;RAN;RAB5A;RRAS2;RND3;DIRAS1;RRAGB;GBP6;RAB22A
prerank,general transcription initiation factor binding (GO:0140296),-0.2930508207211735,-0.8766362576194455,0.6155913978494624,0.9048149756189715,1.0,8/25,22.02%,AHR;RUVBL1;DRAP1;RUVBL2;HHEX;RELA;PSMC5;THRA
prerank,thioesterase binding (GO:0031996),-0.3730211280987376,-0.8753181848442004,0.6338028169014085,0.902209404051333,1.0,5/11,23.41%,ADRA2A;RAC1;TRAF2;ARF6;TRAF4
prerank,nucleoside-triphosphatase activity (GO:0017111),0.27393311288722855,0.8750493612280599,0.7375132837407014,0.9550558966278512,1.0,48/248,16.33%,ARHGDIB;RHOJ;ATL3;MRAS;NRAS;KRAS;GNL1;RAP1A;BMS1;RAB43;DYNC1I1;VCP;RAB6A;CLU;TDRD9;RAP2C;ATL2;RAB18;KIF1C;KLC1;RHOQ;SWSAP1;RAB27B;GNA13;RIT1;GFM2;SAR1B;RHOBTB1;CDC42;GNG8;GNB3;ARL8A;GTPBP4;RHOA;CHD1L;LSG1;RAB42;RAN;RAB5A;RRAS2;RND3;RAB17;DIRAS1;DHX9;NKIRAS2;RRAGB;GBP6;GSPT1
prerank,lipoprotein particle receptor binding (GO:0070325),-0.2930595825789114,-0.8748164685852093,0.6441717791411042,0.8978642427921795,1.0,3/27,1.90%,APOE;HSPG2;PICALM
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.40287733760132105,0.8719929187231036,0.6275510204081632,0.9579145673794783,1.0,3/13,5.02%,PDGFC;ITGA5;PDGFA
prerank,four-way junction DNA binding (GO:0000400),0.3895390961570337,0.8711503747653747,0.6247906197654941,0.9563746426821119,1.0,7/17,24.03%,ABL1;RAD51C;FANCM;WRN;YY1;XRCC2;HMGB2
prerank,phosphoric diester hydrolase activity (GO:0008081),0.34125546467171153,0.870255109519093,0.6511627906976745,0.9549422527606091,1.0,4/35,5.18%,PLCE1;MPPED2;PLCB3;APEX2
prerank,myosin V binding (GO:0031489),0.3977933699832037,0.8671297982967745,0.6180555555555556,0.9580688140460587,1.0,2/15,9.35%,RAB6A;RAB27B
prerank,exonuclease activity (GO:0004527),0.31643842588843174,0.8663376265397306,0.6442307692307693,0.9564947148674872,1.0,15/46,22.38%,REV3L;DXO;APEX2;CNOT7;APLF;EXOSC7;REXO2;EXD2;WRN;EXOSC5;REXO4;MRE11;REXO1;EXOSC4;APEX1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.40540055550829707,0.8634291636153829,0.6206322795341098,0.9588359122247833,1.0,2/13,11.47%,EHHADH;EBP
prerank,dynactin binding (GO:0034452),0.41412188301157676,0.8628403263926431,0.6219931271477663,0.9569546317038866,1.0,2/12,5.93%,GSK3B;PAFAH1B1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.36861162540036396,0.8619952740581637,0.6309904153354633,0.9554598930636933,1.0,5/22,14.10%,ATP2C2;ATP6V0A4;ATP6V0A1;ATP6V0E1;ATP6V0D1
prerank,RNA binding (GO:0003723),0.25712767312284934,0.8599747816099589,0.941,0.9563459393541753,1.0,332/1321,22.45%,MSI2;STRBP;SLTM;RNMT;TES;SAMD4A;SPATS2L;MBNL1;FNDC3A;DDX5;EIF4G3;EZR;AHNAK;RBM47;RBFOX2;DSP;FLNB;GPATCH8;RPSA;CTNNA1;ANXA2;GOLGB1;ZCCHC24;LARP1B;PURG;EIF4G1;HOXB6;YBX3;BMS1;DUSP14;DIAPH1;DXO;RBM6;POLR1G;CAST;L1TD1;CEBPZ;TDRD3;IGHMBP2;HDLBP;ZBED4;VCP;NUDT4;TCF20;SLPI;SYNCRIP;PRRC2C;RPP38;ERI3;LUC7L2;NUFIP2;FAM120C;LARP4B;MBNL2;MOV10;SMG6;BCLAF1;TDRD9;SREK1;PNISR;TRIP6;MRPL32;MRPL14;SON;PABPC4;R3HDM2;CCDC9;HNRNPH1;UTP6;ZCCHC8;CELF1;DDX19B;JUN;PDAP1;MRPL21;RBM34;KIF1C;MARK2;YARS1;DDX42;RBM28;KDM1A;ZC3H12D;FUS;SMG1;KTN1;NOL11;ANKHD1;FDPS;EIF2AK4;ZFR;ALG13;CASC3;SRRM2;USP10;TCERG1;PCBP4;SCAF8;NIP7;WDR3;RDX;NOC3L;DHX57;MRPS31;SNTB2;LBR;PUS10;SEC63;EXOSC7;MKRN1;PRPF3;SERBP1;PPIG;SRSF5;BRIX1;SRSF6;CS;LACTB2;ZC3H7A;CSNK1E;TRIM25;RPF1;PKN2;RBM25;SF3B2;SF3B1;ANXA11;WDR43;NXF1;SRSF12;ELP5;SRRM1;RBMX;EBNA1BP2;NANOS2;ETF1;BZW1;GTPBP4;DDX55;RBM26;TYW5;IMMT;FNDC3B;RAD51AP1;THOC2;PRPF38B;ERH;MTDH;PRPF40B;STAT3;SCAF4;RBM8A;RTF1;BAZ2A;RBMS3;PLEC;SMC1A;SRPK1;LSM2;RBM39;XRCC5;ADD1;SRSF11;CPNE3;EWSR1;DUSP11;KMT2C;FARSA;DDX11;NUDT7;DDX17;NCOA5;TRMT1L;ZC3H14;LSM14B;C1D;LRP1;TRAP1;SNRPD3;HNRNPL;MRPS28;MRPS35;PNLDC1;SECISBP2L;PUM2;DDX1;RAN;FXR2;THOC5;SNRNP70;PUM1;TAF15;WDR75;MATR3;EIF4E2;NOSIP;MTO1;UTP11;MRPL20;AATF;SEPSECS;LLPH;RBM27;ARCN1;DROSHA;TCP1;SNW1;JMJD6;DHX9;MRM1;PRRC2A;MEX3B;GSPT1;PRR3;PRKDC;SCAF11;TOP1;FLNA;MCAT;RCAN3;PDCD11;UBE2N;DNAJC21;DALRD3;ARHGEF1;GPKOW;ZNF346;ZC3H4;EDC3;FAM50A;MRPS27;MYEF2;HUWE1;YTHDF3;TRMT10B;MTIF2;YY1;MRPS30;NELFE;NOP58;TRA2B;TNRC6A;NOL3;EIF2S2;USO1;SRRT;ZFP36L1;REXO4;PWP2;ATXN2;PINX1;MRPS23;YTHDF2;NYNRIN;RC3H2;ZC3H11A;FASTKD1;RBM4B;PTPN1;MEX3C;DDX43;LONP1;CPSF7;PABPC1;CWC22;PHF5A;CHTOP;HMGN2;ZNF326;GRSF1;ALKBH5;ZC3H15;SUGP2;LRPPRC;CHD2;EIF4G2;DDX47;RAE1;DHX32;LUC7L;FAM32A;UTP4;PPIL4;SYNE1;NOP2;ZCCHC7;MRPL9;RTCA;KCTD12;PUM3;PRPF6;HNRNPM;MEPCE;TRUB2;HTATSF1;DDX56;NVL;N4BP1;DDX52;SUMO1;DCAF13;NUP98;ZCRB1;EIF3A;UTP14A;PSIP1;MRPS24;PHF6;EIF4ENIF1;NCBP3;NUDT21;HNRNPUL1;ALKBH8;HNRNPA3;RBM5;ZC3H18;CPSF4;RNASEH1;RRBP1;PUS7;EIF3E;CSDE1;RPN1;SNRPD2;SNRPD1;DDX18;SAFB2;RBM33;DCP1A;APEX1;FMR1;SRPRA
prerank,kinase activity (GO:0016301),0.2874086397950323,0.8594692145523455,0.7004716981132075,0.9542485246237782,1.0,16/109,11.62%,STK39;IP6K2;GSK3B;ABL1;PAPSS2;TRRAP;SHPK;RFK;ETNK1;IP6K3;PPIP5K2;MTOR;PKN2;TAF1;CSNK2A1;DGKA
prerank,LRR domain binding (GO:0030275),0.4006779280126743,0.8593673144492262,0.6193771626297578,0.951431689012292,1.0,7/14,17.73%,PAWR;DDIT3;ERC1;MRTFA;ZXDC;AATF;LRRFIP2
prerank,DNA replication origin binding (GO:0003688),0.3654000979941414,0.8579271706180971,0.640502354788069,0.9511396144788865,1.0,10/23,27.65%,MCM7;DDX11;ORC5;DHX9;MCM9;POLA1;MCM6;MCMDC2;ORC2;MCM2
prerank,cysteine-type peptidase activity (GO:0008234),0.2972907348621554,0.856566353101133,0.6785714285714286,0.9507232990316357,1.0,14/73,12.09%,USP13;USP46;CAPN2;USP24;USP2;OTUD7B;USP49;USP7;USP10;USP33;USP34;USP25;USP21;USP47
prerank,chemokine binding (GO:0019956),0.34652213992662617,0.8551614985975448,0.6511278195488722,0.9503158611325758,1.0,9/30,22.76%,ITGB1;ITGAV;FGF2;CXCR4;ITGB3;PDPN;CCR1;CXCR6;PLP2
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.27500302632292073,-0.8549046652098897,0.6947040498442367,0.9343836156837749,1.0,11/34,20.51%,CALM1;RICTOR;IGF2;CALM3;ETAA1;ALS2;INCENP;STK3;PARP16;CCNK;CDK5R1
prerank,MHC class II protein complex binding (GO:0023026),0.4033392459505959,0.8540490874703419,0.6178010471204188,0.9494818584001923,1.0,1/11,1.46%,ATP1B1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.40742392614321593,0.8533503464522593,0.618421052631579,0.9478974020901179,1.0,2/11,8.42%,APEX2;APLF
prerank,tubulin binding (GO:0015631),0.2650024688378925,0.8531226727565895,0.7951933124346917,0.9453857885897737,1.0,44/296,12.46%,RP1;MAPRE2;NDRG1;EZR;KIF13A;UNC5C;TBCE;FMN1;MTUS1;MID1;GAS2L2;CAPN6;HDGFL3;NDEL1;DYNC1I1;NCALD;MAP7D3;PAFAH1B1;CLIP1;KIF1B;ARL3;TTLL2;KIF1C;FGF13;SPEF1;CEP295NL;VAPA;BRCA2;BCAS3;RMDN1;KIF27;TUBGCP4;WASHC1;KIF2C;ARL8A;BEX4;TOGARAM1;SETD2;CEP44;TTLL6;TUBGCP5;KIF7;CEP57;KIF9
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.3711566028105085,-0.8527307715685948,0.6608315098468271,0.9332872697742088,1.0,4/10,14.71%,CACNA1D;CACNA1B;CACNB4;CACNB1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.34780033734799287,-0.8524874424630206,0.6603325415676959,0.9281430217564127,1.0,2/12,5.54%,CTSH;NOD1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.3879088496135782,0.8523003144780448,0.6409807355516638,0.9441681382107323,1.0,8/15,29.95%,KMT2C;KMT2D;ASH2L;SETD1B;KMT2A;WDR5;SETD4;SETD1A
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.35513901458741715,-0.8521286149341138,0.6415929203539823,0.923383178816377,1.0,7/12,29.08%,PIK3R6;PIK3C2A;IPMK;PIK3CD;PIK3CG;PIK3CB;PIK3C2G
prerank,P-type ion transporter activity (GO:0015662),0.3973828190480132,0.8503635596061493,0.6044905008635578,0.9446316246169963,1.0,2/12,7.46%,ATP2C2;ATP2B4
prerank,MAP-kinase scaffold activity (GO:0005078),-0.35258140439099106,-0.8454750209313844,0.6591422121896162,0.9312826327931909,1.0,2/11,1.64%,KSR1;SH3RF1
prerank,gamma-tubulin binding (GO:0043015),0.36068934599600777,0.8397048479347774,0.6547987616099071,0.9611670889874532,1.0,4/22,12.19%,NDRG1;BRCA2;TUBGCP4;TUBGCP5
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.3447521726580924,-0.8388486762971415,0.6872037914691943,0.9394446494693384,1.0,7/13,29.08%,PIP5K1B;PIK3C2A;PIK3CD;PIK3CG;PIK3CB;PIP4K2B;PIK3C2G
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.3471237182728537,-0.8373470600795275,0.6602870813397129,0.9370662965386318,1.0,3/11,24.69%,SLC22A4;SLC22A5;SLC22A3
prerank,endopeptidase inhibitor activity (GO:0004866),0.28595679935748175,0.8372527503790598,0.7077509529860229,0.9628150634562064,1.0,12/82,11.05%,NGF;ANXA2;BIRC7;CAST;BIRC6;SLPI;SERPINB9;SERPINB7;SERPINE2;TIMP2;UBE2Z;SERPING1
prerank,cytokine receptor activity (GO:0004896),0.29007706455380794,0.8367820990004771,0.7179802955665024,0.9607162437499779,1.0,4/83,2.21%,F3;IL17RE;CD44;IL22RA1
prerank,nucleosomal DNA binding (GO:0031492),-0.2967350727743296,-0.8361523904130824,0.7142857142857143,0.9339015809902939,1.0,6/21,20.27%,MBD2;ACTB;RCC1;HDAC2;SMARCE1;H1-0
prerank,phosphatase activity (GO:0016791),0.29481401642712024,0.8353546111526567,0.7119496855345911,0.9602896361429581,1.0,14/73,14.82%,PLPPR2;PLPP3;DUSP16;NANP;OCRL;DUSP10;ACP3;DUSP5;PLPP1;PPP5C;LPIN2;DUSP11;DUSP12;ARMT1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.3494842762152824,-0.8330094401089249,0.6817155756207675,0.9294956445931831,1.0,4/11,29.46%,PFN1;GRPEL1;HSPBP1;HSPH1
prerank,adenyl nucleotide binding (GO:0030554),-0.3494842762152824,-0.8330094401089249,0.6817155756207675,0.9294956445931831,1.0,4/11,29.46%,PFN1;GRPEL1;HSPBP1;HSPH1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3294435541610134,0.8329265999923681,0.674074074074074,0.9616815714770999,1.0,15/33,27.50%,ERI3;CNOT7;ANGEL1;EXOSC7;DIS3L2;REXO2;EXD2;PNLDC1;EXOSC5;EXOSC4;ANGEL2;ERI2;TOE1;NOCT;PNPT1
prerank,signal sequence binding (GO:0005048),-0.2615977204053077,-0.8327103652721013,0.7537091988130564,0.9249941709725787,1.0,5/35,14.03%,CEMIP;PEX5L;CAT;IPO5;KPNA2
prerank,double-stranded RNA binding (GO:0003725),0.2916062425384791,0.8302035561100046,0.7283163265306123,0.9634691416224173,1.0,2/70,0.89%,STRBP;MBNL1
prerank,neuropeptide receptor activity (GO:0008188),-0.27240780880454846,-0.8296199603971974,0.7363896848137536,0.9257189944122219,1.0,15/29,40.72%,GPR37;SORCS2;NPY1R;NMUR2;GRPR;KISS1R;SORCS1;NPY5R;GPR143;NPY2R;SSTR1;NMUR1;NTSR1;NPFFR1;GAL
prerank,phosphatidic acid binding (GO:0070300),0.3654417112730041,0.8280772563518648,0.677115987460815,0.9644403622294527,1.0,3/19,3.84%,MARK1;PITPNC1;RAPGEF6
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.33660933089981393,0.8279025497217734,0.691044776119403,0.9618396738651614,1.0,9/30,17.90%,BIRC7;CAST;BIRC6;SERPINB9;UBE2Z;BIRC3;PRDX3;CARD16;NOL3
prerank,endodeoxyribonuclease activity (GO:0004520),0.3541498123656089,0.8263456525408585,0.6915739268680445,0.9618526083726127,1.0,10/20,30.03%,APLF;ERCC1;MBD4;RBBP8;MRE11;APEX1;ERCC5;EXO1;DNA2;EXOG
prerank,tumor necrosis factor receptor binding (GO:0005164),0.38741498418380826,0.8218651121679017,0.6561338289962825,0.9667880578573735,1.0,3/12,13.94%,TNFSF11;TRAF5;TRAP1
prerank,N-acyltransferase activity (GO:0016410),-0.26048757812686785,-0.8216964033690501,0.7420382165605095,0.9353066782645038,1.0,7/32,18.60%,CERS4;TGM2;NMT2;CERS1;PLA2G4E;CERS2;SMARCE1
prerank,actin monomer binding (GO:0003785),-0.29159678554918733,-0.8212230314395491,0.7236842105263158,0.9311046755705162,1.0,6/22,13.76%,MTSS1;NOS3;TMSB4X;TMSB10;ABL2;PFN1
prerank,glycine binding (GO:0016594),-0.3467845768178926,-0.8207198955325405,0.7146118721461188,0.9268784857739575,1.0,5/11,18.47%,GRIN2B;GRIN3A;GLRA1;GRIN1;GLRA3
prerank,ATPase activator activity (GO:0001671),0.35296543241124473,0.818779472313777,0.680064308681672,0.9694167921538366,1.0,4/20,12.29%,ATP1B1;TOR1AIP1;DNAJB6;DNAJC19
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.37710044011473387,0.817086276858872,0.6672413793103448,0.969419129626787,1.0,3/13,17.67%,METTL1;TRMT1L;TRMT10B
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.332260868503376,-0.8169924972501766,0.6967592592592593,0.9283603609367431,1.0,2/12,7.42%,ENTPD1;ENTPD5
prerank,phospholipase binding (GO:0043274),-0.32766092510249956,-0.813936096902059,0.7368421052631579,0.9289019206063774,1.0,4/13,16.35%,ARHGAP6;SRC;BLNK;SYK
prerank,pentosyltransferase activity (GO:0016763),-0.25635172635012793,-0.8136746312130069,0.7645161290322581,0.9243077458836144,1.0,7/36,9.82%,PARP14;ART3;PARP8;PARP11;PARP1;TIPARP;LACC1
prerank,protein kinase regulator activity (GO:0019887),0.27373223735800745,0.8114521531117116,0.7685643564356436,0.9763532448055611,1.0,21/95,17.92%,PARVA;CCNA2;WNT11;WNK1;DNAJC3;FGF13;KIDINS220;MARK2;SMCR8;CCNL2;CDKN1B;PRKAR2A;CAB39;STK11;ELP4;CCND3;TAOK3;FAF1;GMFG;GPRC5A;CCNYL1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.32111843802897083,0.8091462330074833,0.72,0.9775454044422621,1.0,10/34,25.29%,SMYD2;SETD2;METTL21C;EHMT2;EHMT1;EEF1AKMT1;CAMKMT;METTL21A;EZH2;KMT5A
prerank,hexosaminidase activity (GO:0015929),0.3911774040198813,0.8088958928796437,0.6846689895470384,0.9751312104372328,1.0,4/12,10.89%,NAGA;HEXA;SPAM1;HYAL3
prerank,voltage-gated chloride channel activity (GO:0005247),0.39893003414367656,0.8081648283024866,0.7092198581560284,0.9735096497125912,1.0,1/10,2.80%,ANO6
prerank,mannosyltransferase activity (GO:0000030),0.34474740841286267,0.8075995833964759,0.6976377952755906,0.9716858408443755,1.0,1/21,0.65%,TMTC1
prerank,transferrin receptor binding (GO:1990459),0.38822290006267446,0.8044489772065865,0.6843971631205674,0.9743787756455543,1.0,4/10,20.05%,CHUK;SNX4;SNX2;HFE
prerank,adenyl ribonucleotide binding (GO:0032559),0.2466548060215176,0.8032325537850808,0.8511530398322851,0.9735744746925717,1.0,31/291,8.75%,ME1;MAP3K5;ABCD3;MARK1;MPPED2;WNK1;PDE10A;MKNK2;EIF4G1;SMC4;P2RX2;ABL1;BMPR1A;GCLC;IGHMBP2;SIK3;TLK1;TGFBR1;N4BP2;SIK2;HACL1;P2RX4;PFKP;IDE;MARK2;DYRK2;PPIP5K2;CARS2;PRPS2;CDC42BPG;DYRK3
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.3903972550216697,0.8011554593666288,0.7083333333333334,0.9743196825596636,1.0,4/12,12.87%,SHC1;IRS1;GAB2;TRADD
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3266915024965463,0.801027296980555,0.7151248164464024,0.9717240142114588,1.0,9/27,26.42%,POLR1A;CRCP;POLR1H;POLR3B;POLR1F;TERT;POLR3K;POLR1D;POLR1C
prerank,DNA secondary structure binding (GO:0000217),0.32346032496195504,0.8009327583804693,0.7181409295352323,0.9690997923320326,1.0,13/31,24.03%,ABL1;RAD51C;RAD51AP1;FANCM;RBBP8;XPC;WRN;YY1;CLSPN;KMT2A;XRCC2;ERCC5;HMGB2
prerank,histone deacetylase binding (GO:0042826),0.27147051376842457,0.7997578875992603,0.7709637046307884,0.968146449329994,1.0,17/88,19.10%,HDAC4;GLI3;HDAC9;MEF2A;CAMTA2;HDAC10;KAT2A;HES1;PKN2;BEX4;KAT2B;LCOR;MAPK8;BRMS1L;IKZF3;MIER2;RBBP4
prerank,bHLH transcription factor binding (GO:0043425),0.3461034442833394,0.7959000524621676,0.6978998384491115,0.9718723749814447,1.0,5/19,9.43%,ISL1;KDM1A;CREBBP;BHLHE40;TCF3
prerank,channel activity (GO:0015267),0.3080676036407935,0.7950006923306554,0.7086834733893558,0.9706550940276917,1.0,4/41,8.55%,TMEM120A;AQP6;CHRNG;MCUB
prerank,nuclear receptor coactivator activity (GO:0030374),-0.22894780767849035,-0.7929067309548963,0.8326996197718631,0.9541600232825952,1.0,11/52,17.39%,TACC1;NCOA1;PPARGC1B;ETS1;PPARGC1A;WDR77;ELK1;RBM14;CNOT9;MED30;PKN1
prerank,carboxypeptidase activity (GO:0004180),0.3107809325169098,0.7906898273590481,0.7374810318664643,0.9749916501488785,1.0,6/35,7.58%,CPA5;CPVL;CPA4;CPA3;SCPEP1;CPB1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.3808455373234269,0.7864521458214754,0.7060931899641577,0.9789750782770135,1.0,5/10,25.02%,CDKN1B;KAT2B;CDKN2D;HEXIM2;CDKN1A
prerank,kinase activator activity (GO:0019209),0.3163127357097279,0.786299368263301,0.7533834586466165,0.9764375285728261,1.0,8/30,14.93%,WNT11;WNK1;FGF13;MARK2;BCL10;MOB1B;CAB39;STK11
prerank,ribosome binding (GO:0043022),0.2963431375244792,0.7833964100245727,0.7459677419354839,0.9782949928380215,1.0,17/46,30.77%,RPSA;IGHMBP2;SERBP1;ETF1;MRPS27;YTHDF3;NCLN;EIF6;FMR1;SEC61A2;CCDC47;YTHDF1;ZC3H12A;SEC61A1;NAA15;EIF3C;MTIF3
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2381198459733962,0.7821149774746706,0.9164118246687054,0.9774478842236392,1.0,76/431,16.56%,MAP3K5;ABCD3;MARK1;RHOJ;ATL3;MRAS;NRAS;KRAS;WNK1;MKNK2;EIF4G1;GNL1;SMC4;RAP1A;P2RX2;BMS1;ABL1;BMPR1A;ARF4;IGHMBP2;SIK3;RAB6A;ARF3;TLK1;TGFBR1;ARHGEF5;N4BP2;SIK2;HACL1;ARL3;RAP2C;ATL2;P2RX4;PFKP;IDE;MARK2;DYRK2;PPIP5K2;CARS2;PRPS2;RHOQ;CDC42BPG;DYRK3;RAB27B;RIT1;CAD;EIF2B2;RHOBTB1;CDC42;ACVR1;ARL8A;GTPBP4;RHOA;ATP1A3;ATP1A1;NLK;PPP5C;SRPK1;ABCE1;TUBB2B;LSG1;RAB42;HSPA1L;RAN;RAB5A;STK11;RRAS2;RND3;ERN2;DIRAS1;WNK3;DHX9;RRAGB;GBP6;MAP4K1;TOP1
prerank,mRNA binding (GO:0003729),0.24171757879064437,0.7809955670318949,0.8861702127659574,0.976571621112841,1.0,72/249,23.54%,SAMD4A;DDX5;EIF4G3;RBM47;RBFOX2;EIF4G1;YBX3;DXO;HDLBP;SLPI;SYNCRIP;LUC7L2;AUH;LARP4B;PABPC4;CELF1;ZC3H12D;SRRM2;PCBP4;SCAF8;SERBP1;SRSF5;SRSF6;RBM25;SF3B1;RBMX;NANOS2;ETF1;THOC2;RBM8A;RBMS3;LSM14B;HNRNPL;SECISBP2L;PUM2;FXR2;THOC5;SNRNP70;PUM1;DHX9;EDC3;MYEF2;YTHDF3;TRA2B;EIF2S2;ZFP36L1;YTHDF2;NYNRIN;RC3H2;ZC3H11A;RBM4B;PABPC1;GRSF1;EIF4G2;LUC7L;PUM3;HNRNPM;N4BP1;NUP98;EIF3A;EIF4ENIF1;NCBP3;NUDT21;RBM5;DCP1A;FMR1;ANGEL2;LARP1;FUBP1;AQR;FYTTD1;MRPS7
prerank,epidermal growth factor receptor binding (GO:0005154),0.3227806239961453,0.7803563493219178,0.7507418397626113,0.974908640976073,1.0,9/25,18.48%,SHC1;EFEMP1;ARF4;PLSCR1;AGR2;SNX4;SNX2;AREG;ATXN2
prerank,thyroid hormone receptor binding (GO:0046966),0.3242449507202971,0.7780860844732712,0.7469512195121951,0.9757860854214806,1.0,7/28,16.54%,JMJD1C;TRIP6;TRIP12;ZNHIT3;BRD8;PRMT2;MED17
prerank,syntaxin binding (GO:0019905),-0.21744942780427634,-0.7777015885673101,0.8841201716738197,0.9737850941559646,1.0,23/61,27.33%,UNC13C;ABCA1;SYT12;DAPK1;SYT9;LRRK2;CPLX1;SYP;STXBP4;SCFD1;BLOC1S6;SNAP25;STX7;UNC13A;TMED10;SYT1;BAIAP3;SYT5;STXBP3;VAMP3;SNAP29;SYT17;SYT2
prerank,titin binding (GO:0031432),0.3655478280264858,0.777483052178053,0.7205387205387206,0.9739748420259103,1.0,1/13,2.01%,CAMK2D
prerank,single-stranded telomeric DNA binding (GO:0043047),0.3805341919075314,0.776876223128031,0.7328519855595668,0.9722462698042026,1.0,2/11,11.37%,STN1;RPA1
prerank,CCR chemokine receptor binding (GO:0048020),-0.25986369025830636,-0.7753607579654921,0.8365384615384616,0.9724106711617054,1.0,19/28,46.41%,NES;CCL19;CCL2;CCL25;NARS1;CCRL2;CCL5;CCL11;CCL4;CX3CL1;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13
prerank,methyl-CpG binding (GO:0008327),-0.2737970357699264,-0.7721567058325015,0.8194070080862533,0.9722798957418672,1.0,7/22,19.73%,MBD2;CXXC4;CXXC5;WDR77;ZBTB33;PRMT1;TET3
prerank,signaling receptor complex adaptor activity (GO:0030159),0.2962930801253145,0.7706352732464329,0.7825464949928469,0.9793588592761626,1.0,5/38,7.52%,SORBS1;SHC1;NCK2;IRS1;GAB2
prerank,transcription coregulator binding (GO:0001221),0.2787569755073076,0.767253311941481,0.8002699055330634,0.9820425115082084,1.0,13/50,17.97%,ZBTB16;CIT;PER2;ZBTB49;WIZ;EHMT2;EHMT1;LCOR;PER3;SUZ12;RORA;ZBTB7A;AR
prerank,cAMP response element binding (GO:0035497),0.37092372545906543,0.7672121682015628,0.7183098591549296,0.979408318382804,1.0,4/10,17.41%,NR4A3;JUN;ATF7;ATF2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2767811625166673,0.7667191848761334,0.7848761408083442,0.9774213088021203,1.0,6/60,6.30%,PPP3CA;PPTC7;PPP1R3C;PPM1H;PHLPP2;PPEF2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.30082211196675523,0.7636864098671888,0.7811594202898551,0.9794269259106517,1.0,9/33,18.00%,RNF19A;RNF185;ARIH1;DCUN1D4;TCERG1;ARIH2;ZMYM2;UBE3D;RNF144A
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.3426022933505535,0.7626244709264632,0.7266666666666667,0.9757428164230537,1.0,4/16,14.10%,ATP6V0A4;ATP6V0A1;ATP6V0E1;ATP6V0D1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.3426022933505535,0.7626244709264632,0.7266666666666667,0.9757428164230537,1.0,4/16,14.10%,ATP6V0A4;ATP6V0A1;ATP6V0E1;ATP6V0D1
prerank,pseudouridine synthase activity (GO:0009982),0.36334494911604387,0.7587955946769289,0.7518382352941176,0.9786550136660872,1.0,7/13,30.30%,RPUSD1;PUS10;TRUB2;PUS7;RPUSD3;RPUSD4;PUS3
prerank,adenylyltransferase activity (GO:0070566),0.3244763817201459,0.7562768959573973,0.7562893081761006,0.9797333876754605,1.0,2/21,4.13%,NMNAT2;ABL1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.3688535859030028,0.7560530449879059,0.7261698440207972,0.9774704562105759,1.0,2/11,9.82%,SGMS2;PIGN
prerank,exoribonuclease activity (GO:0004532),0.35233203165270205,0.755710495291648,0.7367491166077739,0.9753525351859169,1.0,6/12,27.35%,CNOT7;EXOSC7;EXOSC5;EXOSC4;EXOSC1;ZC3H12A
prerank,lysophospholipase activity (GO:0004622),-0.27339778383268964,-0.7527087254949134,0.8125,0.995987106837743,1.0,3/20,9.89%,ENPP2;ABHD12;ASPG
prerank,ribosomal small subunit binding (GO:0043024),-0.2790480371613183,-0.7517629223676285,0.7916666666666666,0.9921164037663843,1.0,4/17,16.86%,CPEB2;EIF4H;EIF1B;PIM1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.3070954238934511,-0.7514987501708149,0.7645687645687645,0.9872772720091623,1.0,1/13,5.01%,FAN1
prerank,retinoic acid receptor binding (GO:0042974),0.3361463864005391,0.7509321911811325,0.7646103896103896,0.979572947860035,1.0,5/17,15.93%,NR4A2;RARG;NRIP1;SNW1;PRMT2
prerank,vitamin D receptor binding (GO:0042809),0.3530048436827348,0.7505465741418372,0.7286432160804021,0.9775470224064933,1.0,4/14,16.54%,MED14;RXRA;SNW1;MED17
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.31048335596907195,-0.7504468969587905,0.7889125799573561,0.9836612435668448,1.0,1/11,3.12%,HCN1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.32868352873218576,-0.7487467329563268,0.7699115044247787,0.9808774146495257,1.0,3/10,15.94%,STAMBPL1;ATXN3;TNFAIP3
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3678362940179526,0.7474947945525594,0.743879472693032,0.9795256847969404,1.0,10/10,63.24%,NAA50;NAA15;NAA16;NAA20;NAA10;NAA80;NAA60;NAA25;NAA11;NAA30
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.30250484681772855,0.7464610330567186,0.7924528301886793,0.9784709115385352,1.0,5/27,15.20%,POLR1A;CRCP;POLR1H;POLR3B;POLR1F
prerank,phospholipase A2 activity (GO:0004623),0.3102942189039087,0.7448924153972442,0.7917304747320061,0.9781654252162661,1.0,4/26,15.95%,PNPLA3;PLA2G4F;PLA2G4A;PLA2G15
prerank,"DNA binding, bending (GO:0008301)",0.3383945696708209,0.7397948585210364,0.7741407528641571,0.9829095465539672,1.0,1/14,1.49%,FOXD1
prerank,microtubule motor activity (GO:0003777),0.272187947588559,0.7349170370043503,0.8170894526034713,0.9871869016782402,1.0,10/51,14.10%,KIF13A;DYNC1I1;KIF1B;DNAH8;KIF1C;KIF27;KIF2C;KIF7;KIF9;APPBP2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.3115161399021357,-0.7339189035997183,0.7944862155388471,0.9958253283142283,1.0,5/12,28.49%,TENT5A;TENT4B;PAPOLG;PAPOLB;PAPOLA
prerank,calcium-release channel activity (GO:0015278),-0.2739773194584867,-0.7330132368525982,0.8567839195979899,0.9920042820913552,1.0,1/17,0.30%,ITPR1
prerank,U6 snRNA binding (GO:0017070),-0.28827727239963175,-0.7327756314918091,0.8255528255528255,0.9872038902634062,1.0,4/14,25.34%,METTL16;PRPF8;LARP7;SART3
prerank,carboxylic ester hydrolase activity (GO:0052689),0.2553678249779752,0.7309785727335285,0.8787878787878788,0.9901147298841833,1.0,15/85,15.95%,PNPLA3;PON3;MGLL;DAGLB;ABHD6;PLA2G4F;GDPD3;ABHD4;APMAP;ABHD5;ABHD15;PAFAH1B2;LCAT;PLA2G4A;PLA2G15
prerank,peptide hormone receptor binding (GO:0051428),0.3517393407961897,0.7304122342962351,0.7539267015706806,0.9882042399625258,1.0,3/11,19.62%,VIP;PTHLH;ADCYAP1
prerank,ribonuclease activity (GO:0004540),0.2647002147509474,0.7277218025472008,0.8430311231393776,0.9893135049165688,1.0,22/56,28.08%,SMG6;CNOT7;ZC3H12D;RNASE6;EXOSC7;DIS3L2;LACTB2;ERN2;EXOSC5;PIWIL4;NYNRIN;RNASE7;N4BP1;RNASEH1;EXOSC4;RNASEH2A;EXOSC1;ELAC2;AGO3;ZC3H12A;RNASE12;ANG
prerank,hyaluronic acid binding (GO:0005540),0.3589313618861343,0.7244672150165045,0.7787456445993032,0.991404442479305,1.0,1/10,1.60%,CD44
prerank,translation elongation factor activity (GO:0003746),-0.2891426320623123,-0.7229015742228307,0.8218527315914489,0.9944155854571977,1.0,5/14,24.55%,EEF1A1;EEF1B2;EIF5A2;EEF2;EEF1A2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.2742410784877948,-0.7208877446694111,0.8777777777777778,0.9917818159613202,1.0,4/18,11.29%,TNFAIP8;SNCA;GAS6;RPS6KA1
prerank,protein kinase activator activity (GO:0030295),0.2599675815569118,0.7202500563322551,0.8533685601056803,0.9943879654632694,1.0,13/60,15.70%,ABI1;WNT11;WNK1;FGF13;MARK2;IQGAP1;MLST8;PAK2;CAB39L;CAB39;STK11;FAM20A;MAP2K2
prerank,disordered domain specific binding (GO:0097718),0.3001366557615929,0.7195686912782541,0.8184615384615385,0.9927088881709349,1.0,3/23,11.30%,FN1;DFFB;RB1
prerank,water transmembrane transporter activity (GO:0005372),-0.30231775462713173,-0.7161664545289617,0.8102678571428571,0.9926775495627794,1.0,2/11,6.29%,AQP4;AQP11
prerank,peptidase inhibitor activity (GO:0030414),0.27934303482668044,0.7126382527545354,0.8294117647058824,0.9994542580966268,1.0,4/33,7.84%,GPC3;CAST;SLPI;TIMP2
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.24694533874628094,0.7105995743901729,0.8988621997471555,0.999522014703793,1.0,8/73,13.03%,EDNRA;NLRP6;BDKRB1;FPR3;MAS1;NPR3;GALR1;CRHR2
prerank,peptidase activator activity (GO:0016504),0.3048031717187234,0.7102936826550224,0.8067092651757188,0.997304631375087,1.0,2/22,4.82%,TANK;VCP
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.2874755126217233,0.7098602158765459,0.8503086419753086,0.9953630962018452,1.0,15/28,31.33%,RPP38;DROSHA;EDC3;RNASEH1;ELAC1;RNASEH2A;APEX1;POP4;POP1;EXO1;ELAC2;AGO3;NUDT16L1;NUDT16;RPP14
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3092854387150762,0.7087838511590708,0.8310708898944194,0.994137489345439,1.0,5/22,16.06%,DUSP16;DUSP10;DUSP5;DUSP12;CDKN3
prerank,C-C chemokine binding (GO:0019957),-0.244639979437155,-0.7083539727280765,0.8767123287671232,0.9973448099678843,1.0,1/22,1.69%,CCR9
prerank,retinoid X receptor binding (GO:0046965),0.3430752649046419,0.7078025749760537,0.8052173913043478,0.9927659691450536,1.0,2/11,6.12%,NR4A2;RARG
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.24841136536990327,-0.7053492212513158,0.8632478632478633,0.995728781342741,1.0,5/21,17.91%,GRM5;GRM1;CHRFAM7A;CHRNA7;ANXA9
prerank,C-C chemokine receptor activity (GO:0016493),-0.25345380430627235,-0.7051307446269427,0.8706896551724138,0.9910574047254797,1.0,1/21,1.69%,CCR9
prerank,acylglycerol lipase activity (GO:0047372),0.34403199597840106,0.7038673318092015,0.8098591549295775,0.9952065929364158,1.0,4/11,18.09%,MGLL;ABHD6;ABHD15;ABHD2
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3061493846699771,0.7033042920820037,0.8220472440944881,0.993382541978134,1.0,2/21,7.45%,EZR;PRRC1
prerank,Tat protein binding (GO:0030957),0.3440750959997727,0.7014555649692488,0.7953020134228188,0.9932290106777478,1.0,2/10,8.85%,MDFIC;SMARCA4
prerank,nuclear import signal receptor activity (GO:0061608),0.31683904726440915,0.701385428366048,0.8085106382978723,0.9907962106334951,1.0,3/15,15.06%,KPNA1;TNPO2;KPNA4
prerank,phosphatase inhibitor activity (GO:0019212),0.30358447829461893,0.699657708529773,0.8381877022653722,0.9903239960531945,1.0,11/20,31.02%,CABIN1;BOD1L1;STYXL1;PPME1;URI1;SAG;PPP1R1B;LGALS3;STYX;ARPP19;MGAT5
prerank,glutathione transferase activity (GO:0004364),-0.24552863672020425,-0.699344530540706,0.8880407124681934,0.9926462009862709,1.0,17/23,48.49%,MGST3;HPGDS;GSTZ1;GSTK1;GSTA3;GSTA4;GSTT1;ALOX5AP;MGST1;LTC4S;GSTP1;GSTA2;GSTT4;GSTM2;GSTT2;GSTO1;GSTM1
prerank,tau protein binding (GO:0048156),0.26881904447384136,0.6987492459006991,0.8615384615384616,0.9888913561982676,1.0,11/40,20.02%,MARK1;GSK3B;CLU;EP300;MARK2;MARK3;PPP5C;PRKAA1;PPP2CB;MAP1A;DCTN1
prerank,exopeptidase activity (GO:0008238),-0.19969578777891028,-0.6982364636515093,0.9335664335664335,0.9888791821192042,1.0,14/50,21.29%,CTSH;ACE;ENPEP;CTSZ;CTSA;DPP4;TRHDE;ACE2;PRCP;DPP10;LNPEP;DPP6;CPM;ZMPSTE24
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.32445533621947753,0.6975592400370958,0.8103756708407871,0.9878586851637228,1.0,1/13,1.78%,ARHGDIB
prerank,pyrophosphatase activity (GO:0016462),-0.208232023899527,-0.6952489365565715,0.9465648854961832,0.9868131957892303,1.0,13/50,21.69%,ENTPD1;ENPP1;ENTPD5;ENPP3;BNIP2;PPA1;LHPP;CILP;DCP2;PLPP5;CILP2;PRUNE2;ENTPD3
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.2925907428198638,0.690222328500448,0.8304,0.9943130246877552,1.0,10/22,26.55%,TAB3;OTUD7B;RNF168;SQSTM1;IKBKE;ZRANB1;MINDY2;WDR81;UIMC1;ZBTB1
prerank,3'-5' DNA helicase activity (GO:0043138),0.3155990183197531,0.6878890815920493,0.8163606010016694,0.9945074133580155,1.0,7/16,21.94%,MCM7;ERCC3;FANCM;DHX9;WRN;RECQL5;MCM6
prerank,nuclear export signal receptor activity (GO:0005049),0.3279052518556667,0.6834217511225864,0.8067978533094812,0.9972309627422847,1.0,4/11,26.23%,XPO1;RAN;EIF4ENIF1;XPO5
prerank,metallocarboxypeptidase activity (GO:0004181),0.27494777218749694,0.6737116047991966,0.8547140649149922,1.0,1.0,4/26,7.58%,CPA5;CPA4;CPA3;CPB1
prerank,CXCR chemokine receptor binding (GO:0045236),-0.2862745621536839,-0.6732427165028101,0.8738317757009346,1.0,1.0,1/11,3.83%,CXCL12
prerank,purinergic nucleotide receptor activity (GO:0001614),0.31138426836057714,0.6724906610957139,0.8165289256198347,1.0,1.0,2/15,7.14%,P2RX2;P2RX4
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.2842241482298241,-0.6719494875130235,0.8938053097345132,0.9994226121006168,1.0,3/10,19.74%,FAN1;ANKRD13A;DNAJB2
prerank,G protein-coupled receptor activity (GO:0004930),0.21091922148771683,0.6701299141168867,0.985945945945946,1.0,1.0,22/239,13.62%,GPR156;GPR4;ADRA1B;ADGRL2;AGTR1;ADRB2;LPAR4;PDGFRL;ADGRG6;SSTR3;BDKRB1;AGTR2;CXCR4;FPR3;MAS1;DRD3;NPR3;CMKLR1;GALR1;CRHR2;OPRL1;ADGRD1
prerank,serotonin receptor activity (GO:0099589),0.28210083016501974,0.6699335917395537,0.8538461538461538,0.9977915447646419,1.0,3/22,12.74%,CHRM5;HTR1B;HTR2B
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.28210083016501974,0.6699335917395537,0.8538461538461538,0.9977915447646419,1.0,3/22,12.74%,CHRM5;HTR1B;HTR2B
prerank,G protein-coupled amine receptor activity (GO:0008227),0.28210083016501974,0.6699335917395537,0.8538461538461538,0.9977915447646419,1.0,3/22,12.74%,CHRM5;HTR1B;HTR2B
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.21951929070416887,-0.668986813576068,0.9281609195402298,0.9973120989667759,1.0,5/26,15.23%,PPP1R1A;SET;PPP1R14A;ENSA;PABIR1
prerank,voltage-gated anion channel activity (GO:0008308),0.30059159334755964,0.6680812457460744,0.8236272878535774,0.9972443886175446,1.0,1/15,2.80%,ANO6
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.2636913449877506,-0.6636627581514173,0.9011764705882352,0.9971552929743785,1.0,2/14,6.83%,CYBA;MICAL1
prerank,histone methyltransferase binding (GO:1990226),0.3222478587435953,0.6614772897247221,0.8419243986254296,1.0,1.0,4/11,22.72%,WIZ;LCOR;CBX1;NOP56
prerank,FMN binding (GO:0010181),-0.2760547449771613,-0.6613758634253812,0.8614318706697459,0.9943686941175219,1.0,1/11,1.83%,NOS3
prerank,endonuclease activity (GO:0004519),0.24483398944624746,0.6600903741804889,0.9205921938088829,1.0,1.0,11/49,19.95%,N4BP2;SMG6;ZC3H12D;APLF;LACTB2;MBD4;ERN2;PIWIL4;REXO4;NYNRIN;MRE11
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.26806071576465623,0.6592088118998096,0.8843226788432268,0.9988800579439274,1.0,7/29,14.68%,CIT;SPRED2;CDKN1B;SFN;PRKAR2A;KAT2B;CDKN2D
prerank,tRNA binding (GO:0000049),0.24975090256998606,0.6585827693060423,0.9046961325966851,0.9970626687190236,1.0,19/43,30.76%,IGHMBP2;EIF2AK4;ELP5;TYW5;SEPSECS;DALRD3;MRPS27;TRMT10B;ALKBH8;AARS1;XPOT;TERT;FARS2;KARS1;TRNAU1AP;THG1L;RPUSD4;NEMF;PTCD1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.2501718825681769,0.6577193956155198,0.9122807017543859,0.9955544419542991,1.0,13/42,26.25%,CCNA2;CCNL2;CDKN1B;KAT2B;CDKN2D;CCND3;CCNYL1;CKS1B;CCNT1;CCNE2;HEXIM2;CDKN1A;CCNF
prerank,Toll-like receptor binding (GO:0035325),-0.2727148769772617,-0.6565392211805002,0.8534883720930233,0.9938778381423838,1.0,2/11,6.39%,DAB2IP;UNC93B1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.30791249504801665,0.6546769349697187,0.8441780821917808,0.9959706847064579,1.0,3/12,14.27%,PAN3;CNOT7;PNLDC1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.2457140977525878,0.6535415666311526,0.9033557046979865,0.9946400412649262,1.0,11/49,14.82%,MPPED2;DUSP16;DUSP10;ACP3;PLCXD3;DUSP5;GDPD3;PPP5C;DUSP11;DUSP12;ARMT1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.2922888173503957,0.6527362124952509,0.8430717863105175,0.9930175996726219,1.0,4/16,24.90%,CDO1;ADI1;ALOXE3;HAAO
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.2664198021836016,0.6522407010990201,0.9131736526946108,0.9911465743710054,1.0,10/27,24.42%,RNF19A;ARIH1;DCUN1D4;ARIH2;ZMYM2;UBE3D;RNF144A;RNF14;ANKIB1;RNF217
prerank,methyltransferase activity (GO:0008168),0.24445965598847866,0.6516186614788689,0.9205921938088829,0.9893761859833259,1.0,13/46,23.16%,CARNMT1;MRM2;METTL4;EHMT1;ARMT1;EEF1AKMT1;NSUN4;NNMT;PRMT8;MEPCE;GAMT;NDUFAF7;FTSJ3
prerank,O-methyltransferase activity (GO:0008171),-0.2873382334969784,-0.6487510552216327,0.8807339449541285,0.9954415355840559,1.0,2/10,20.45%,COMT;CMTR2
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.2532081915348732,0.6485045863881004,0.8946608946608947,0.9899177426543557,1.0,9/38,16.78%,WIPI2;PLEKHA4;ZFYVE1;ZFYVE26;PARD3;SNX12;PLA2G4A;SNX20;ATG2A
prerank,cardiolipin binding (GO:1901612),-0.28067562203823615,-0.646995249297783,0.8866666666666667,0.9922406243783941,1.0,2/10,17.92%,GSDME;GSDMD
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.27171676407283724,0.6458076054458367,0.8842443729903537,0.9900965308278686,1.0,6/24,18.50%,ZDHHC11;ZDHHC23;ZDHHC15;GLUL;GOLGA7;ZDHHC7
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.23856249485319506,0.6439605984048777,0.9301075268817204,0.9894192544961303,1.0,10/49,18.18%,VCP;TAB3;OTUD7B;UFD1;RNF168;SQSTM1;IKBKE;RAD23B;ZRANB1;TNIP1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.24220142347941745,-0.6384123018974414,0.9093078758949881,0.9938295197863213,1.0,8/16,34.05%,INPP5F;MTMR10;MTMR9;MTMR2;MTMR1;MTM1;MTMR4;MTMR7
prerank,store-operated calcium channel activity (GO:0015279),-0.2730274255510318,-0.636359761598701,0.8812095032397408,0.9908076489728852,1.0,4/10,17.61%,TRPC3;TRPC4;TRPC6;ORAI2
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.26275383056991963,-0.6358403618490946,0.9075829383886256,0.9865756284948627,1.0,8/12,51.45%,ELOVL4;GPR88;RRH;GPR52;OPN5;OPN1SW;GNAT2;OPN4
prerank,DNA polymerase binding (GO:0070182),0.27869455775638274,0.6354741895646365,0.8885245901639345,0.9945908442075813,1.0,5/18,18.94%,SMG6;SMARCA4;POLG2;ACD;LONP1
prerank,palmitoyltransferase activity (GO:0016409),0.2597201677204394,0.6341359607059368,0.9009287925696594,0.9934006876378947,1.0,7/28,18.50%,ZDHHC11;ZDHHC23;ZDHHC5;ZDHHC15;GLUL;GOLGA7;ZDHHC7
prerank,SH2 domain binding (GO:0042169),0.25216449880382624,0.6333378752946913,0.9231927710843374,0.9917689661580709,1.0,7/31,16.15%,ABL1;IRS1;AFAP1;SQSTM1;NLK;ARHGAP5;LAX1
prerank,motor activity (GO:0003774),0.22897745854124016,0.6311849235445397,0.9328165374677002,0.9913693986977186,1.0,11/60,14.10%,KIF13A;DYNC1I1;KIF1B;DNAH8;KIF1C;KLC1;KIF27;KIF2C;KIF7;KIF9;APPBP2
prerank,phosphatidylinositol kinase activity (GO:0052742),0.2902971935411715,0.623625000196441,0.8799313893653516,0.9953609478531468,1.0,5/15,24.45%,ATM;PI4KB;PIK3C2B;PIKFYVE;PIK3R3
prerank,mRNA 3'-UTR binding (GO:0003730),0.21798167789468773,0.6226106020431372,0.9676584734799483,0.9939132421392052,1.0,13/79,14.95%,DDX5;YBX3;AUH;LARP4B;PABPC4;CELF1;PCBP4;SERBP1;RBMS3;SECISBP2L;PUM2;FXR2;PUM1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.2850274988542167,0.6189507972875128,0.8841059602649006,0.9944045337666735,1.0,2/15,15.54%,PLA2G4F;PLA2G4A
prerank,regulatory RNA binding (GO:0061980),-0.19292836821144976,-0.6169426834953281,0.9726962457337884,0.9950058997603453,1.0,10/38,24.58%,AGO1;YBX1;AGO4;TLR7;TARBP2;ELAVL1;SPOUT1;ZC3H10;RBM10;ZC3H7B
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.2797395224854557,0.6169031936580736,0.8846815834767642,0.9936569677975334,1.0,3/14,15.53%,MTMR12;MTMR11;SYNJ1
prerank,protein phosphatase regulator activity (GO:0019888),0.22708564086222438,0.6162086293177579,0.9463548830811555,0.9918597848426507,1.0,14/53,17.78%,CABIN1;SHOC2;PPP2R2D;BOD1L1;PPP6R2;RCAN1;STYXL1;PPP2R1B;PPP4R1;PPP6R3;PPME1;PPP4R2;RCAN3;PPP2R5C
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.23282638839841638,-0.6154347142883303,0.9458762886597938,0.9914248733563026,1.0,3/16,12.31%,RPS3;CD38;MACROD1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.2952748761730075,0.6097008318706242,0.8890814558058926,0.9945192419528976,1.0,4/11,28.41%,CHRNA4;CHRNB1;CHRNB2;CHRNA3
prerank,ribonuclease P RNA binding (GO:0033204),0.2960652185127975,0.609601287438527,0.8886925795053003,0.9922918200807795,1.0,1/10,5.54%,RPP38
prerank,NADPH binding (GO:0070402),-0.24993192737479125,-0.605867054335093,0.926829268292683,0.9925861333296946,1.0,3/13,14.21%,KCNAB1;QDPR;CRYZ
prerank,semaphorin receptor activity (GO:0017154),0.2939939166154724,0.6052879274025647,0.9003436426116839,0.9932959300066171,1.0,4/11,20.71%,PLXNA2;NRP1;PLXNA3;PLXNA1
prerank,nucleotidyltransferase activity (GO:0016779),0.2633503692664648,0.5953100467189341,0.9236883942766295,0.9978345665457256,1.0,3/19,13.24%,PAPSS2;MOCS3;REV1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.2460508028132226,-0.5933548707472374,0.9330357142857143,0.994720057236802,1.0,5/11,26.03%,LRRC8A;SLC35B3;SLC25A24;SLC25A42;SLC17A9
prerank,ubiquitin-specific protease binding (GO:1990381),0.2498985293533781,0.592388245923802,0.9159519725557461,0.9975206606593405,1.0,7/19,32.73%,VCP;LCOR;SUMO1;RAD23A;DERL2;SYVN1;RHBDD2
prerank,single-stranded DNA helicase activity (GO:0017116),0.2558509993522651,0.5895395240902345,0.9332298136645962,0.9970277694308751,1.0,7/19,29.77%,MCM7;RFC5;DHX9;MCM6;MCM2;POLQ;DNA2
prerank,chemokine receptor activity (GO:0004950),-0.2034815732081856,-0.5893924620530788,0.9519519519519519,0.9923367679328376,1.0,1/24,1.69%,CCR9
prerank,5'-3' exonuclease activity (GO:0008409),0.2744853972973161,0.5879013099918214,0.9240282685512368,0.9957778509052502,1.0,1/14,3.97%,DXO
prerank,hormone activity (GO:0005179),0.21108576041313995,0.5876970870060663,0.9821428571428571,0.9936310275174731,1.0,3/54,5.09%,INHBA;C1QTNF12;ERFE
prerank,ATPase regulator activity (GO:0060590),0.2300782245537752,0.5859633989645489,0.9646539027982327,0.9925829224862313,1.0,4/38,12.29%,ATP1B1;TOR1AIP1;DNAJB6;DNAJC19
prerank,kinesin binding (GO:0019894),0.24069391176856866,0.5829343749488881,0.9534534534534534,0.9921011499873389,1.0,8/27,22.38%,ARHGEF10;KIF1B;MAPK8IP3;IFT88;SPAG9;PLEKHM2;CROCC;NEK6
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.23893121318095895,-0.5807471259645973,0.9415887850467289,0.9918926732389558,1.0,5/12,26.03%,LRRC8A;SLC35B3;SLC25A24;SLC25A42;SLC17A9
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.24645090032929817,-0.5756039850646888,0.9377880184331797,0.9895125741444436,1.0,2/10,10.30%,FAN1;ANKRD13A
prerank,alpha-tubulin binding (GO:0043014),0.23188029500565557,0.5731916023539724,0.9560761346998536,0.995532192951052,1.0,5/31,11.77%,TBCE;WASHC1;ARL8A;BEX4;SETD2
prerank,MAP kinase kinase activity (GO:0004708),-0.21790460926099434,-0.5613132188947884,0.9670886075949368,0.9909373704270724,1.0,2/15,8.91%,MAP2K6;LRRK2
prerank,neuropeptide receptor binding (GO:0071855),0.25353173855716693,0.560689961508237,0.9454545454545454,0.999956241870915,1.0,14/14,74.67%,SHANK1;NMU;NTS;UCN3;APELA;AGRP;QRFP;GHRH;NPPA;UCN2;GAL;PPY;APLN;NPY
prerank,miRNA binding (GO:0035198),-0.18437707413346766,-0.5548045447979129,0.9814814814814815,0.9888710850063831,1.0,9/30,27.64%,AGO1;YBX1;AGO4;ELAVL1;SPOUT1;ZC3H10;RBM10;ZC3H7B;HNRNPA1
prerank,telomerase RNA binding (GO:0070034),-0.19478380611177742,-0.553981090066826,0.9748603351955307,0.9848044371958331,1.0,10/22,33.71%,SNRPB;TENT4B;DCP2;HNRNPU;EXOSC10;SMG7;SMG5;NOP10;DKC1;NHP2
prerank,tRNA methyltransferase activity (GO:0008175),0.250146071952984,0.5536724899017145,0.9522240527182867,1.0,1.0,5/16,26.37%,TRMT13;TRDMT1;ALKBH8;TRMT12;TARBP1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.2051205430306991,0.5519994388707563,0.9736842105263158,0.9997609060471979,1.0,14/44,25.39%,SMYD2;SETD5;SETD2;EHMT2;EHMT1;KMT2C;KMT2D;ASH2L;SETD1B;KMT2A;EED;EZH2;KMT5A;WDR5
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.22027042896357069,0.543352652188689,0.9737654320987654,1.0,1.0,2/26,8.63%,B3GNT2;B3GNT6
prerank,fibroblast growth factor receptor binding (GO:0005104),0.23364158699716367,0.5416790855918383,0.9722675367047309,0.9997821437478105,1.0,4/21,15.66%,FGF22;FGF2;KLB;FGF18
prerank,nuclear localization sequence binding (GO:0008139),0.23986462119857727,0.5414748627692146,0.9558823529411765,0.9976447684053031,1.0,3/18,15.06%,KPNA1;TNPO2;KPNA4
prerank,microtubule minus-end binding (GO:0051011),-0.22126603856050026,-0.5387784602065636,0.9689737470167065,0.9855381251669657,1.0,6/13,30.41%,MACF1;CAMSAP2;HAUS4;TUBGCP3;CAMSAP1;TUBGCP2
prerank,pyridoxal phosphate binding (GO:0030170),0.23240010549393075,0.5381364265356571,0.9577922077922078,0.9968361295329322,1.0,4/20,21.27%,PYGB;PNPO;OAT;ACCS
prerank,acyl-CoA hydrolase activity (GO:0047617),0.23492480276911443,0.5327419955534352,0.9595959595959596,0.996922822730953,1.0,5/17,25.37%,ACOT8;ACOT13;ACOT12;ACOT9;ACOT1
prerank,neuropeptide binding (GO:0042923),0.22514606568879747,0.5266389449365527,0.9639934533551555,0.9970853307486998,1.0,3/18,21.03%,SSTR3;OPRL1;OPRM1
prerank,endoribonuclease activity (GO:0004521),0.20933011880767427,0.5244676920277141,0.9754335260115607,0.995717549973453,1.0,6/32,18.68%,SMG6;ZC3H12D;LACTB2;ERN2;PIWIL4;NYNRIN
prerank,ribonuclease P activity (GO:0004526),0.25032162937947516,0.5232849548202347,0.9534883720930233,0.9939564251845999,1.0,1/11,5.54%,RPP38
prerank,RNA stem-loop binding (GO:0035613),0.2498569244106322,0.5231474234191869,0.9568221070811744,0.9918245983498615,1.0,5/12,27.35%,DHX9;RC3H2;CSDE1;FMR1;ZC3H12A
prerank,snRNA binding (GO:0017069),0.19820557939053354,0.5218872081738655,0.9833564493758669,0.9900686994332862,1.0,19/42,32.51%,SNRPB2;LSM2;SNRPD3;SNRNP70;MEPCE;RNPC3;CCNT1;HEXIM2;NCBP2;DDX21;TOE1;COIL;LSM8;PRPF31;LSM4;SF3B3;LSM11;SNRNP35;EIF5A
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.24276357010274047,0.49753761136697183,0.974169741697417,0.9953735863605496,1.0,4/10,26.40%,EXD2;TATDN1;APEX1;EXO1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.23714996853206702,0.48466229107751785,0.9709618874773139,0.9965127092374457,1.0,2/10,12.94%,NOX1;DUOX1
prerank,carbohydrate kinase activity (GO:0019200),0.23488400453261007,0.4825179286115989,0.9621993127147767,0.99489711019225,1.0,2/11,10.23%,GALK2;GNE
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.18505957753606084,0.4814924052800963,0.9943899018232819,0.9929846856337892,1.0,12/40,26.82%,CARNMT1;GNMT;METTL4;ARMT1;NNMT;PRMT8;MEPCE;GAMT;METTL18;DPH5;TARBP1;PCMTD2
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.24158912052167442,0.4733286969653441,0.9618181818181818,0.9927043510225618,1.0,2/10,15.29%,ATM;PIK3C2B
prerank,antiporter activity (GO:0015297),-0.16422881846277632,-0.45695028978454505,0.9972375690607734,0.9985599501828747,1.0,6/20,28.45%,SLC35D1;SLC25A11;SLC25A30;SLC35E2A;SLC35E2B;SLC35D2
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.20603342394264937,0.44623334561911193,0.9896193771626297,0.9955999155666092,1.0,1/14,5.54%,RPP38
prerank,transaminase activity (GO:0008483),0.20888086221043836,0.43689677112564873,0.9840142095914742,0.9948207033519756,1.0,3/11,19.90%,BCAT2;OAT;GOT1
prerank,neuropeptide hormone activity (GO:0005184),-0.14542370751931652,-0.41631881444387936,0.9974093264248705,0.9978489360605904,1.0,22/22,85.48%,PENK;NPY;CCK;NMB;PNOC;PPY;GAL;CALCB;UCN;SPX;NPFF;NPPA;GHRH;QRFP;AGRP;CORT;OXT;HCRT;GRP;CRH;ADCYAP1;VIP
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.19692947299705707,0.4160710906064365,0.9899497487437185,0.9953655597565555,1.0,2/12,16.91%,AIFM2;CBR4
